CODE | TEST NAME | SPECIMEN | STABILITY | METHOD | REPORT |
---|---|---|---|---|---|
Z785 | Abortion Panel **CD3 *CD19 *CD16 + CD56 * TNF-alpha *HLA DR, DQA1 & DQB1 (Class II) Typing | 2 mL SERUM + 6 mL EDTA WB + 3 mL Heparinized WB | 18–22°C within 24 hrs | Flow Cytometry, CLIA, PCR | S: Mon 4 pm R: 2 days |
H022 | Absolute Eosinophil Count | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence, VCS | Daily |
H052 | Absolute Lymphocyte Count | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence, VCS | Daily |
H051 | Absolute Neutrophil Count | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence, VCS | Daily |
S220 | Acetyl Choline Receptor (ACHR) Binding Antibody | 2 mL SERUM Avoid general anaesthetic or muscle relaxant drugs 24 hrs prior to sampling. | R 1 week F 4 weeks | RIA | S: Wed / Sat 9 am R: Same day |
RW002 | Acetyl Choline Receptor (ACHR) Blocking Antibody | 2 mL SERUM No Additive Tube | R 14 days F 30 days | RIA | S: By 7th of Month R: 2 - 3 weeks |
RW003 | Acetyl Choline Receptor (ACHR) Modulating Antibody | 2 mL SERUM No Additive Tube Avoid general anaesthetic or muscle relaxant drugs 24 hrs prior to sampling. | R 2 weeks F 6 weeks | Radiobinding Assay | S: By 7th of Month R: 2 - 3 weeks |
RW004 | Acetyl Cholinesterase, Amniotic Fluid | 3 mL Amniotic FLUID Avoid blood contamination Sample to be drawn between 13 -24 weeks gestation | R 21 days F 1 year | Gel Electrophoresis | S: By 7th of Month R: 2 - 3 weeks |
B054 | Acid Phosphatase, Prostatic | 2 mL SERUM Add 2 drops 5% Acetic Acid | R 5 days F 2 weeks | Spectrophotometry | Daily |
B053 | Acid Phosphatase, Total | 2 mL SERUM Add 2 drops 5% Acetic Acid | R 1 week F 2 weeks | Spectrophotometry | Daily |
R040 | ACTH | 2 mL EDTA PLASMA Draw sample between 8-10 a.m Separate plasma & freeze immediately | F 4 weeks | CLIA | Daily |
E016 | Activated Protein C Resistance; APCR | 3 mL CITRATED PPP Separate plasma & freeze immediately | F 2 weeks | Electromechanical Clot Detection | S: Wed 11 am R: Next day |
OS100 | ACTN3 (Sports Gene), Genotyping | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S: Mon 11 am R: 10 days |
Z805 | Acute Kidney Injury Panel *Cystatin C *Neutrophil Gelatinase - Associated Lipocalin (NGAL) *Creatinine, serum *Fractional excretion of Sodium | 5 mL SERUM + 10 mL random URINE | R 1 week F 4 weeks | CMIA, Nephelometry, Jaffe's reaction, Indirect ISE | S: Mon / Wed / Fri 4 pm R: Same day |
Z865 | Acute Leukemia Diagnostic Comprehensive Profile *CBC *Peripheral blood smear *Bone Marrow Examination Panel 1 *Leukemia diagnostic panel : Acute leukemia - T. B or Myeloid *Cytogenetic / Molecular genetic studies for : AML- FISH - t(8;21)(q22;q22.1);RUNX1- RUNX1T1; t(15;17); PML- RARA;inv(16)(p13.1q22)/ t(16;16)(p13.1;q22);CBFB- MYH11; t(9;11)(p21.3;q23.3);MLLT3- | 5 mL EDTA WB + 4 mL Heparinized BONE MARROW + 2 peripheral blood SMEARS + 4 Bone marrow ASPIRATE SMEARS | 18–22°C within 48 hrs | Electrical Impedance, VCS, Microscopy, Flow cytometry, FISH, Karyotyping, PCR Fragment Analysis | S: Mon 11 am R: Sat |
Z775 | Acute Lymphoblastic Leukemia (ALL), Cytogenetics Panel *BCR/ABL or Philadelphia translocation * t(variable;11q23) ; MLL gene breakapart *t(12;21) (p13;q22); TEL/AML1 *Chromosome analysis, Hematological malignancy | 8 mL Heparinized WB + 4 mL Heparinized BONE MARROW | 18–22°C within 24 hrs | FISH, Conventional Karyotyping | S: Daily 6 pm R: 7 days |
Z774 | Acute Myeloid Leukemia (AML), Cytogenetics Panel *t(8;21) or LSI ETO/AML1 * inv (16) (p13q22) or t(16;16) (p13;q22) or CBFB * t(15;17) or LSI PML/RARA *t(variable;11q23) ; MLL gene breakapart *Chromosome analysis, Hematological malignancy | 8 mL Heparinized WB + 4 mL Heparinized BONE MARROW | 18–22°C within 24 hrs | FISH, Conventional Karyotyping | S: Daily 6 pm R: 7 days |
R156 | Adenosine Deaminase; ADA | 2 mL SERUM / PLASMA / BODY FLUID / CSF | R 1 week F 6 months | Spectrophotome try | Daily |
M211 | Adenovirus Antigen for Gastroenteritis. Stool | 5 g Fresh STOOL | R 24 hrs F Unacceptable | ICT | S: Daily 1 pm R: Same day |
M213 | Adenovirus Antigen for Respiratory infections | Nasal SWAB / Nasopharyngeal / BAL / Endotracheal tube SECRETIONS | R 24 hrs F Unacceptable | ICT | S: Daily 1 pm R: Same day |
N126 | Adenovirus, Qualitative PCR | 3 mL EDTA WB / 3 mL CSF | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
OS102 | ADRB2 Genotyping For Beta-2 Agonist Responsiveness | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S: Sat 11 am R: 10 days |
M094 | AFB Identification, Rapid; PNB Test | PURE GROWTH | R 1 month F Unacceptable | Automated Fluorescent | S: Daily 3.30 pm R: 15 days |
P030 | AFB Stain | BODY FLUIDS / TISSUE / SWABS / BONE MARROW / GASTRIC LAVAGE/ URINE / PUS | R 24 hrs F Unacceptable | Fluorescent & Conventional microscopic examination | S: Daily 3.30 pm R: Same day |
R030 | AFP (Alpha Fetoprotein), Maternal | 2 mL SERUM | R 1 week F 2 weeks | CLIA | Daily |
R084 | AFP (Alpha Fetoprotein), Amniotic Fluid | 3 mL Amniotic FLUID | R 1 week F 2 weeks | CLIA | Daily |
F001 | AFP (Alpha Fetoprotein), Tumor Marker | 2 mL SERUM | R 1 week F 2 weeks | CLIA | Daily |
P094 | Albert Stain | THROAT SWABS in Aerobic transport medium / AIR DRIED SMEARS | R 72 hrs F Unacceptable | Gram & Metachromatic staining | Daily |
Z088 | Albumin & IgG CSF | 2 mL CSF | R 72 hrs F 6 months | Nephelometry | S: Mon through Sat by 4 pm R: Same day |
B094 | Albumin CSF | 2 mL CSF | R 72 hrs F 6 months | Nephelometry | S: Mon through Sat by 4 pm R: Same day |
P086 | Albumin, Fluid | 2 mL BODY FLUID | R 72 hrs F 6 months | BCG | Daily |
B039 | Albumin Serum | 2 mL SERUM | R 72 hrs F 6 months | BCG | Daily |
K017 | Alcohol (Ethanol) Screen, Serum | 2 mL SERUM Cleanse collection site with non- alcoholic agent | R 2 weeks F 4 weeks | Alcohol Dehydrogenase UV | Daily |
G184 | Alcohol Ethyl Glucuronide (EtG) & Ethyl Sulphate (EtS), Quantitative, Urine | 5 mL URINE | R 3 days F 1 week | LC-MS / MS | S: Daily by 5 pm R: Next day |
S024 | Aldehyde Chopra Test for Kala Azar | 2 mL SERUM | R 1 week F 2 weeks | Tube Clotting | Daily |
B052 | Aldolase | 2 mL SERUM / Heparinized / EDTA PLASMA | R 5 days F 6 months | Spectrophotometry | Daily |
B175 | Aldosterone / Plasma Renin Direct Ratio | 2 mL SERUM + 3 mL EDTA PLASMA Draw sample between 8-10 a.m Patient Ambulatory or Upright 2 hrs prior to sampling Separate plasma & freeze immediately | F 4 weeks | CLIA | S: Tue / Fri 9 am R: Same day |
U039 | Aldosterone, 24 Hr Urine | 5 mL aliquot of 24 Hr URINE State Total Volume Add Boric Acid, 1 gor100 mL to maintain pH below 7.5 | R 24 hrs F 2 weeks | CLIA | S:Thu 4 pm R:Next day |
R049 | Aldosterone, Serum | 2 mL SERUM Patient Ambulatory / Upright 2 hrs prior to sampling | R 24 hrs F 2 weeks | CLIA | S: Tue / Fri 9 am R: Same day |
E011 | Alkaline Phosphatase (ALP), Isoenzymes | 2 mL SERUM Separate serum within 1 hr | R 48 hrs F 4 weeks | Agarose Gel Electrophoresis | S: Thu 9 am R: Next day |
R121 | Alkaline Phosphatase, Bone Specific | 2 mL SERUM | R 48 hrs F 2 months | EIA | S: Mon 9 am R: Same day |
B041 | Alkaline Phosphatase; ALP | 2 mL SERUM | R 72 hrs F 4 weeks | IFCC | Daily |
G102 | Alkaptonuria, Urine, Qualitative | 10 mL URINE Wrap in aluminium foil to protect from light | R 24 hrs F 72 hrs | Chemical | Daily |
G182 | Alkaptonuria, Urine, Quantitative | 15 mL URINE | R 72 hrs F 4 weeks | Gas Chromatography / Mass Spectrometry | S:Daily by 5 pm R: 5 days |
Z089 | Allergy Comprehensive Profile *Allergy Screen * 7 Allergy Panels * 32 Individual allergens | 6 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: 3 days |
A111 | Allergy Phadiatop, Adult | 3 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: Same day |
A112 | Allergy Phadiatop, Pediatric | 3 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: Same day |
Z092 | Allergy Post Screening Profile * 7 Allergy Panels * 32 Individual allergens | 6 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: 3 days |
A001 | Allergy Screen *Total IgE * PhadiaTop | 3 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: Same day |
Allergy Individual Marker | 3 mL SERUM | R 1 week F 2 weeks | ImmunoCAP Specific IgE | S: Daily by 11 am R: Same day | |
A024 A093 A075 A028 A049 A005 A086 A050 A040 A022 A092 A038 A053 A011 A004 A069 A059 A077 A063 A047 A073 A030 A070 A007 A097 A010 A071 A076 A072 A089 | Acacia Alder Almond Alternaria tenuis Apple Aspergillus fumigatus Bahia grass Banana Beef Bermuda Grass Brinjal Buckwheat Cabbage Cat epithelium & dander Candida albicans Carob Carrot Casein Cashewnut Celery Cheddar Chicken Chickpea Cladosporium herbarum Cocklebur Cockroach Cocoa Coconut Coffee Common Pigweed | 3 mL SERUM | R 1 week F 2 weeks | ImmunoCAP Specific IgE | S: Daily by 11 am R: Same day |
A095 A014 A061 A015 A016 A041 A090 A027 A031 A045 A019 A088 A013 A008 A023 A057 A066 A078 A036 A080 A084 A034 A091 A006 A009 A025 A096 A109 A119 A079 | CottonwoodCow dander Cucumber Dog dander Egg white Egg yolk Elm Eucalyptus Fish Garlic Gluten Goosefoot Horse dander House dust Johnson grass Lemon Lentil Lobster Maize Mango Meadow grass Melaleuca Mesquite Milk Mites Mug wort Mulberry MushroomMussel Mutton | 3 mL SERUM | R 1 week F 2 weeks | ImmunoCAP Specific IgE | S: Daily by 11 am R: Same day |
A094 A035 A032 A046 A048 A054 A067 A051 A021 A056 A062 A003 A058 A064 A039 A060 A087 A098 A029 A074 A082 A120 A037 A020 A017 A052 A055 | Oak Oat Olive Onion Orange Paprika Pea Peach Peanut Pear Pecan Penicillium Notatum Pineapple Pistachio Pork Potato Ragweed Rapeseed Rice Rye Ryegrass Salmon Sesame Shrimp Soybean Spinach Strawberry | 3 mL SERUM | R 1 week F 2 weeks | ImmunoCAP Specific IgE | S: Daily by 11 am R: Same day |
A083 A043 A121 A042 A065 A018 A026 A068 A033 A044 | Timothy grass Tomato Tuna Turkey Walnut Wheat White pine White bean Willow Yeast | 3 mL SERUM | R 1 week F 2 weeks | ImmunoCAP Specific IgE | S: Daily by 11 am R: Same day |
ALLERGY PANELS | 6 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: 3 days | |
Z164 Z684 Z685 Z690 | Animal Panel (Cat epithelium, Cow, Dog & Horse Dander) Asthma / Rhinitis Screening Panel, Adults (Common Ragweed, Dermatophagoides pteronyssinus, Dermatophagoides farinae, Alterneria tenuis, Aspergillus fumigatus, Candida albicans, Penicillium notatum, House dust & Cockroach) Asthma / Rhinitis Screening Panel, Pediatric (Common Ragweed, Dermatophagoides pteronyssinus, Dermatophagoides farinae, Aspergillus fumigatus, Candida albicans, Penicillium notatum, Egg white, Milk & Cockroach ) Eczema Panel for Non- Vegetarians (Wheat, Rice, Peanut, Soybean, Potato, Milk, Dermatophagoides pteronyssinus, Dermatophagoides farinae, Fish, | 6 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: 3 days |
Z689 Z527 Z881 Z091 | Eczema Panel for Vegetarians(Wheat, Rice, Peanut, Lentil, Soybean, Potato, Milk, Dermatophagoides pteronyssinus & Dermatophagoides farinae) Eczema Comprehensive Panel(Egg white, Cow's milk, Fish, Shimp, Wheat, Rice, Peanut, Lentil, Soybean, Chick pea, Lemon, Banana, Mites, Dog dander, Cow dander, Horse dander & Cat epithelium) Food Screening Panel For Indian Population (Cow milk, Egg yolk, Milk powder, Wheat flour, Rice, Soybean, Peanut, Coconut, Apple, Grape, Potato, Spinach, Onion, Cucumber, Chicken, Mustard, Coffee, Ginger, Crab, Shrimp / Prawn) Food Panel 1 (Egg white, Milk, Wheat, Soybean, Fish, Chicken, Rice, Gluten, Shrimp & Peanut) | 6 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: 3 days |
Z691 Z524 Z692 Z693 | Food Panel 2 (Egg white, Milk, Wheat, Soybean, Fish & Peanut) Fruit Comprehnsive Panel(Orange, Apple, Banana, Peach, Mango, Strawberry, Pear, Lemon, Pineapple & Coconut) Fruit Panel 1 (Orange, Apple, Banana & Peach) Fruit Panel 2 (Strawberry, Pear, Lemon & Pineapple) | ||||
Z525 Z882 Z160 | Grass Panel (Bermuda grass, Rye grass, Timothy grass, Meadow grass, Johnson grass & Bahia grass) Inhalation Screening Panel For Indian Population (Timothy grass, Cultivated rye, Corn, Eucalyptus, False ragweed, Carnation flower, Sunflower, House dust Mites, Dermatophagoides farina, Cockroach, Cat, Dog, Pigeon feathers, Chicken feathers, Aspergillus fumigatus, Trichophyton, Cotton yarn, Strawdust, Jute, Sheep wool) Mold Panel (Penicillium notatum, Cladosporium herbarum, Aspergillus fumigatus, Candida albicans & Alternaria tenuis) | 6 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: 3 days |
Z520 Z695 Z523 | Non Vegetarian Panel 1(Pork, Beef, Egg, Turkey & Chicken) Non Vegetarian Panel 2(Fish, Shrimp, Lobster Mussel, Tuna & Salmon) Nut Panel (Pecan, Cashew nut, Pistachio, Walnut, Almond & Peanut) | ||||
Z885 Z522 Z531 | Pediatric Food & Inhalation Panel for Indian Population(Apple, α-lactalbumin, β- lactalbumin, Bovine serum albumin (BSA), Carrot, Casein, Codfish, Egg white, Egg yolk, Hazelnut, Milk, Peanut, Potato, Rice, Soy bean, Wheat flour, Alternaria alternata , Aspergillus fumigatus, Birch, Cat, Caldosporium herbarum, Dermatophagoides farinae, Dermatophagoides pteronyssinus, Dog, Grass Mix (Timothy grass & Cultivated rye), Horse & Mugwort) Pulses Panel (Lentils, White bean & Chick panel) Vegetable Comprehensive Panel (Spinach, Cabbage, Paprika, Tomato, Mushroom, Garlic, Onion, Celery, Carrot, Potato, Cucumber & Brinjal) | 6 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: 3 days |
Z686 Z687 Z688 Z526 | Vegetable Panel 1 Tomato, Yeast, Garlic, Onion & Celery) Vegetable Panel 2 (Tomato, Spinach, Cabbage & Paprika) Vegetable Panel 3(Carrot, Spinach, Potato & Cucumber) Weed Panel (Ragweed, Goosefoot, Common pigweed, Cocklebur, Mugwort & Rapeseed) | 6 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: 3 days |
Z529 Z528 | Wheeze / Rhinitis Comprehensive Panel, Adult(Elm, Bermuda grass, Rye grass, Timothy grass, Johnson grass, Meadow grass, Bahia grass, Alder, Mugwort, Common pigweed, Gluten, Pea, Casein, Housedust, Cocoa, Coffee, Cheddar, Mesquite, Ragweed, Goosefoot, Cat epithelium, Dog dander, Cockroach, Alterneria tenuis, Aspergillus fumigatus, Candida albicans, Penicillium notatum & Cladosporium herbarum) Wheeze / Rhinitis Comprehensive Panel, Pediatric (Elm, Lemon, Egg white, Milk, Rice, Lentil, Pea, White bean, Mesquite, Ragweed, Goosefoot, Cat epithelium, Dog dander, Mites, Cockroach, Alterneria tenuis, Aspergillus fumigatus, Candida albicans, Penicillium notatum & Cladosporium herbarum) | 6 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: 3 days |
Z521 Z161 Z162 | Cereal Panel (Oat, Maize, Sesame, Buckwheat, Rye, Wheat, Rice & Carob) Dust Panel (House dust, Mites like Dermatophagoides Pteronyssinus, Dermatophagoides Farinae & Cockroach) Tree Panel (Acacia, Olive, Willow, Melaleuca, White pine & Eucalyptus) | 6 mL SERUM | R 1 week F 2 weeks | ImmunoCAP | S: Daily by 11 am R: 3 days |
RW009 | Alpha Subunit | 2 mL SERUM No Additive Tube | R 7 days F 28 days | RIA | S: By 7th of Month R: 2 - 3 weeks |
OS103 | Alpha Thalassemia Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Tue 11 am R: 9 days |
OS104 | Alpha Thalassemia Mutation Detection, Prenatal | 4 mL EDTA WB both parents + 10 mL Amniotic FLUID or CVS | R 1 week F Unacceptable | PCR | S: Thu 11 am R: 9 days |
RW006 | Alpha 1 Acid Glycoprotein | 2 mL SERUM No Additive Tube | R 7 days F 6 weeks | Fixed Rate Time Nephelometry | S: By 7th of Month R: 2 - 3 weeks |
B096 | Alpha 1 Antitrypsin Quantitation : AAT | 2 mL SERUM No Additive Tube | R 1 week F 3 months | Nephelometry | S: Mon / Thu 4 pm R: Same day |
RW007 | Alpha 1 Antitrypsin (AAT) Phenotype | 2 mL SERUM No Additive Tube | R 1 week F 4 weeks | Isoelectrofocusing | S: By 7th of Month R: 2 - 3 weeks |
B194 | Alpha 2 Macroglobulin | 2 mL SERUM | R 7 days F 6 weeks | Nephelometry | S: Tue / Fri 4 pm R: Same day |
C001 | Aluminium, Dialysis Fluid | 10 mL DIALYSIS FLUID Metal Free Container Use powderless gloves Patients should refrain from taking antacids & aluminium containing medications prior to specimen collection. | R 1 week F 2 weeks | ICPMS | S: Daily by 6 pm R: Next day |
C002 | Aluminium, Plasma | 3 mL K2EDTA PLASMA Metal Free tube Use powderless gloves Patients should refrain from taking antacids & aluminium containing medications prior to specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 1 week F 2 weeks | ICPMS | S: Daily by 6 pm R: Next day |
C003 | Aluminium, Serum | 3 mL SERUM Metal Free tube Use powderless gloves Patients should refrain from taking antacids & aluminium containing medications prior to specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 1 week F 2 weeks | ICPMS | S: Daily by 6 pm R: Next day |
Z094 | Amenorrhoea Profile * E2 * FSH * LH* Prolactin * Progesterone* TSH | 3 mL SERUM 4 hrs after patient has awakened | R 48 hrs F 6 months | CLIA | Daily |
Z479 | Amenorrhoea / Andrology Screen *FSH * LH * Prolactin | 3 mL SERUM 4 hrs after patient has awakened | R 48 hrs F 6 months | CLIA | Daily |
RW270 | Amikacin | 2 mL SERUM No Additive Tube | R 7 days F 7 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
U033 | 5-Aminolevulinic Acid (5 -ALA), Random, Urine | 10 mL random URINE Protect from light | R 2 weeks F 4 weeks | Column Chromatography | S: Tue / Fri 9 am R: Next day |
U099 | 5-Aminolevulinic Acid (5 -ALA), 24 Hours, Urine | 10 mL aliquot of 24 Hr URINE State Total Volume Protect from light | R 2 weeks F 4 weeks | Column Chromatography | S: Tue / Fri 9 am R: Next day |
G178 | Amino Acid, Non-Ketotic Hyperglycinemia Panel Quantitative, CSF & Plasma | 1 mL CSF + 2 mL Heparinized PLASMA | R 48 hrs F 2 weeks | LC-MS / MS | S: Mon / Wed 5 pm R: 3 days |
G176 | Amino Acid Quantitative, CSF, 45 Amino Acids / Full Panel | 1 mL CSF | R 48 hrs F 2 weeks | LC-MS / MS | S: Mon / Wed 5 pm R: 3 days |
G165 | Amino Acids Quantitative, Blood, 10 Amino Acids *Alanine *Arginine *Citrulline *Glycine *Leucine *Methionine *Ornithine *Phenylalanine *Tyrosine *Valine | 1 drop heel prick blood each on 3 spots of filter paper OR 2 mL EDTA WB | R 1 week F Unacceptable | Tandem Mass Spectrometry | S: Mon / Wed / Fri 4 pm R: 2 days |
G175 | Amino Acids Quantitative, Plasma, 45 Amino Acids / Full Panel | 2 mL Heparinized PLASMA | R 48 hrs F 2 weeks | LC-MS / MS | S: Mon / Wed 5 pm R: 3 days |
G179 | Amino Acids, Maple Syrup Urine Disease (MSUD) Panel, Plasma | 2 mL Heparinized PLASMA | R 48 hrs F 2 weeks | LC-MS / MS | S: Mon / Wed 5 pm R: 3 days |
G106 | Amino Acids Qualitative, CSF | 1 mL CSF | R 48 hrs F 2 weeks | TLC One Dimensional | S: Mon / Wed / Fri 4 pm R: 2 days |
G104 | Amino Acids Qualitative, One Dimensional, Urine | 5 mL First morning URINE | R 48 hrs F 1 week | TLC One Dimensional | S: Mon / Wed / Fri 4 pm R: 2 days |
G105 | Amino Acids Qualitative, Plasma | 2 mL Heparinized PLASMA | R 48 hrs F 2 weeks | TLC One Dimensional | S: Mon / Wed / Fri 4 pm R: 2 days |
G107 | Amino Acids Qualitative, Two Dimensional, Urine | 5 mL First morning URINE | R 48 hrs F 1 week | TLC Two Dimensional | S: Mon / Wed / Fri 4 pm R: 2 days |
G109 | Amino Acids Qualitative, Urine & Plasma | 5 mL first morning URINE+ 2 mL Heparinized PLASMA | R 48 hrs F 2 weeks | TLC One Dimensional | S: Mon / Wed / Fri 4 pm R: 2 days |
G174 | Amino Acids, Quantitative Urine, 45 Amino Acids / Full Panel | 5 mL First morning URINE | R 48 hrs F 2 weeks | LC-MS / MS | S: Mon / Wed 5 pm R: 3 days |
G177 | Amino Acids, Quantitative, Urine & Plasma , 45 Amino Acids / Full Panel | 5 mL first morning URINE+ 2 mL Heparinized PLASMA | R 48 hrs F 2 weeks | LC-MS / MS | S: Mon / Wed 5 pm R: 3 days |
RW012 | Amitriptyline *Amitryptyline *Nortriptyline & Total | 3 mL SERUM >12 hrs post oral dose No Additive tube | R 7 days F Not established | LC-MS / MS | S: By 7th of Month R: 2 - 3 weeks |
Z535 | AML Categorization, PCR *PML RARA t(15;17)(q22;q12) Gene rearrangement *AML ETO t(8;21) Gene rearrangement *Inv 16 ( p13 q22) / t(16;16)(p13;q22) Gene rearrangement | 3 mL EDTA WB or BONE MARROW | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N045 | AML ETO t(8;21) Gene Rearrangement, PCR Qualitative | 3 mL EDTA WB or BONE MARROW | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
B061 | Ammonia | 3 mL EDTA PLASMA Separate plasma immediately | R 3 hrs F 24 hrs | Colorimetry | Daily |
S014 | Amoebic Serology, IgG, Serum | 2 mL SERUM | R 1 week F 2 weeks | EIA | S: Wed / Sat 9 am R : Same day |
K013 | Amphetamine, Screen, Urine | 10 mL random URINE | R 1 week F 2 weeks | Lateral Flow Immunoassay | Daily |
RW013 | Amylase, Isoenzymes *Total Amylase * Pancreatic isoenzymes * Salivary isoenzymes | 3 mL SERUM | R 30 days F 30 days | Enzymatic, Immunoinhibitio n enzymatic | S: By 7th of Month R: 2 - 3 weeks |
U017 | Amylase (Diastase), Urine | 10 mL random URINE | R 10 days F Unacceptable | Spectrophotometry | Daily |
P053 | Amylase, Fluid | 2 mL FLUID | R 4 weeks F 4 weeks | Spectrophotometry | Daily |
B050 | Amylase, Serum | 2 mL SERUM | R 4 weeks F 4 weeks | Spectrophotometry | Daily |
Z018 | Analyzer 18 ; SMA 18 Test Panel *Glucose (F) *Urea *Creatinine *Uric Acid*Cholesterol *SGOT *SGPT *GGTP *Bilirubin,Total *Protein, Total *Albumin *A:G Ratio*Alkaline Phosphatase *Calcium *Phosphorus *Sodium *Potassium *Chloride | 3 mL SERUM + 2 mL Fluoride PLASMA 12 hrs fasting mandatory | R 24 hrs F 1 week | Spectrophotometry, Indirect ISE, Hexokinase | Daily |
Z015 | Analyzer 26 ; SMA 26 Test Panel *Glucose (F&PP) *Urea *Creatinine *UricAcid*Cholesterol *Triglycerides *CPK *HBDH *LDH *SGOT *SGPT *GGTP *Bilirubin, Total *Bilirubin, Direct *Bilirubin, Indirect *Protein, Total*Albumin *A:G Ratio *Alkaline Phosphatase *Calcium *Phosphorus *Sodium *Potassium *Chloride *Amylase | 3 mL SERUM + 2 mL Fluoride PLASMA each for F & PP 12 hrs fasting mandatory | R 24 hrs F 1 week | Spectrophotometry, Indirect ISE, Hexokinase | Daily |
S171 | ANCA (Anti Neutrophil Cytoplasmic Antibodies), IFAIncludes differentiation of c- ANCA & p-ANCA | 2 mL SERUM | R 1 week F 2 weeks | IFA | S:Daily by 11 am R: Same day |
S172 | ANCA (Anti Neutrophil Cytoplasmic Antibodies), IFA in dilutions | 2 mL SERUM | R 1 week F 2 weeks | IFA | S:Daily by 11 am R: Next day |
S048 | ANCA - MPO (Anti Myeloperoxidase antibodies), EIA Corresponds with p-ANCA | 2 mL SERUM | R 72 hrs F 2 weeks | EIA | S:Tue / Thu / Sat 9 am R:Same day |
S047 | ANCA - PR 3 (Serin Proteinase 3 antibodies), EIA Corresponds with c-ANCA | 2 mL SERUM | R 72 hrs F 2 weeks | EIA | S:Tue / Thu / Sat 9 am R:Same day |
Z553 | Androgen Index *Sex hormone binding globulin *Testosterone, Total | 3 mL SERUM | R 1 week F 3 months | CLIA | S:Mon / Thu 4 pm R:Same day |
Z099 | Andrology Panel *FSH * LH * Testosterone Total & Free | 3 mL SERUM | R 48 hrs F 6 months | CLIA, RIA | S: Mon through Sat 9 am R: Same day |
R060 | Androstenedione | 3 mL SERUM | R 24 hrs F 2 months | CLIA | S:Mon / Thu 4 pm R:Same day |
Z009 Y014 Basal Y015 90 min Y017 Customized | Androstenedione Stimulation by ACTH | 3 mL SERUM for each timed specimen. Draw fasting baseline sample; Administer 250 ug synthetic ACTH IV; draw additional sample at 90 min | R 24 hrs F 2 months | CLIA | S:Mon / Thu 4 pm R:Same day |
Z288 | Anemia Panel Basic *CBC *Serum Iron Studies * Ferritin * CRP | 3 mL SERUM + 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence, VCS, Spectrophotometry, CLIA, Immunoturbidim etry | Daily |
Z289 | Anemia Panel 1 *CBC *Serum Iron Studies * Ferritin * CRP * Protein Total * Albumin * A:G Ratio * Transferrin *Hemoglobin electrophoresis | 3 mL SERUM + 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence, VCS, Spectrophotometry, CLIA, Immunoturbidim etry, HPLC | S:Daily by 9 am R:Next day |
Z513 | Anemia Panel 2 *CBC *Serum Iron Studies * Ferritin * CRP * Protein Total * Albumin * A:G Ratio * Transferrin *Lead blood | 3 mL SERUM + 3 mL EDTA WB + 2 mL K2EDTA WB Metal Free tube | R 48 hrs F Unacceptable | Electrical Impedence, VCS, Spectrophotometry, CLIA, Immunoturbidim etry, AAS | S:Daily by 6 pm R:Next day |
OS105 | Angelman Syndrome | 4 mL EDTA WB | R 1 week F Unacceptable | Methylation Specific PCR | S: Sat 11 am R: 12 days |
B063 | Angiotensin Converting Enzyme; ACE | 2 mL SERUM | R 1 week F 6 months | Spectrophotometry | Daily |
RW015 | Angiotensin II | 2 mL EDTA PLASMA | R 24 hrs F 28 days | RIA | S: By 7th of Month R: 2 - 3 weeks |
Z290 | Antenatal Panel Basic *Complete Blood Count *Blood Group + Rh Factor *Urine R/E *HIV-1 & 2 *HBsAg *VDRL*Glucose F / PP / R | 3 mL EDTA WB + 2 mL Fluoride PLASMA + 3 mL SERUM + 10 mL random URINE | R 48 hrs F Unacceptable | Electrical Impedence, VCS, EMT, Dipstick, CMIA, Flocculation, Hexokinase | Daily |
Z546 | Antenatal Panel 1 *Complete Blood Count *Blood Group + Rh Factor *Urine R/E *HIV-1 & 2 *HBsAg *VDRL*Glucose F / PP / R *Hemoglobin electrophoresis | 6 mL EDTA WB + 2 mL Fluoride PLASMA + 3 mL SERUM + 10 mL random URINE | R 48 hrs F Unacceptable | Electrical Impedence, VCS, EMT, Dipstick, CMIA, Flocculation, Hexokinase, HPLC | S:Daily by 9 am R:Next day |
H076 | Anti A Titre, IgG | 2 mL SERUM + 3 mL EDTA WB | R 72 hrs F Unacceptable | Erythrocyte Magnetized Technology | S:Daily by 9 am R:Next day |
H046 | Anti A Titre, IgM | 2 mL SERUM + 3 mL EDTA WB | R 72 hrs F Unacceptable | Erythrocyte Magnetized Technology | S:Daily by 9 am R:Next day |
H077 | Anti B Titre, IgG | 2 mL SERUM + 3 mL EDTA WB | R 72 hrs F Unacceptable | Erythrocyte Magnetized Technology | S:Daily by 9 am R:Next day |
H047 | Anti B Titre, IgM | 2 mL SERUM + 3 mL EDTA WB | R 72 hrs F Unacceptable | Erythrocyte Magnetized Technology | S:Daily by 9 am R:Next day |
S119 | Anti ds-DNA, Antibody, Crithidia, IFA in Dilutions | 3 mL SERUM | R 72 hrs F 2 weeks | IFA | S:Daily by 11 am R:Next day |
S029 | Anti ds-DNA, Antibody, EIA | 2 mL SERUM | R 72 hrs F 2 weeks | EIA | S:Mon through Sat 9 am R:Same day |
S097 | Anti ss-DNA Antibody | 2 mL SERUM | R 72 hrs F 2 weeks | EIA | S:Thu 9 am R:Same day |
B149 | Anti Cyclic Citrullinated Peptide ; Anti CCP | 2 mL SERUM | R 48 hrs F 1 week | CMIA | Daily |
B075 | Anti DNAse B; Anti Deoxyribonuclease B | 2 mL SERUM | R 1 week F 3 months | Latex Enhanced Nephelometry | S:Mon / Thu 4 pm R:Same day |
S096 | Anti ds-DNA, Antibody, Crithidia, IFA (Double stranded, Native) | 2 mL SERUM | R 72 hrs F 2 weeks | IFA | S:Daily 11 am R:Same day |
S246 | Anti IA-2; Insulinoma Associated Antigen | 2 mL SERUM | R 2 weeks F 6 months | EIA | S:Fri 9 am R:Next day |
B171 | Anti Mullerian Hormone; AMH | 2 mL SERUM | R 6 days F 4 weeks | CLIA | S:Daily 4 pm R:Same day |
S239 | Anti NMDA Receptor / Anti Glutamate Antibody | 2 mL SERUM | R 1 week F 2 weeks | IFA | S:Daily 9 am R:5 days |
S044 | Anti Nuclear Antibody / Factor (ANA / ANF), IFA (Hep-2) End Titre | 2 mL SERUM | R 1 week F 2 weeks | IFA (Hep-2 substrate) | S:Daily 11 am R:Next day |
S235 | Anti Nuclear Antibody / Factor (ANA / ANF), IFA (Hep-2) Reflex To ENA Profile | 2 mL SERUM | R 1 week F 2 weeks | Immunofluoresc ence Assay (Hep-2 Substrate), Immunoblot | S:Mon through Sat by 11 am R:Next day |
S027 | Anti Nuclear Antibody / Factor (ANA / ANF), EIA | 2 mL SERUM | R 48 hrs F 2 weeks | EIA | S:Daily 9 am R:Same day |
B154 | Anti Soluble Liver Antigen; SLA | 2 mL SERUM | R 72 hrs F 2 months | EIA | S: Sat 9 am R: Same day |
S012 | Anti Sperm Antibody, Serum | 2 mL SERUM | R 1 week F 2 weeks | EIA | S:Wed / Sat 9 am R:Same day |
B073 | Anti Streptolysin - O (ASO) Titre | 2 mL SERUM | R 1 week F 2 weeks | Immunoturbidimetry | Daily |
S095 | Anti Thyroglobulin Antibody; Anti Tg | 2 mL SERUM | R 48 hrs F 2 weeks | CLIA | Daily |
Z201 | Anti Thyroid Antibodies Panel | 2 mL SERUM | R 48 hrs F 2 weeks | CLIA | Daily |
S094 | Anti Thyroid Peroxidase Antibody; Anti TPO | 2 mL SERUM | R 48 hrs F 2 weeks | CLIA | Daily |
S238 | Anti - NMO (Neuromyelitis Optica) Antibody / Aquaporin 4 | 2 mL SERUM | R 1 week F 2 weeks | IFA | S:Daily by 9 am R:5 days |
RW016 | Antithrombin III, Antigenic | 3 mL CITRATED PPP Separate plasma & freeze immediately | F 21 days | Fixed Rate Time Nephelometry | S: By 7th of Month R: 2 - 3 weeks |
H101 | Antithrombin Activity, Functional | 3 mL CITRATED PPP Separate plasma & freeze immediately | F 2 weeks | Chromogenic | S:Daily 11 am R:Same day |
OS106 | Apo E Genotyping | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Hybridization | S:Sat 11 am R:10 days |
Z212 | Apolipoproteins A1 & B Includes Apo B / Apo A1 Ratio | 2 mL SERUM | R 1 week F 2 weeks | Immunoturbidimetry | Daily |
G149 | Arginase | 4 mL EDTA WB | R 72 hrs F Unacceptable | Spectrophotometry | S: Mon 4 pm R: Thu |
RW017 | Arginine Vasopressin / Anti Diuretic Hormone (ADH), Plasma | 4 mL EDTA PLASMA Separate plasma & freeze immediately | R Unacceptable F 6 weeks | Extraction, RIA | S: By 7th of Month R: 2 - 3 weeks |
C004 | Arsenic, 24 Hour Urine | 10 mL aliquot of 24 hr URINE Metal Free Container State Total volume Use powderless gloves AvoidSea food & Herbal supplements 3 days prior to sample collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S:Daily by 6 pm R:Next day |
C005 | Arsenic, Random Urine | 10 mL random URINE Metal Free Container Use powderless gloves Avoid Sea food & Herbal supplements 3 days prior to sample collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S:Daily by 6 pm R:Next day |
C006 | Arsenic, Blood | 2 mL K2 EDTA WB Metal Free tube Use powderless gloves Avoid Sea food & Herbal supplements 3 days prior to sample collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F Unacceptable | ICPMS | S:Daily by 6 pm R:Next day |
Z316 | Arthritis Panel, Basic *CBC *CRP * RA Factor * ASO * Uric Acid | 3 mL EDTA WB + 3 mL SERUM | R 48 hrs F Unacceptable | Electrical Impedence, VCS, Spectrophotometry, Immunoturbidim etry | Daily |
Z260 | Arthritis Panel 1 *CBC * CRP * RA Factor * ANA / ANF * ASO * Uric Acid | 3 mL EDTA WB + 3 mL SERUM | R 48 hrs F Unacceptable | Electrical Impedence, VCS, Spectrophotometry, Immunoturbidim etry, EIA | S:Daily by 9 am R: Same day |
Z261 | Arthritis Panel 2 *CBC * CRP * RA Factor * ANA / ANF * ASO * Uric Acid *Complement C3 *Complement C4 | 3 mL EDTA WB + 3 mL SERUM | R 48 hrs F Unacceptable | Electrical Impedence, VCS, Spectrophotometry, Immunoturbidim etry, EIA | S:Daily by 9 am R: Same day |
S219 | ASCA (Anti Saccharomyces Cerevisiae Antibody), IgA | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Thu 9 am R:Same day |
Z675 | ASCA (Anti Saccharomyces Cerevisiae Antibody), IgA & IgG Panel | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Thu 9 am R:Same day |
S218 | ASCA (Anti Saccharomyces Cerevisiae Antibody), IgG | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Thu 9 am R:Same day |
S102 | Aspergillus Antibody, IgG, Serum | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Wed 9 am R:Same day |
S155 | Aspergillus Antibody, IgM, Serum | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Wed 9 am R:Same day |
Z215 | Aspergillus Antibodies Panel, IgG & IgM, Serum | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Wed 9 am R:Same day |
RW259 | Autoimmune Cerebellar Ataxia Panel | 3 mL SERUM No Additive tube | R 7 days F 21 days | Immunoassay,IFA, Immunoturbidim etry, RBA | S: By 7th of Month R: 2 - 3 weeks |
S253 | Autoimmune Encephalitis Panel *NMDA *AMPA (GLUR 1 & GLUR 2) *GABA -B *LG1 *CASPR2 | 2 mL SERUM or 1 mL CSF | R 1 week F 2 weeks | IFA | S:Thu 11 am R: Fri |
Z619 | Autoimmune Hepatitis Panel *ANA *AMA *ASMA *LKM Antibody | 3 mL SERUM | R 1 week F 4 weeks | IFA | S:Daily by 11 am R:Next day |
RW019 | Babesia Antibodies, IgG & IgM 2 mL SERUM No Additive Tube | 2 mL SERUM No Additive Tube | R 7 days F 30 days | IFA | S: By 7th of Month R: 2 - 3 weeks |
S103 | Bacterial Meningitis Screen * Group B Streptococcus * H.influenzae Type B * Streptococcus pneumoniae * Neisseria meningitidis Group A, C, Y, W 135 & B * E. coli K1 | 2 mL SERUM or CSF or random URINE | R 24 hrs F 2 weeks | Latex Agglutination | Daily |
OS107 | Bacterial Meningitis Confirmatory Panel *H.influenzae *N.meningitidis * S.pneumoniae | 1 mL CSF or THROAT SWAB | R 1 week F Unacceptable | PCR | S:Tue / Sat 11 am R:Sat / Tue |
OS108 | Bacterial Pneumonia Panel, PCR *Mycoplasma pneumonia *S. pneumoniae * Chlymydia genus | Throat or Nasopharyngeal SWAB or Respirataory SECRETIONS or BAL FLUID | R 72 hrs F Unacceptable | PCR | S : Mon / Wed / Fri 11 am R: 4 days |
K014 | Barbiturate Screen Urine *Amobarbital *Butabarbital *Butalbital *Pentobarbital *Phenobarbital *Secobarbital | 10 mL random URINE | R 1 week F 2 weeks | Lateral Flow Immunoassay | Daily |
OS109 | B-Cell Rearrangement Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR, Fragment Analysis | S:Sat 11 am R:10 days |
N037 | BCR-ABL PCR, Qualitative | 5 mL EDTA WB or BONE MARROW | R 4 days F Unacceptable | Real Time PCR | S:Mon / Wed / Fri 9 am R Tue / Thu / Sat |
N035 | BCR-ABL PCR, Quantitative | 5 mL EDTA WB or BONE MARROW | R 4 days F Unacceptable | Real Time PCR | S:Mon / Wed / Fri 9 am R Tue / Thu / Sat |
U103 | Bence Jones Protein, Urine, Qualitative | 15 mL random URINE | R 1 week F Unacceptable | Chemical | Daily |
K002 | Benzodiazepine Screen, Qualitative, Urine *Chlordiazepoxide *Clonazepam *Demoxepam *Desalkylflurazepam *Diazepam *Flunitrazepam *Flurazepam *Lorazepam *Nitrazepam *Nordiazepam *Oxazepam *Triazolam | 10 mL random URINE | R 48 hrs F 2 weeks | Lateral Flow Immunoassay | Daily |
U051 | Beta 2 Microglobulin, 24 Hour Urine | 10 mL aliquot of 24 hr URINE | R 24 hrs F 2 weeks | CLIA | Daily |
R061 | Beta 2 Microglobulin, Serum | 2 mL SERUM | R 24 hrs F 2 weeks | CLIA | Daily |
B179 | Beta 2 Glycoprotein 1, IgA | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Mon / Thu 9 am R Same day |
B177 | Beta 2 Glycoprotein 1, IgG | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Mon / Thu 9 am R Same day |
B178 | Beta 2 Glycoprotein 1, IgM | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Mon / Thu 9 am R Same day |
Z547 | Beta 2 Glycoprotein 1 Panel, IgG, IgM, IgA | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Mon / Thu 9 am R Same day |
RW245 | Beta -2- Transferrin, Fluid | 2 mL FLUID | R: 7 days F: 7 days | Electrophoresis, Immunofixation | S: By 7th of Month R: 2 - 3 weeks |
R168 | Beta Crosslaps; Beta CTx | 2 mL EDTA PLASMA Overnight fasting mandatory | R 8 days F 30 days | ECLIA | S:Mon 4 pm R Same day |
OS111 | Beta Thalassemia Mutation Detection, Prenatal *5 common mutations | 4 mL EDTA WB from both parents + 10 mL Amniotic FLUID or CVS | R 1 week F Unacceptable | PCR | S:Daily by 11 am R 10 days |
B162 | Bicarbonate, Serum | 2 mL SERUM | R 72 hrs F 4 weeks | Enzymatic end point | Daily |
B197 | Bile Acids Total, Serum | 2 mL SERUM | R 1 week F 3 months | Enzymatic Colorimetric | S: Mon through Sat by 4 pm R: Same day |
Z106 | Bilirubin, Total, Direct & Indirect | 2 mL SERUM | R 72 hrs F 2 weeks | DPD, Calculated | Daily |
B036 | Bilirubin, Direct | 2 mL SERUM | R 72 hrs F 2 weeks | DPD | Daily |
B035 | Bilirubin, Total | 2 mL SERUM | R 72 hrs F 2 weeks | DPD | Daily |
P099 | Bilirubin, Fluid | 2 mL FLUID | R 72 hrs F 2 weeks | DPD, Calculated | Daily |
G129 | Biotinidase Deficiency Quantitative, Blood 2 mL SERUM / HEPARIN PLASMA | 2 mL SERUM or Heparinized PLASMA | R 48 hrs F 4 weeks | Enzyme Assay | S: Daily 4 pm R: Same day |
R165 | Biotinidase Newborn Screen | 1 drop heel prick blood each on 3 spots of filter paper | R 1 week F 1 week | Fluoroimmunoassay | S: Tue / Thu / Sat 5 pm R: 2 days |
RW021 | Bismuth, 24 Hour Urine | 10 mL aliquot of 24 hr URINE Metal Free Container Avoidmineral supplements and bismuth preparations like Pepto-Bismal for at least 1 week prior to specimen collection. | R 5 days F 14 days | ICPMS | S: By 7th of Month R: 2 - 3 weeks |
RW022 | Bismuth, Random Urine10 mL random URINE Metal Free Container | 10 mL aliquot of andom URINE Metal Free Container Avoidmineral supplements and bismuth preparations like Pepto-Bismal for at least 1 week prior to specimen collection. | R 5 days F 14 days | ICPMS | S: By 7th of Month R: 2 - 3 weeks |
N069 | BK Virus, PCR, Qualitative | 3 mL EDTA PLASMA or 15 mL random URINE | R 72 hrs F 1 week | Real Time PCR | S:Mon / Thu 11 am R:Wed / Sat |
N096 | BK Virus, PCR, Quantitative | 3 mL EDTA PLASMA or 15 mL random URINE | R 72 hrs F 1 week | Real Time PCR | S:Mon / Thu 11 am R:Wed / Sat |
RW023 | Blastomyces Antibody | 2 mL SERUM | R 14 days F 30 days | Immunodiffusion | S: By 7th of Month R: 2 - 3 weeks |
H015 | Bleeding Time: BT | Conducted on patient | NA | Ivy"s Method | Daily |
P001 | Blood Gas Analysis, Arterial | 2 mL Heparinized ARTERIAL BLOOD | R 24 hrs F Unacceptable | ISE, Amperometry,Reflectance Photometry | Daily |
P002 | Blood Gas Analysis, Venous | 2 mL Heparinized VENOUS BLOOD | R 24 hrs F Unacceptable | ISE, Amperometry,Reflectance Photometry | Daily |
H206 | Blood Group, ABO & Rh *Forward & Reverse Grouping | 4 mL EDTA WB | R 48 hrs F Unacceptable | Erythrocyte Magnetized Technology / Tube agglutination | Daily |
H029 | Blood Picture: Peripheral Blood Smear Examination | 2 peripheral blood SMEARS | NA | Microscopy | Daily |
B147 | BNP: B-Type Natriuretic Peptide | 2 mL EDTA PLASMA | R 24 hrs F 4 weeks | CLIA | Daily |
Z169 | BOH (Bad Obstetric History) Panel *Cardiolipin Antibodies Panel *Lupus Anticoagulant Panel | 3 mL SERUM + 3 mL Citrated PPP | R Unacceptable F 4 weeks | EIA, Electromechanical Clot detection | S: Daily 3 pm R: Next day |
Z886 | BOH (Bad Obstetric History) Extended Panel *TORCH Panel, IgG & IgM Extended * Phospholipid antibodies Panel, IgG & IgM * Anti Nuclear antibody / Factor (ANA/ANF) * TSH Ultrasensitive | 4 mL SERUM | R 48 hrs F 2 weeks | CLIA, EIA | S: Tue / Fri 9 am R: Same day |
Z476 | Bone Marrow Examination Panel 1 * Microscopy of Bone Marrow & Peripheral Smear * Special Stains * CBC | 2 mL EDTA Bone Marrow + 4 Marrow Aspirate SMEARS + 4 mL EDTA WB + 2 peripheral blood SMEARS | R 48 hrs F Unacceptable | Microscopy, Electrical Impedence, VCS | S: Daily 1 pm R: Next day |
Z477 | Bone Marrow Aspirate Examination Panel 2 * Microscopy of Bone Marrow & Peripheral Smear * Special Stains * CBC * Histopathology | 2 mL EDTA Bone Marrow + 4 Marrow Aspirate SMEARS + 4 mL EDTA WB + 2 peripheral blood SMEARS + Bone marrow trephine BIOPSY | R 48 hrs F Unacceptable | Microscopy, Electrical Impedence, VCS, HPE | S: Daily 6 pm R: 5 days |
H227 | Bone Marrow Iron Stain | 4 Marrow Aspirate SMEARS + 2 peripheral blood SMEARS | NA | Prussian Blue Reaction | S: Daily 12 noon R: Next day |
Z499 | Bone Marrow Trephine Biopsy Panel *Histopathology *Reticulin Stain * Iron Stain | Bone marrow trephine BIOPSY | NA | Processing,Staining, Microscopy | S: Daily 6 pm R: 5 Days |
N113 | BRAF Mutation Analysis | Paraffin BLOCK (for Solid tumors) OR 3 mL EDTA WB (for Hairy cell Leukemia) | R 72 hrs F Unacceptable | PCR, Sequencing | S: Tue 11 am R: Mon |
N081 | BRCA1 & BRCA2 Mutation Comprehensive Panel *All BRCA1 & BRCA2 gene mutations mapped | 3 mL EDTA WB | R 72 hrs F Unacceptable | Sequencing | S: 1st /. 16th of month R: 15th / 30th same month |
N080 | BRCA1 & BRCA2 Mutation Screen *BRCA1 exon2 (187delAG) * BRCA1 exon20 (5385insc) * BRCA2 exon11 (6174delT) * 5 Experimental markers | 3 mL EDTA WB | R 72 hrs F Unacceptable | SNP Genotyping using Microarray | S: Daily 9 am R: 8 weeks |
Z240 | Breast Cancer Panel 1 *ER (Estrogen Receptor) *PR (Progesterone Receptor) Includes pathologist review for presence of malignant cells. | BIOPSY or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: 5 days (Block / ; 7 days (Biopsy) |
Z242 | Breast Cancer Panel 2 *ER *PR *Cathepsin D Includes pathologist review for presence of malignant cells. | BIOPSY or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: 5 days (Block / ; 7 days (Biopsy) |
Z293 | Breast Cancer Panel 3 *ER *PR *HER-2 Includes Pathologist review for presence of malignant cells. | BIOPSY or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: 5 days (Block / ; 7 days (Biopsy) |
Z298 | Breast Cancer Panel 4 *ER *PR *HER-2 *Ki67 Includes Pathologist review for presence of malignant cells. | BIOPSY or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: 5 days (Block / ; 7 days (Biopsy) |
Z387 | Breast Metastatic Marker *ER (Estrogen Receptor) *PR (Progesterone Receptor) *CA 15.3 Includes pathologist review for presence of malignant cells. | BIOPSY or Paraffin BLOCK + 2 mL SERUM | R 72 hrs F 2 weeks | IHC, CLIA | S: Daily 6 pm R: 5 days (Block / ; 7 days (Biopsy) CA 15.3: Same day |
Z388 | Breast Monitor Panel CA 15.3* CEA | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
S003 | Brucella Agglutination TestIncludes antibody to B.abortus and B.melitensis | 2 mL SERUM | R 48 hrs F 2 weeks | Tube Agglutination | S: Daily 6 pm R: Next day |
Z676 | Brucella Antibodies, IgG & IgM | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Tue / Fri 9 am R:Same day |
S221 | Brucella Antibody, IgG | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Tue / Fri 9 am R:Same day |
S222 | Brucella Antibody, IgM | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Tue / Fri 9 am R:Same day |
J003 | Buccal Smear for Barr bodies (Sex chromatin) | SCRAPINGS Buccal mucosa right & left cheek | R 72 hrs F Unacceptable | Aceto - Orcein stain | S: Daily 6 pm R: Next day |
B022 | BUN: Blood Urea Nitrogen | 2 mL SERUM | R 1 week F 2 weeks | Urease UV | Daily |
RW025 | Bupropion *Bupropion *Hydroxybupropion | 3 mL SERUM No Additive Tube Trough level | R Unacceptable F 30 days | HPLC - MS/MS | S: By 7th of Month R: 2 - 3 weeks |
T006 | C.difficle Toxin A & B, Stool | 2 g fresh STOOL | R 72 hrs F Unacceptable | ICT | Daily |
H102 | C1 Esterase Inhibitor, Protein Quantitation; C1 Inhibitor Quantitative | 2 mL SERUM No Additive Tube | R 1 week F 2 weeks | Radial Immunodiffusion | S: Wed 9 am R: Next Mon |
RW027 | C1 Esterase Inhibitor, Functional Activity; C1 Inactivator, Functional | 2 mL SERUM No Additive Tube | R Unacceptable F 30 days | EIA | S: By 7th of Month R: 2 - 3 weeks |
RW028 | C1q Complement | 2 mL SERUM Separate serum within 1 hour of collection. | R 10 days F 29 days | Radial Immunodiffusion | S: By 7th of Month R: 2 - 3 weeks |
RW029 | C2 Complement | 2 mL SERUM | R 28 days F 28 days | Radial Immunodiffusion | S: By 7th of Month R: 2 - 3 weeks |
Z108 | C3 & C4 Complement Panel 2 mL SERUM No Additive Tube | 2 mL SERUM | R 1 week F 2 weeks | Immunoturbidimetry | Daily |
H105 | C3 Complement | 2 mL SERUM | R 1 week F 2 weeks | Immunoturbidimetry | Daily |
H106 | C4 Complement | 2 mL SERUM | R 1 week F 2 weeks | Immunoturbidimetry | Daily |
RW030 | C5 Complement | 2 mL SERUM | R 14 days F 30 days | Radial Immunodiffusion | S: By 7th of Month R: 2 - 3 weeks |
RW031 | C6 Complement | 2 mL SERUM | R 14 days F 30 days | Radial Immunodiffusion | S: By 7th of Month R: 2 - 3 weeks |
RW032 | C7 Complement | 2 mL SERUM | R 14 days F 30 days | Radial Immunodiffusion | S: By 7th of Month R: 2 - 3 weeks |
RW033 | C8 Complement | 2 mL SERUM | R 14 days F 21 days | Radial Immunodiffusion | S: By 7th of Month R: 2 - 3 weeks |
RW034 | C9 Complement | 2 mL SERUM | R 14 days F 30 days | Radial Immunodiffusion | S: By 7th of Month R: 2 - 3 weeks |
F007 | CA 125; Ovarian Cancer Marker | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
F010 | CA 15.3: Breast Cancer Marker | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
F008 | CA 19.9: Pancreatic Cancer Marker | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
RW035 | CA 27.29; Breast Cancer Marker | 2 mL SERUM | R 7 days F 28 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
Z306 | CA 27.29 & CA 15.3: Breast Cancer Markers Panel | 2 mL SERUM | R 1 week F 2 weeks | CMIA, Immunoassay | S: By 7th of Month R: 2 - 3 weeks CA 15.3: Daily |
F009 | CA 72.4: Gastric Cancer Marker | 2 mL SERUM | R 4 weeks F 3 months | Electrochemiluminescence | S: Mon / Thu 4 pm R: Same day |
F015 | CA Cyfra 21-1: Lung Cancer Marker | 2 mL SERUM | R 4 weeks F 6 months | Electrochemiluminescence | S: Mon 4 pm R: Same day |
C007 | Cadmium, Blood | 2 mL K2 EDTA WB Metal Free tube Use powderless gloves AvoidSea food 3 days prior to sample collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F Unacceptable | ICPMS | S: Daily 6 pm R: Next day |
C008 | Cadmium, 24 Hour Urine | 10 mL aliquot of 24 hr URINE Metal Free Container Use powderless gloves AvoidSea food 3 days prior to sample collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
C009 | Cadmium, Random Urine | 10 mL aliquot of random URINE Metal Free Container Use powderless gloves AvoidSea food 3 days prior to sample collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
R062 | Calcitonin | 2 mL SERUM No Additive Tube | R Unacceptable F 2 weeks | CLIA | S: Mon / Thu 4 pm R: Same day |
Z046 Y018 Basal Y121 1 min Y019 2 min Y020 5 min Y021 10 min Y022 customized | Calcitonin Stimulation by Calcium Pentagastrin For suspected Medullary Thyroid Carcinoma | 2 mL SERUM for each timed specimen ; Draw fasting baseline sample; Administer 2 mg or kg body weight Calcium gluconate IV; draw additional samples at 1,2,5 & 10 min | R Unacceptable F 2 weeks | CLIA | S: Mon / Thu 4 pm R: Same day |
U096 | Calcium / Creatinine Ratio, Random Urine | 10 mL aliquot of random URINE in 2 mL 6N HCl | R 4 days F 2 weeks | Spectrophotome try | Daily |
U097 | Calcium Excretion 2 Hour Fasting Urine | 10 mL aliquot of 2 hr URINE | R 4 days F 2 weeks | Arsenazo-III | Daily |
U011 | Calcium, 24 Hour Urine | 10 mL aliquot of 24 hr URINE in 25 mL 50% HCl | R 4 days F 2 weeks | Arsenazo-III | Daily |
B055 | Calcium Ionized | 3 mL Heparinized WB or 2 mL SERUM Avoidtourniquet & fist clenching during sampling | R 1 week F Unacceptable | Ion Selective Electrode | Daily |
B042 | Calcium, Serum | 2 mL SERUM | R 4 days F 2 weeks | Arsenazo-III | Daily |
Z117 | Calcium, Total & Ionized | 2 mL SERUM or 3 mL Heparinized WB Avoid tourniquet & fist clenching during sampling | R 1 week F Unacceptable | Ion Selective Electrode, Arsenazo-III | Daily |
U073 | Calcium, Random Urine | 10 mL aliquot of random URINE in 2 mL 6N HCl | R 4 days F 2 weeks | Arsenazo-III | Daily |
N112 | CALR Mutation Detection | 3 mL EDTA WB | R 72 hrs F Unacceptable | PCR Sequencing | S:Mon 11 am R:Sat |
M215 | Campylobacter Antigen, Stool | 5 g fresh STOOL | R 24 hrs F Unacceptable | ICT | S:Daily 1 pm R:Same day |
G172 | Canavan Disease | 10 mL aliquot of random URINE | R 72 hrs F 4 weeks | Gas Chromatography / Mass Spectrometry | S:Daily 9 am R:5 days |
Z867 | Cancer Breast Comprehensive Panel *ERBB2 reflex to FISH *ER *PR *Ki67 | Paraffin BLOCK | NA | IHC, FISH | S:Tue 9 am R:10 days |
Z874 | Cancer Targeted Gene Panel, CNS Tumor *1p19q codeletion *EGFR amplification *IDH1, IHC *Ki67 *ATRX *TP53 *IDH1 & 2 mutation *PTEN * BRAF | Paraffin BLOCK | NA | IHC, NGS, FISH | S:Tue 9 am R:10 days |
Z868 | Cancer Targeted Gene Panel, Colon / Colorectal *Microsatellite Instability Panel *KRAS *BRAF *PIK3CA *PTEN | Paraffin BLOCK | NA | IHC, NGS | S:Tue 9 am R:10 days |
Z869 | Cancer Targeted Gene Panel, Gastrointestinal Stromal Tumor (GIST) *CD117 *DOG1 *ERBB2 *KIT *BRAF *PDGFRA *TP53 | Paraffin BLOCK | NA | IHC, NGS | S:Tue 9 am R:10 days |
Z870 | Cancer Targeted Gene Panel, Lung *ALK1 *ROS1 *MET amplification *MET mutation *KRAS *BRAF *ERBB2 *EGFR | Paraffin BLOCK | NA | NGS, FISH | S:Tue 9 am R:10 days |
N097 | Cancer 50 Gene Panel, NGSABL1, EGFR, GNAS, KRAS, PTPN11, AKT1, ERBB2, GNAQ, MET, RB1, ALK, ERBB4, HNF1A, MLH1, RET, APC, EZH2, HRAS, MPL, SMAD4, ATM, FBXW7, IDH1, NOTCH1, SMARCB1, BRAF, FGFR1, JAK2, NPM1, SMO, CDH1, FGFR2, JAK3, NRAS, SRC, CDKN2A, FGFR3, IDH2, PDGFRA, STK11, CSF1R, FLT3, KDR, PIK3CA, TP53, CTNNB1, GNA11, KIT, PTEN, VHL | 3 mL EDTA WB / Paraffin BLOCK | R 72 Hrs F Unacceptable | Next Generation Sequencing | S:Mon 11 am R:10 days |
N149 | Cancer Gene Any 3 Markers, NGS ABL1, EGFR, GNAS, KRAS, PTPN11, AKT1, ERBB2, GNAQ, MET, RB1, ALK, ERBB4, HNF1A, MLH1, RET, APC, EZH2, HRAS, MPL, SMAD4, ATM, FBXW7, IDH1, NOTCH1, SMARCB1, BRAF, FGFR1, JAK2, NPM1, SMO, CDH1, FGFR2, JAK3, NRAS, SRC, CDKN2A, FGFR3, IDH2, PDGFRA, STK11, CSF1R, FLT3, KDR, PIK3CA, TP53, CTNNB1, GNA11, KIT, PTEN, VHL | 3 mL EDTA WB / Paraffin BLOCK | R 72 Hrs F Unacceptable | Next Generation Sequencing | S:Mon 11 am R:10 days |
OS114 | Candida albicans Detection, PCR | 4 mL EDTA WB or 1 mL CSF or SPUTUM or BODY FLUID or TISSUE | R 1 week F Unacceptable | PCR | S:Daily 11 am R:13 days |
K003 | Cannabinoids (Delta - 9 -THC Metabolites) / Marijuana, Screen, Urine 10 mL random URINE | 10 mL aliquot of random URINE | R 1 week F 2 weeks | Lateral Flow Immunoassay | Daily |
RW036 | Carbamazepine, Free | 4 mL SERUM No Additive Tube | R 14 days F 6 weeks | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
D051 | Carbamazepine | 2 mL SERUM drawn just before next dose No Additive Tube | R 48 hrs F 2 weeks | CLIA | Daily |
Z003 | Cardiac / Myocardial Infarction Panel *CPK-MB Mass * Troponin I * Troponin T | 2 mL SERUM | R 72 hrs F 1 week | CLIA, ECLIA | Daily |
Z102 | Cardiolipin Antibodies Panel, IgG, IgA & IgM | 4 mL SERUM | R 72 hrs F 1 week | EIA | S:Mon through Sat 9 am R:Same day |
S053 | Cardiolipin Antibody, IgA | 2 mL SERUM | R 72 hrs F 1 week | EIA | S:Mon through Sat 9 am R:Same day |
S055 | Cardiolipin Antibody, IgG | 2 mL SERUM | R 72 hrs F 1 week | EIA | S:Mon through Sat 9 am R:Same day |
S054 | Cardiolipin Antibody, IgM | 2 mL SERUM | R 72 hrs F 1 week | EIA | S:Mon through Sat 9 am R:Same day |
G181 | Cardiometabolic Panel | 2 mL EDTA PLASMA Overnight fasting mandatory | R 48 hrs F 2 weeks | LC-MS/MS | S:Daily 5 pm R:5 days |
G170 | Carnitine Includes Acylcarnitine | 2 mL SERUM | R 1 week F 1 week | LC-MS/MS | S:Daily 9 am R:2 days |
RW038 | Carotene | 2 mL SERUM No Additive Tube Protect from light Overnight fasting mandatory Avoid Vitamin A supplement & Alcohol 24 hrs prior to sampling | R 6 days F 30 days | HPLC | S: By 7th of Month R: 2 - 3 weeks |
U024 | Catecholamines, 24 Hour UrineIncludes Epinephrine, Norepinephrine and Dopamine | 50 mL aliquot of 24 hr URINE in 50% HCl Avoid Alpha-one blockers, Aminophylline, Amphetamines, Ampicillin, Beta-blockers, Ephedrine, Imipramine, Methyldopa, MAO inhibitors, Nicotine, Phenacetin, Phenothiazine, Theophylline, Vasodilators, Aspirin, PAS, Alpha-2 agonists, Bromocriptine, Calcium channel blockers ( long term use), Clofibrate, Propranolol, Penicillin, Reserpine, Thyroxine, Alpha- methyldopa, Isoproterenol, Labetalol, Mandelamine, Paracetamol, Cimetidine, Metoclopramide, vigorous exercise, alcoholic beverages, teaorcoffee and tobacco at least 72 hrs before and during specimen collection | R 5 days F 30 days | HPLC | S: Wed / Sat 9 am R: 2 days |
Z118 | Catecholamines & VMA, 24 Hour Urine Includes Epinephrine, Norepinephrine and Dopamine | 50 mL aliquot of 24 hr URINE in 50% HCl Avoid Alpha-one blockers, Aminophylline, Amphetamines, Ampicillin, Beta-blockers, Ephedrine, Imipramine, Methyldopa, MAO inhibitors, Nicotine, Phenacetin, Phenothiazine, Theophylline, Vasodilators, Aspirin, PAS, Alpha-2 agonists, Bromocriptine, Calcium channel blockers (long term use), Clofibrate, Propranolol, Penicillin, Reserpine, Thyroxine, Alpha- methyldopa, Isoproterenol, Labetalol, Mandelamine, Paracetamol, Cimetidine, Metoclopramide, vigorous exercise, alcoholic beverages, teaorcoffee, tobacco , chocolate, vanilla & banana at least 72 hrs before and during specimen collection. | R 5 days F 30 days | HPLC | S: Wed / Sat 9 am R: 2 days |
R097 | Catecholamines, PlasmaIncludes Epinephrine, Norepinephrine and Dopamine | 8 mL Heparinized PLASMA with 5 mg Sodium metabisulphite Avoid drugs like Aldomet (Alpha methyldopa), Labetalol, Isoproterenol, Isoetharine, Alpha- one blockers, Aminophylline, Amphetamines, Ampicillin, Beta- blockers, Ephedrine, Imipramine, Nicotine, Phenacetin, Theophylline, Phenothiazine, Vasodilators (Minoxidil, Nitrates & Hydralazine), Aspirin, PAS, Alpha-2 agonists, Bromocriptine, Calcium channel blockers (long term use), L-dopa, Cimetidine, clofibrate, MAO inhibitors, Propranolol, Penicillin, Reserpine, Thyroxine, vigorous exercise, severe stress and cigarette smoking at least 72 hrs before and during specimen collection | R Unacceptable F 30 days | HPLC | S: Wed 9 am R: Fri |
U043 | Catecholamines, Random Urine | 50 mL aliquot of random URINE in 50% HCl Avoid Alpha-one blockers, Aminophylline, Amphetamines, Ampicillin, Beta-blockers, Ephedrine, Imipramine, Methyldopa, MAO inhibitors, Nicotine, Phenacetin, Phenothiazine, Theophylline, Vasodilators, Aspirin, PAS, Alpha-2 agonists, Bromocriptine, Calcium channel blockers ( long term use), Clofibrate, Propranolol, Penicillin, Reserpine, Thyroxine, Alpha- methyldopa, Isoproterenol, Labetalol, Mandelamine, Paracetamol, Cimetidine, Metoclopramide, vigorous exercise, alcoholic beverages, teaorcoffee and tobacco at least 72 hrs before and during specimen collection | R 5 days F 30 days | HPLC | S: Wed / Sat 9 am R: 2 days |
F003 | CEA; Carcinoembryonic Antigen | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
OS115 | CEBPA Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Daily 11 am R: 10 days |
S079 | Centromere Antibody | 2 mL SERUM | R 72 hrs F 2 weeks | EIA | S:Tue / Fri 9 am R:Same day |
B087 | Ceruloplasmin | 2 mL SERUM | R 72 hrs F 4 weeks | Nephelometry | S:Mon through Sat 4 pm; Sun 9 am; R:Same day |
Z770 | Cervical Screen *Cervical PAP Smear, Genital, Female (Liquid based) * Human Papilloma Virus (HPV) Detection & Genotyping, PCR, Qualitative | Endocervical SMEARS | R 72 hrs F Unacceptable | Microscopy, RT- PCR | S: Wed / Sat 11 am R: Fri / Tue |
N131 | Chikungunya Virus, PCR Qualitative | 3 mL EDTA Whole Blood or 2 mL CSF | R 72 hrs F Unacceptable | Real Time PCR | S: Daily 11 am R: Next day |
S209 | Chikungunya Virus Antibody, IgM | 2 mL SERUM | R 5 days F 2 weeks | ICT | Daily |
N110 | Chimerism Split Cell Analysis | 3 mL EDTA WB | R 72 hrs F Unacceptable | PCR, Fragment Analysis | S: Daily 11 am R: 7 days |
N058 | Chimerism, Post engraftment | 4 mL EDTA WB | R 72 hrs F Unacceptable | PCR, Fragment Analysis | S: Daily 11 am R: 7 days |
N059 | Chimerism, Pre engraftment | 4 mL EDTA WB | R 72 hrs F Unacceptable | PCR, Fragment Analysis | S: Daily 11 am R: 7 days |
N057 | Chimerism, Pre engraftment, Donor & Recipient | 4 mL EDTA WB each for donor & recipient | R 72 hrs F Unacceptable | PCR, Fragment Analysis | S: Daily 11 am R: 7 days |
S156 | Chlamydia IgG Antibody Panel *Chlamydia trachomatis, IgG *Chlamydophila pneumoniae, IgG | 3 mL SERUM | R 1 week F 2 weeks | EIA | S: Fri 9 am R: Same day |
N056 | Chlamydia Trachomatis, PCR | 10 mL URINE or Genital or Conjunctival SWABS | R 1 week F 4 weeks | PCR | S: Daily 11 am R: Next day |
RW039 | Chlamydia / Chlamydophila Serology *C.pneumoniae IgA, IgG & IgM *C.psittaci IgA, IgG & IgM *C.trachomatis IgA, IgG & IgM | 3 mL SERUM No Additive Tube | R 14 days F 30 days | IFA | S: By 7th of Month R: 2 - 3 weeks |
S236 | Chlamydia Trachomatis IgG | 3 mL SERUM | R 1 week F 2 weeks | EIA | S: Fri 9 am R: Same day |
Z779 | Chlamydia trachomatis & Neisseria gonorrhoeae, PCR Qualitative | 15 mL first morning URINE or Vaginal or Endocervical or Conmjunctival SWABS | R 1 week F 4 weeks | Real time PCR | S: Daily 11 am R: Next day |
S237 | Chlamydophila pneumoniae IgG | 3 mL SERUM | R 1 week F 2 weeks | EIA | S: Fri 9 am R: Same day |
P088 | Chloride, Fluid | 5 mL FLUID | R 72 hrs F 1 week | Indirect Ion Selective Electrode | Daily |
U044 | Chloride, 24 Hour Urine | 10 mL aliquot of 24 hr URINE | R 72 hrs F 1 week | Indirect Ion Selective Electrode | Daily |
U015 | Chloride, Random Urine | 10 mL aliquot of random URINE | R 72 hrs F 1 week | Indirect Ion Selective Electrode | Daily |
B046 | Chloride, Serum | 2 mL SERUM | R 1 week F 2 weeks | Indirect Ion Selective Electrode | Daily |
P054 | Cholesterol, Fluid | 2 mL FLUID | R 72 hrs F 1 week | CHO-POD | Daily |
B025 | Cholesterol, Total | 2 mL SERUM | R 1 week F 2 weeks | CHO-POD | Daily |
B065 | Cholinesterase, Serum | 2 mL SERUM | R 1 week F 2 weeks | Spectrophotometry | Daily |
C052 | Chromium, Blood | 2 mL K2 EDTA WB Metal Free tube Use powderless gloves | R 72 hrs F Unacceptable | ICPMS | S: Daily 6 pm R: Next day |
C012 | Chromium, 24 Hour Urine | 10 mL aliquot of 24 hr URINE Metal Free Container Use powderless gloves | R 72 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
C013 | Chromium, Random Urine | 10 mL aliquot of random URINE Metal Free Container Use powderless gloves | R 72 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
R098 | Chromogranin A; CGA | 2 mL EDTA PLASMA | R Unacceptable F 2 weeks | TRACE | S:Tue / Fri 9 am R:Same day |
Q023 | Chromofic Chromosome SNP Microarray 750k, High Resolution | 4 mL EDTA WB | R 24 hrs F Unacceptable | Affymetrix CytoScan™ 750K Microarray | S: Daily 4 pm R: 10 days |
Q024 | Chromotouch Chromosome SNP Microarray Optima, Prenatal | 15 mL Amnotic FLUID / 30 mg Chorionic villus BIOPSY collected asceptically in 10 mL transport medium / 4 mL EDTA Umblical Cord BLOOD. Consent form for Prenatal genetic testing is mandatory. | R 24 hrs F Unacceptable | Affymetrix Optima Suite™ Microarray | S: Daily 4 pm R: 10 days |
Q025 | Chromotouch Chromosome SNP Microarray Optima, Products Of Conception | 5 mg curretted TISSUE in normal saline. | R 24 hrs F Unacceptable | Affymetrix Optima Suite™ Microarray | S: Daily 4 pm R: 10 days |
Q005 | Chromosome Analysis for Hematologic malignancy | 3 mL Heparinized WB or BONE MARROW | R 24 hrs F Unacceptable | Culture,Robotic Microscopy,Kary otype | S: Daily by 9 am R: 4 days |
Q008 | Chromosome Analysis (Karyotype), Blood | 5 mL Heparinized WB | R 24 hrs F Unacceptable | Culture,Robotic Microscopy,Kary otype | S: Daily by 9 am R: 12 days |
Q015 | Chromosome Analysis, Products of Conception reflex testing to FISH for Aneuploidy detection | Curetted TISSUE | 18 -22°C within 24 hrs | Culture,Microscopy,Karyotype, FISH | S: Daily 6 pm R: 4 weeks |
Q014 | Chromosome Analysis, Solid Tumor | Tumor TISSUE | R 24 hrs F Unacceptable | Culture,Microscopy,Karyotype | S: Daily 9 am R: 21 days |
N091 | Chromosome Analysis For Autism, Microarray 180K | 4 mL EDTA WB | R 24 hrs F Unacceptable | Microarray 180K | S: Daily 11 am R: 25 days |
N092 | Chromosome Analysis For Unipaternal Disomy (UPD), Microarray 180K | 4 mL EDTA WB | R 24 hrs F Unacceptable | Microarray 180K | S: Daily 11 am R: 25 days |
N074 | Chromosome Analysis, Microarray 60K | 4 mL EDTA WB | R 24 hrs F Unacceptable | Microarray | S: Daily 11 am R: 25 days |
Q016 | Chromosome Analysis, Philadelphia | 3 mL Heparinized BONE MARROW | R 24 hrs F Unacceptable | Culture,Microscopy,Karyotype | S: Daily 9 am R: 7 days |
Q017 | Chromosome Analysis, Amniotic Fluid | 20 mL Amniotic FLUID | R 48 hrs F Unacceptable | Culture,Microscopy,Karyotype | S: Daily 6 pm R: 21 days |
Q018 | Chromosome Analysis, Chorionic Villus | 40 mg Chorionic Villus BIOPSY | R 48 hrs F Unacceptable | Culture,Microscopy,Karyotype | S: Daily 6 pm R: 21 days |
Q019 | Chromosome Analysis, Cord Blood | 4 mL Heparinized CORD BLOOD | R 24 hrs F Unacceptable | Culture,Microscopy,Karyotype | S: Daily 9 am R: 10 days |
Q020 | Chromosome Analysis, High Resolution, Neonatal | 4 mL Heparinized WB | R 48 hrs F Unacceptable | Culture,Microscopy, High Resolution Karyotype | S: Daily 6 pm R: 21 days |
Q022 | Chromosome Interphase Profiling, Amniotic Fluid | 20 mL Amniotic FLUID | R 48 hrs F Unacceptable | FISH | S: Daily 4 pm R: 7 days |
Q021 | Chromosome Interphase Profiling, Products of Conception | 5 mg Placental or Fetal TISSUE | R 48 hrs F Unacceptable | FISH | S: Daily 4 pm R: 7 days |
Z799 | Chronic Fatigue Syndrome *CBC * C-Reactive Protein * LFT *KFT *CPK * Glucose, fasting * Iron Studies *TSH, Ultrasensitive | 5 mL SERUM + 3 mL EDTA WB + 2 mL Fluoride PLASMA Overnight fasting mandatory | R 48 hrs F 4 weeks | Electrical Impedence, Immunoturbidim etry, Spectrophotome try, IFCC, Hexokinase | Daily |
N138 | Chronic Lymphocytic Leukemia (CLL), Mutations Detection Panel 1 *Chromosome 2p gain *6q deletion *8p loss & 8q amplification *9p21 loss *11q deletion *Trisomy 12 *13q14 deletion *17p deletion | 4 mL EDTA WB | R 72 hrs F NA | PCR - MLPA | S: Mon 11 am R: Sat |
N139 | Chronic Lymphocytic Leukemia (CLL), Mutations Detection Panel 2 *SF3B1 K700E mutation *MYD88 L265P mutation *NOTCH1 p.2514*fs mutation *PTEN loss at 10q23.31 *11q deletion *Trisomy 12 *13q14 deletion *14q deletion *17p deletion *Trisomy 19 | 4 mL EDTA WB | R 72 hrs F NA | PCR - MLPA | S: Mon 11 am R: Sat |
N140 | Chronic Lymphocytic Leukemia (CLL), Mutations Detection Comprehensive Panel *SF3B1 K700E mutation *MYD88 L265P mutation *NOTCH1 p.2514*fs mutation *PTEN loss at 10q23.31 *11q deletion *Trisomy 12 *13q14 deletion *14q deletion *17p deletion *Trisomy 19 *Chromosome 2p gain *6q deletion *8p loss & 8q amplification *9p21 loss | 4 mL EDTA WB | R 72 hrs F NA | PCR - MLPA | S: Mon 11 am R: Sat |
P072 | Chyle Examination | 10 mL aliquot of random URINE | R 1 week F 2 weeks | Staining,Microsc opy | S: Daily 6 pm R: Next day |
G147 | Citrate, 24 Hour Urine | 10 mL aliquot of 24 hr URINE | R Unacceptable F 2 weeks | Spectrophotometry,Enzymatic | S: Daily 4 pm R: Same day |
OS118 | C-KIT Mutation Detection, PCR | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Wed / Sat 11 am R: 9 days |
RW044 | Clomipramine Includes metabolite N- Desmethylclomipramine & Total | 4 mL SERUM >12 hrs post oral dose No Additive tube | R 5 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
RW045 | Clonazepam | 3 mL SERUM before next dose No Additive tube | R 72 hrs F 14 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
RW046 | Clorazepate Measured as metabolite Nordiazepam | 3 mL SERUM before next dose No Additive tube | R 7 days F 60 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
OS119 | Clostridium difficle detection, PCR | 5 g STOOL | R 72 hrs F Unacceptable | PCR | S: Tue / Sat 11 am R: Mon / Thu |
H037 | Clot Retraction Test | 5 mL WB in graduated tube | NA | Manual | Daily |
H016 | Clotting Time;CT | Conducted on patient | NA | Lee & White | Daily |
RW047 | Clozapine Includes metabolite Norclozapine | 2 mL SERUM 0,5 -1,0 hr before next dose No Additive tube | R 5 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
Z042 | Coagulation Profile 1 CBC *BT *CT *PT *APTT *TT | 3 mL EDTA WB + 3 mL Citrated PPP BT& CT conducted on patient | R 48 hrs (WB) F 2 weeks (PPP) | Electrical Impedence, Photo-optical Clot Detection, Ivy, Lee & White | Daily |
Z041 | Coagulation Profile 2 *CBC *BT *CT *PT *APTT *TT * Factor VIII Functional | 3 mL EDTA WB + 3 mL Citrated PPP BT & CT conducted on patient | R 48 hrs (WB) F 2 weeks (PPP) | Electrical Impedence, Photo-optical Clot Detection, Ivy, Lee & White | S: Wed / Sat 9 am R: Fri / Tue |
H243 | Coagulation Screen *Platelet Count *Prothrombin studies *APTT | 3 mL EDTA WB + 3 mL Citrated PPP | R 48 hrs (WB) F 2 weeks (PPP) | Electrical Impedence, Photo-optical Clot Detection, | Daily |
C014 | Cobalt,Blood | 2 mL K2 EDTA WB Metal Free tube Use powderless gloves Avoid mineral supplements, Vitamin B12 or Vitamin B Complex 3 days prior to specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F Unacceptable | ICPMS | S: Daily 6 pm R: Next day |
C015 | Cobalt 24 Hour Urine | 10 mL aliquot of 24 hr URINE Metal Free Container Use powderless gloves Avoidmineral supplements, Vitamin B12 or Vitamin B Complex 3 days prior to specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
C016 | Cobalt Random Urine | 10 mL aliquot of random URINE Metal Free Container Use powderless gloves Avoidmineral supplements, Vitamin B12 or Vitamin B Complex 3 days prior to specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
K011 | Cocaine & Metabolite ScreenMeasured primarily as metabolite Benzoylecgonine | 10 mL aliquot of random URINE | R 1 week F 2 weeks | Lateral Flow Immunoassay | Daily |
RW048 | Coccidioides Antibody | 3 mL SERUM | R 14 days F 30 days | Immunodiffusion | S: By 7th of Month R: 2 - 3 weeks |
Z155 | Collagen Disease Antibodies Panel *ANA *Anti-ds-DNA *Sm *SS- A/Ro *SS-B/La *Scl-70 *Jo-1 *Centromere *U1RNP | 4 mL SERUM | R 1 week F 2 weeks | EIA | S: Tue / Fri 9 am R: Same day |
RW049 | Complement Total (CH50) | 3 mL SERUM | R Unacceptable F 28 days | Liposome | S: By 7th of Month R: 2 - 3 weeks |
Z048 | Complete Body Panel *SMA 26 *Hemogram *Lipid Profile, Extended * Urine R/E | 2 mL Fluoride PLASMA + 3 mL SERUM + 2 mL EDTA WB + 10 mL aliquot of random URINE Overnight fasting mandatory | R 48 hrs F Unacceptable | See Individual assays | S: Daily 9 am R:3 days |
Z021 | Complete Blood Count; CBC *Hemoglobin *PCV *TLC *RBC Count *MCV *MCH *MCHC *Platelet Count *Automated DLC *Absolute Differential Counts *RDW Does not include ESR & Peripheral Smear | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence, VCS | Daily |
OS121 | COMT Genotyping | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S: Sat 11 am R: 10 days |
OS122 | CONNEXIN 26 Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S: Sat 11 am R: 13 days |
OS123 | CONNEXIN 30 Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S: Sat 11 am R: 15 days |
H028 | Coombs Test, Direct | 3 mL EDTA WB | R 48 hrs F Unacceptable | Erythrocyte Magnetised Technology | S: Daily 9 am R: Same day |
H027 | Coombs Test, Indirect | 2 mL SERUM | R 1 week F 2 weeks | Erythrocyte Magnetised Technology | S: Daily 9 am R: Same day |
C017 | Copper, 24 Hour Urine | 10 mL aliquot of 24 hr URINE Metal Free Container Use powderless gloves If barium containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 1 week F 2 weeks | ICPMS | S: Daily 6 pm R:Next day |
C018 | Copper, Random Urine | 10 mL aliquot of random URINE Metal Free Container Use powderless gloves. If barium containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 1 week F 2 weeks | ICPMS | S: Daily 6 pm R:Next day |
C019 | Copper Serum | 2 mL SERUM White top Metal free tube. Use powderless gloves. If gadolinium, iodine or barium containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 1 week F 2 weeks | ICPMS | S: Daily 6 pm R:Next day |
G199 | Corticosterone | 2 mL SERUM No Additive tube Collect sample between 8 -10 am / 4-6 pm. | R 7 days F 7 weeks | LC-MS/MS | S: Daily 4 pm R: 2 days |
G200 | Cortisone : Cortisol Ratio | 2 mL SERUM No Additive tube Collect sample between 8 -10 am / 4-6 pm. | R 7 days F 7 weeks | LC-MS/MS | S: Daily 4 pm R: 2 days |
RW053 | Cortisol Free, Serum | 2 mL SERUM No Additive tube | R 7 days F 6 weeks | LC-MS/MS, Equilibrium Dialysis | S: By 7th of Month R: 2 - 3 weeks |
R175 | Cortisol, Saliva | 5 ml SALIVA Collect specimen before brushing teeth. Avoid stress, exercise, eating & drinking 30 minutes prior to sample collection. Rinse mouth thoroughly before collecting sample. | R 4 days F 1 year | ECLIA | S: Mon 9 am R: Same day |
Z010 Y028 Basal Y029 30 min Y030 60 min Y039 Customized | Cortisol Stimulation by ACTH | 2 mL SERUM for each timed specimen; Draw fasting baseline sample; Administer 250 ug synthetic ACTH IV; draw additional sample at 30 & 60 min | R 48 hrs F 2 weeks | CLIA | Daily |
Z059 Y038 Basal Y039 Post dexamethasone | Cortisol Suppression by Dexanmethasone, Overnight High dose | 2 mL SERUM for each timed specimen; Draw fasting baseline sample; Administer 4 mg Dexamethasone orally at 11 pm previous night; draw additional sample at 8 am next day | R 48 hrs F 2 weeks | CLIA | Daily |
Z058 | Cortisol Suppression by Dexanmethasone, Overnight Low dose | 2 mL SERUM at 8 am after administering Dexamethasone orally at 11 pm previous night | R 48 hrs F 2 weeks | CLIA | Daily |
U021 | Cortisol Free, 24 Hour Urine | 10 mL aliquot of 24 hr URINE Add 10 g Boric acid | R 48 hrs F 2 weeks | CLIA | Daily |
R016 | Cortisol Serum, Morning sample | 2 mL SERUM drawn between 7- 9 am. | R 48 hrs F 2 weeks | CLIA | Daily |
R017 | Cortisol Serum, Evening sample | 2 mL SERUM drawn between 3- 5 pm | R 48 hrs F 2 weeks | CLIA | Daily |
Z075 | Cortisol Serum, Morning & Evening samples | 2 mL SERUM each drawn between 7-9 am & 3-5 pm | R 48 hrs F 2 weeks | CLIA | Daily |
R043 | Cortisol Serum, Midnight sample | 2 mL SERUM drawn at 11 pm - midnight. | R 48 hrs F 2 weeks | CLIA | Daily |
RW054 | Cortisone (Compound E), 24 Hour Urine Includes Creatinine | 10 mL aliquot of 24 hr URINE Add 10 g Boric acid | R 72 hrs F 60 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
G198 | Cortisone, Serum | 2 mL SERUM No Additive tube Collect sample between 8 -10 am / 4-6 pm. | R 7 days F 7 weeks | LC-MS/MS | S: Daily 4 pm R: 2 days |
S110 | Coxsackie Antibody, IgG | 2 mL SERUM | R 1 week F 2 weeks | EIA | S:Wed 9 am R:8 days |
S176 | Coxsackie Antibody, IgM | 2 mL SERUM | R 1 week F 2 weeks | EIA | S:Wed 9 am R:8 days |
Z217 | Coxsackie Antibodies Panel, IgG & IgM | 2 mL SERUM | R 1 week F 2 weeks | EIA | S:Wed 9 am R:8 days |
RW056 | Coxsackie A Antibody Panel Includes 2, 4, 7, 9, 10 & 16 | 2 mL SERUM | R 14 days F 30 days | Complement Fixation | S: By 7th of Month R: 2 - 3 weeks |
Z037 Y074 Basal Y075 0.5 hr Y076 1.0 hr Y077 1.5 hr Y078 2.0 hr Y079 2.5 hr Y080 3.0 hr Y081 4.0 hr Y082 5.0 hr Y083 Customized | C-Peptide Response to Glucose, 5 Hours | 2 mL Fluoride PLASMA + 2 mL SERUM for each timed specimen Draw fasting baseline sample; Dissolve 82.5 g glucose monohydrate (equivalent to 75 g anhydrous glucose) in adults or 1.92 g / Kg body wt in children in 300 mL water; Draw additional samples at 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0 & 5.0 hrs. Overnight fasting mandatory | R 24 hrs F 1 week | CLIA, Hexokinase | Daily |
Z276 Y041 Basal Y042 5 min Y043 10 min Y044 15 min Y045 Customized | C-Peptide Stimulation by Glucagon | 2 mL SERUM for each timed specimen Draw fasting baseline sample; Administer 1 mg Glucagon IV; Draw additional samples at 5, 10 & 15 min. Overnight fasting mandatory | R 24 hrs F 2 weeks | CLIA | Daily |
U095 | C-Peptide, 24 hour urine | 5 mL aliquot of 24 hr URINE | R Unacceptable F 6 weeks | CLIA | Daily |
R055 | C-Peptide, Fasting, Serum | 2 mL SERUM Overnight fasting mandatory | R 24 hrs F 2 weeks | CLIA | Daily |
R157 | C-Peptide, Post prandial, Serum | 2 mL SERUM 2 hrs after starting meal | R 24 hrs F 2 weeks | CLIA | Daily |
E007 | CPK Isoenzyme ElectrophoresisIncludes Total CPK | 2 mL SERUM | R 72 hrs F 1 week | Agarose Gel Electrophoresis | S:Wed 9 am R: Same day |
B029 | CPK; Creatine Kinase | 2 mL SERUM | R 1 week F 2 weeks | IFCC | Daily |
B051 | CPK- MB | 2 mL SERUM | R 1 week F 2 weeks | Enzymatic Immunoinhibition | Daily |
R169 | CPK- MB Mass | 2 mL SERUM | R 8 hrs F 30 days | ECLIA | Daily |
B134 | C-Reactive Protein, Cardio; hs CRP | 2 mL SERUM | R 2 months F 6 months | Immunoturbidimetry | Daily |
B074 | C-Reactive Protein; CRP | 2 mL SERUM | R 2 months F 6 months | Immunoturbidimetry | Daily |
Z107 | Creatinine Clearance Test | 10 mL aliquot of 24 hr URINE + 2 mL SERUM Record Total Volume, Height & Weight | R 1 week F 2 weeks | Compensated Jaffe's Reaction IDMS Traceable | Daily |
U007 | Creatinine, 24 Hour Urine | 10 mL aliquot of 24 hr URINE Record Total Volume & Weight | R 1 week F 2 weeks | Compensated Jaffe's Reaction IDMS Traceable | Daily |
P082 | Creatinine Fluid | 10 mL FLUID | R 72 hrs F 1 week | Compensated Jaffe's Reaction IDMS Traceable | Daily |
U045 | Creatinine, Random Urine | 10 mL aliquot of random URINE | R 1 week F 2 weeks | Compensated Jaffe's Reaction IDMS Traceable | Daily |
B023 | Creatinine, Serum | 2 mL SERUM | R 1 week F 2 weeks | Compensated Jaffe's Reaction IDMS Traceable | Daily |
H117 | Cryoglobulins PanelImmunofixation Electrophoresis for classification of Cryoglobulins | 3 mL SERUM in a pre-warmed syringe & needle at 37°C. Allow to clot and centrifuge | 18 - 22°C within 72 hrs | Immunofixation Electrophoresis | S: Daily 9 am R: 5 days |
H115 | Cryoglobulins Qualitative Test | 3 mL EDTA WB | 18 -22°C within 72 hrs | Precipitation | S: Daily 9 am R: 5 days |
RW057 | Cryptococcus Antibody | 2 mL SERUM | R 14 days F 30 days | Agglutination | S: By 7th of Month R: 2 - 3 weeks |
S112 | Cryptococcus Antigen, Serum | 2 mL SERUM No Additive tube | R 72 hrs F 2 weeks | EIA | S:Wed 9 am R:Same day |
S111 | Cryptoccocus Antigen, CSF | 2 mL CSF | R 72 hrs F 2 weeks | EIA | S:Wed 9 am R:Same day |
T011 | Cryptosporidium / Isospora Identification, Stool | 5 g fresh STOOL | 18 - 22°C within 72 hrs | Conventional Microscopic Examination | S: Daily 3.30 pm R: Same day |
M202 | Cryptosporidium Antigen, Stool | 5 g fresh STOOL | R 24 hrs F Unacceptable | ICT | S Daily 1 pm R:Same day |
OS124 | Cryptococcus neoformans Detection, PCR | 4 mL EDTA WB or 1 mL CSF or SPUTUM or BODY FLUID | R 1 week F Unacceptable | PCR | S: Daily 11 am R: 13 days |
M072 | Culture ActinomycesDoes not include antibiotic sensitivity | Pus / IUD / Exudates / CSF / Body Fluids in Anaerobic transport medium | 18 - 22°C within 24 hrs | Anaerobic culture on specific media | S: Daily 3.30 pm R: Interim : 1 week Final 3 weeks |
M010 | Culture Aerobic Blood RapidIncludes antibiotic sensitivity if indicated | Adults - 8 - 10 mL BLOOD in Special Plus Aerobic Blood Culture bottle Pediatrics - 2 mL BLOOD in Special Paeds Aerobic Blood Culture bottle | 18 - 22°C within 24 hrs | Rapid Automated Aerobic Culture, Identification & Sensitivity | S: Daily 3.30 pm R: Interim : 24 & 48 hrs Final 6 days |
M133 | Culture Aerobic Body Fluids Rapid Includes antibiotic sensitivity if indicated | Adults - 8 - 10 mL BODY FLUID in Special Plus Aerobic Culture bottle Pediatrics - 3 mL BODY FLUIDS in Special Paeds Aerobic Culture bottle | 18 - 22°C within 48 hrs | Rapid Automated Aerobic Culture, Identification & Sensitivity | S: Daily 3.30 pm R: Interim : 24 & 48 hrs Final 6 days |
M145 | Culture Aerobic, CSFIncludes antibiotic sensitivity if indicated | 2 mL CSF in sterile container | 18 - 22°C within 48 hrs | Conventional Culture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M015 | Culture Aerobic, Ear SwabIncludes antibiotic sensitivity if indicated | EAR SWAB in special Aerobic transport medium | R 48 hrs F Unacceptable | Conventional Culture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M014 | Culture Aerobic, Eye SwabIncludes antibiotic sensitivity if indicated | EYE SWAB in special Aerobic transport medium | R 48 hrs F Unacceptable | Conventional Culture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
P058 | Culture Aerobic Miscellaneous with Gram Stain Includes antibiotic sensitivity if indicated | CATHETER TIP or 5 mL BODY FLUIDS or ASPIRATES or SWAB in Aerobic transport medium | R 48 hrs F Unacceptable | Conventional Culture, Automated Sensitivity, Gram stain | S: Daily 3.30 pm R: 3 days |
M020 | Culture Aerobic, MiscellaneousIncludes antibiotic sensitivity if indicated | CATHETER TIP or 5 mL BODY FLUIDS or ASPIRATES or SWAB in Aerobic transport medium | R 48 hrs F Unacceptable | Conventional Culture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M017 | Culture Aerobic, Nasal SwabIncludes antibiotic sensitivity if indicated | NASAL SWAB in special Aerobic transport medium | R 24 hrs F Unacceptable | Conventional Culture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M012 | Culture Aerobic, PusIncludes antibiotic sensitivity if indicated | PUS or SWAB in special Aerobic transport medium | R 48 hrs F Unacceptable | Conventional Culture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M013 | Culture Aerobic, SemenIncludes antibiotic sensitivity if indicated | SEMEN in sterile container | R 48 hrs F Unacceptable | Conventional Culture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M011 | Culture Aerobic, SputumIncludes antibiotic sensitivity if indicated | 5 - 10 mL SPUTUM in sterile container | R 48 hrs F Unacceptable | Conventional Culture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M016 | Culture Aerobic Vaginal SwabIncludes antibiotic sensitivity if indicated | VAGINAL SWAB in Amie's charcoal transport medium | R 48 hrs F Unacceptable | Conventional Culture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M139 | Culture AFB (Mycobacterium), Rapid with PNB Test Does not include Anti-tubercular drug sensitivity | 8 mLWB or BONE MARROW in Myco or F - Lytic bottle or 2 mL CSF or PUS or BODY FLUIDS or ASPIRATES or SEMEN or BAL or SWABS or 5-10 mL SPUTUM or URINE or GASTRIC LAVAGE in sterile container or Endometrial TISSUE in sterile normal saline | R 48 hrs F Unacceptable | Rapid Automated Fluorescent AFB Culture & Automated AFB Identification by PNB Test | S: Daily 3.30 pm R: Interim : 14 days & 4 weeks Final 6 weeks PNB test : 10 days after AFB culture is positive |
M050 | Culture AFB (Mycobacterium), Rapid Does not include Anti-tubercular drug sensitivity | 8 mLWB or BONE MARROW in Myco or F - Lytic bottle or 2 mL CSF or PUS or BODY FLUIDS or ASPIRATES or SEMEN or BAL or SWABS or 5-10 mL SPUTUM or URINE or GASTRIC LAVAGE in sterile container or Endometrial TISSUE in sterile normal saline | R 48 hrs F Unacceptable | Automated Fluorescent , ICT, MALDITOF | S: Daily 3.30 pm R: Interim : 14 days & 4 weeks Final 6 weeks |
M068 | Culture Anaerobic Does not include antibiotic sensitivity | 1 mL CSF or PUS or BODY FLUIDS or ASPIRATES or Endometrial TISSUE or BONE MARROW in Anaerobic transport medium | 18 -22°C within 48 hrs | Conventional Anaerobic culture & Automated Identification | S: Daily 3.30 pm R: 8 Days |
M021 | Culture Anaerobic, Blood, Rapid Does not include antibiotic sensitivity | 8 - 10 mL BLOOD in Special Plus Anaerobic Culture bottle | 18 -22°C within 48 hrs | Rapid Automated Anaerobic culture & Identification | S: Daily 3.30 pm R: 6 Days |
M134 | Culture Anaerobic Body fluid, Rapid Does not include antibiotic sensitivity | 8 - 10 mL BODY FLUID in Special Plus Anaerobic Culture bottle | 18 -22°C within 48 hrs | Rapid Automated Anaerobic culture & Identification | S: Daily 3.30 pm R: 6 Days |
M076 | Culture Cholera Includes antibiotic sensitivity if indicated | 5 mL STOOL in special transport medium | R 48 hrs F Unacceptable | Conventional Culture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 Days |
M070 | Culture Clostridium difficleDoes not include antibiotic sensitivity | 5 gm fresh STOOL in Anaerobic transport medium | R 48 hrs F Unacceptable | Conventional Anaerobic Culture & Automated Identification | S: Daily 3.30 pm R: 8 Days |
M078 | Culture Diptheria Does not include antibiotic sensitivity | NASAL or THROAT SWAB in Amie's transport medium | R 48 hrs F Unacceptable | Conventional Culture | S: Daily 3.30 pm R: 3 Days |
M195 | Culture ESBL (Extended Spectrum Beta-Lactamase), Screening | Rectal / Wound SWABS / Pure GROWTH in Amies transport medium | R 24 hrs F Unacceptable | Chromogenic | S: Daily 11 am R: Next day |
M104 | Culture Fungus Does not include Anti-fungal sensitivity | 2 mL Heparinized BONE MARROW or 2 mL CSF or PUS or BODY FLUIDS or ASPIRATES or SEMEN or STOOL or SWABS or 5-10 mL SPUTUM or URINE or SKIN SCRAPINGS or HAIR or NAIL CLIPPINGS in sterile container or Endometrial TISSUE in sterile normal saline | 18 - 22°C within 48 hrs | Conventional fungus Culture | S: Daily 3.30 pm R: Interim 1: 1 week Interim 2: 2 weeks Interim 3: 3 weeks Final: 4 weeks |
M024 | Culture Fungus, Blood / Body Fluids, Rapid Includes antibiotic sensitivity for Yeast only if indicated | 8-10 mL WB or BODY FLUIDS in Myco or F-Lytic bottle | 18 - 22°C within 48 hrs | Rapid Automated Fungus culture | S: Daily 3.30 pm R: Interim : 2 days Final: 15 days |
M018 | Culture GonococcusDoes not include antibiotic sensitivity | Urethra or Anus or Eye or Endocervix or Pharynx SWAB in Amie's Charcoal medium | 18 - 22°C within 48 hrs | Conventional Culture & Automated identification | S: Daily 3.30 pm R: 3 days |
M095 | Culture HemophilusDoes not include antibiotic sensitivity | Throat or Eye or Ear SWAB or SPUTUM in Amie's transport medium or CSF in sterile container | 18 - 22°C within 48 hrs | Conventional Culture & Automated identification | S: Daily 3.30 pm R: 3 days |
M198 | Culture KPC (Carbapenemase), Screening | Rectal / Wound SWABS / Pure GROWTH in Amies transport medium | R 24 hrs F Unacceptable | Chromogenic | S: Daily 11 am R: Next day |
M197 | Culture MRSA (Methicillin Resistant Staphylococcus aureus), Screening | Nasal / Axilla / Groin / Wound SWABS / Pure GROWTH in Amies transport medium | R 24 hrs F Unacceptable | Chromogenic | S: Daily 11 am R: Next day |
M096 | Culture Nocardia Does not include antibiotic sensitivity | PUS or SPUTUM or TISSUE or SWABS in sterile container | R 48 hrs F Unacceptable | Conventional Culture | S: Daily 3.30 pm R: Interim: 1 week Final: 3 weeks |
M008 | Culture Stool Includes antibiotic sensitivity if indicated | 2 -5 g STOOL in special Stool culture transport medium | R 48 hrs F Unacceptable | Conventional Culture & Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M007 | Culture Urine Includes antibiotic sensitivity if indicated . | Mid Stream URINE in special urine collection vacutainer kit | R 48 hrs F Unacceptable | Conventional Culture & Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M035 | Culture Water; Presumptive Coliform Count | 180 mL Potable WATER (3 x 60 mL) in sterile containers Specify water source | R 48 hrs F Unacceptable | Multiple tube test | S: Daily 3.30 pm R: 3 days |
M009 | Culture Aerobic, Throat SwabIncludes antibiotic sensitivity if indicated | THROAT SWAB in Amie's transport medium | R 48 hrs F Unacceptable | Conventional Culture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M141 | Cultured Aerobic Bacteria Identification & Sensitivity | Pure ISOLATE on appropriate media | R 48 hrs F Unacceptable | Subculture, Automated Identification & Sensitivity | S: Daily 3.30 pm R: 3 days |
M069 | Cultured Aerobic Bacteria Identification Does not include antbiotic sensitivity | Pure ISOLATE on appropriate media | R 48 hrs F Unacceptable | Subculture, Automated Identification | S: Daily 3.30 pm R: Next day |
M140 | Cultured Aerobic Bacteria Sensitivity | Pure ISOLATE on appropriate media | 18 - 22°C within 48 hrs | Subculture,Automated sensitivity | S: Daily 3.30 pm R: Next day |
M182 | Cultured AFB Anti-tubercular DST, Rapid 10 second line drugs panel *Amikacin *Kanamycin *Capreomycin *Clofazimine *Ethionamide *Ofloxacin * Levofloxacin * Moxifloxacin *PAS * Cycloserine | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 48 hrs F 4 weeks | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M228 | Cultured AFB Anti-tubercular DST, Rapid 19 drugs panel *Streptomycin *Isoniazid *Rifampicin * Ethambutol *Pyrazinamide *Amikacin *Kanamycin *Capreomycin *Clofazimine *Ethionamide *Ofloxacin * Levofloxacin * Moxifloxacin *PAS * Cycloserine *Linezolid *Rifabutin *Amoxyclav * Clarithromycin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 48 hrs F 4 weeks | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M183 | Cultured AFB Anti-tubercular DST, Rapid 5 second line drugs panel *Ofloxacin * Levofloxacin * Moxifloxacin *PAS *Cycloserine | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 48 hrs F 4 weeks | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M181 | Cultured AFB other than Tuberculosis (MOTT) DST for Rapid growers | Pure GROWTH of MOTT on appropriate media | R 48 hrs F 4 weeks | Broth Microdilution (MIC) | S: Daily 3.30 pm R :7 days |
M180 | Cultured AFB other than Tuberculosis (MOTT) DST for Slow growers | Pure GROWTH of MOTT on appropriate media | R 48 hrs F 4 weeks | Broth Microdilution (MIC) | S: Daily 3.30 pm R :14 days |
M092 | Cultured Anaerobic Bacteria Identification Does not include antibiotic sensitivity | PURE ISOLATE on appropriate medium | R 48 hrs F Unacceptable | Subculture & Automated Identification | S: Daily 3.30 pm R: 8 Days |
M093 | Cultured Fungus IdentificationDoes not include anti-fungal sensitivity | PURE ISOLATE on appropriate medium | R 7 days F Unacceptable | Conventional Fungus Culture & Identification | S: Daily 3.30 pm R: 3-28 days |
M107 | Cultured AFB Anti-tubercular DST, Rapid 10 Drugs Panel *Streptomycin *Isoniazid *Rifampicin *Ethambutol *Pyrazinamide *Clofazimine *Ethionamide *Capreomycin *Kanamycin *Amikacin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M123 | Cultured AFB Anti-tubercular DST, Rapid 11 Drugs Panel *Streptomycin *Isoniazid *Rifampicin *Ethambutol *Pyrazinamide *Clofazimine *Ethionamide *Capreomycin *Kanamycin *Amikacin *Ofloxacin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M124 | Cultured AFB Anti-tubercular DST, Rapid 12 Drugs Panel *Streptomycin *Isoniazid *Rifampicin *Ethambutol *Pyrazinamide *Clofazimine *Ethionamide *Capreomycin *Kanamycin *Amikacin *Ofloxacin *PAS | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M176 | Cultured AFB Anti-tubercular DST, Rapid 15 Drugs Panel *Streptomycin *Isoniazid *Rifampicin *Ethambutol *Pyrazinamide *Clofazimine *Ethionamide *Capreomycin *Kanamycin *Amikacin *Ofloxacin *PAS *Cycloserine *Levofloxacin *Moxifloxaxin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M224 | Cultured AFB Anti-tubercular DST, Rapid 16 Drugs Panel *Streptomycin *Isoniazid *Rifampicin *Ethambutol *Pyrazinamide *Clofazimine *Ethionamide *Capreomycin *Kanamycin *Amikacin *Ofloxacin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M105 | Cultured AFB Anti-tubercular DST, Rapid 4 Drugs Panel *Streptomycin *Isoniazid *Rifampicin *Ethambutol | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M106 | Cultured AFB Anti-tubercular DST, Rapid 5 Drugs Panel *Streptomycin *Isoniazid *Rifampicin *Ethambutol *Pyrazinamide | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M108 | Cultured AFB Anti-tubercular DST, Pyrazinamide | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M225 | Cultured AFB Anti-tubercular DST, Linezolid | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M109 | Cultured AFB Anti-tubercular DST, Streptomycin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M179 | Cultured AFB Anti-tubercular DST, Moxifloxacin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M110 | Cultured AFB Anti-tubercular DST, Isoniazid | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M117 | Cultured AFB Anti-tubercular DST, Capreomycin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M114 | Cultured AFB Anti-tubercular DST, Amikacin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M178 | Cultured AFB Anti-tubercular DST, Levofloxacin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M120 | Cultured AFB Anti-tubercular DST, PAS | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M111 | Cultured AFB Anti-tubercular DST, Rifampicin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M112 | Cultured AFB Anti-tubercular DST, Ethambutol | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M118 | Cultured AFB Anti-tubercular DST, Clofazimine | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M177 | Cultured AFB Anti-tubercular DST, Cycloserine | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M115 | Cultured AFB Anti-tubercular DST, Ethionamide | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M113 | Cultured AFB Anti-tubercular DST, Kanamycin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M119 | Cultured AFB Anti-tubercular DST, Ofloxacin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M226 | Cultured AFB Anti-tubercular DST, Amoxyclav | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M227 | Cultured AFB Anti-tubercular DST, Rifabutin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M229 | Cultured AFB Anti-tubercular DST, Clarithromycin | Pure GROWTH of Mycobacterium tuberculosis complex on appropriate media | R 4 weeks F Unacceptable | Automated fluorescent | S: Daily 3.30 pm R :21 days |
M223 | Cultured Mold Antifungal Drug sensitivity (DST) Test | Pure GROWTH of Mold on appropriate media | 18 - 22°C within 48 hrs | Micro broth | S: Daily 9 am R :7 days |
G159 | Cyclosporine A | 3 mL EDTA WB drawn just before next dose | R 7 days F Unacceptable | LC-MS/MS | S: Daily 5 pm R :Same day |
OS125 | CYP2C19 Genotyping | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S: Sat 11 am R : 15 days |
OS126 | CYP3A *22 Genotyping | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S: Sat 11 am R : 10 days |
B173 | Cystatin C | 2 mL SERUM | R 1 week F 3 months | Nephelometry | S: Mon / Wed / Fri 4 pm R : Same day |
OS127 | Cystic Fibrosis Mutation Detection | 4 mL EDTA WB or 10 mL Amniotic FLUID in a sterile container | R 1 week F Unacceptable | PCR Sequencing | S: Daily 11 am R : 6 weeks |
R162 | Cystic Fibrosis, Newborn Screen | 1 drop heel prick blood each on 3 spots of filter paper | R 1 week F 1 week | Fluoroimmunoassay | S: Tue / Thu / Sat 5 pm R: 2 days |
S033 | Cysticercosis (Taenia solium) Antibody, IgG | 2 mL SERUM | R 1 week F 2 weeks | EIA | S:Mon 9 am R:Same day |
J006 | Cytology (PAP Smear), Genital, Female Conventional | 2 Absolute Alcohol Fixed SMEARS Do not allow smears to air dry before fixation Do not collect smears during menstruation | NA | Microscopy | S: Daily 6 pm R: Next day |
J152 | Cytology (PAP Smear), Genital, Female Liquid based | ENDOCERVICAL SMEARS in special collection kit Do not collect smears during menstruation | NA | Microscopy | S: Daily 6 pm R: Next day |
J008 | Cytology Consultation, Second Opinion | Cytology SLIDES | NA | Microscopy | S: Daily 6 pm R: Next day |
J011 | Cytology Examination, Body fluids | BODY FLUIDS or CSF or SYNOVIAL or PROSTATIC or URETHRAL or BAL or SPUTUM or URINE or NIPPLE DISCHARGE in a sterile container with 50% Absolute alcohol or smeared onto 4 glass slides fixed in Absolute alcohol. Do not allow smears to air dry before fixation | NA | Microscopy | S: Daily 6 pm R: Next day |
J074 | Cytology, Cell Block Examination | Cytopathological MATERIAL | R 72 hrs F Unacceptable | Cell Block | S: Daily 6 pm R: 3 days |
J004 | Cytology, Fine Needle Aspiration; FNAC | ASPIRATE from Breast, Superficial lumps, CT or USG guided deep lumps smeared onto 4 glass slides fixed in Absolute alcohol Do not allow smears to air dry before fixation | NA | Microscopy | S: Daily 6 pm R: Next day |
Z122 | Cytomegalovirus (CMV) Antibodies Panel, IgG & IgM | 2 mL SERUM | R 2 weeks F 4 weeks | CLIA | Daily |
S041 | Cytomegalovirus (CMV) Antibody, IgG | 2 mL SERUM | R 2 weeks F 4 weeks | CLIA | Daily |
S022 | Cytomegalovirus (CMV) Antibody, IgM | 2 mL SERUM | R 2 weeks F 4 weeks | CLIA | Daily |
B156 | Cytomegalovirus (CMV) Avidity, IgG | 2 mL SERUM | R 2 weeks F 4 weeks | EIA | S: Daily 9 am R: Same day |
N031 | Cytomegalovirus (CMV), DNA Quantitative, PCR | 2 mL EDTA PLASMA | R 72 hrs F 10 days | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N017 | Cytomegalovirus (CMV), Qualitative, PCR | 5 mL Amniotic FLUID (after 21 weeks pregnancy) in a sterile container or 10 mL URINE or SALIVA or 2 mL EDTA PLASMA or 2 mL SERUM or 2 mL CSF or BAL FLUID in a sterile container or 5g fresh TISSUE in normal saline | R 1 week F 2 weeks | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
H134 | D-Dimer, Quantitative | 3 mL Citrated PPP Separate plasma & freeze immediately | F 2 weeks | Immunoturbidimetry | Daily |
Z056 | Deep Vein Thrombosis Panel; DVT Panel *Antithrombin Activity Functional *Cardiolipin Antibodies IgG and IgM *dRVVT *Protein C Functional *Protein S (Free) Antigen | 2 mL SERUM + 6 mL CITRATED PPP Separate plasma & freeze immediately | F 2 weeks | Electromechanical Clot Detection, EIA, Immunoturbidim etry, Chromogenic | S: Daily 3 pm R: Next day |
N132 | Dengue Virus PCR, Qualitative | 3 mL EDTA WB or PLASMA or 2 mL SERUM or 1 mL CSF | R 1 week F Unacceptable | PCR | S: Daily 11 am R: Next day |
Z674 | Dengue Fever Antibodies, IgG & IgM, EIA | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S: Daily 12 noon R: Same day |
S151 | Dengue Fever Antibodies Panel, IgG & IgM | 2 mL SERUM | R 1 week F 2 weeks | ICT | Daily |
Z510 | Dengue Fever Combined Panel *Dengue fever antibodies IgG & IgM *Dengue fever NS1 antigen | 2 mL SERUM | R 1 week F 1 week | ICT, Lateral Flow ICT | Daily |
S217 | Dengue Fever IgG Antibody, EIA | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S: Daily 12 noon R: Same day |
S225 | Dengue Fever NS1 Antigen, EIA | 2 mL SERUM | R 1 week F 1 week | EIA | S: Daily 12 noon R: Same day |
H063 | Dengue Fever NS1 Antigen, Rapid | 2 mL SERUM or 2 mL EDTA PLASMA | R 1 week F 1 week | Lateral Flow ICT | Daily |
S216 | Dengue Fever IgM Antibody, EIA | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S: Daily 12 noon R: Same day |
N132 | Dengue Virus, PCR Qualitatative | 3 mL EDTA Whole Blood / Plasma or 2 mL Serum or 2 mL CSF | R 72 hrs F Unacceptable | Real Time PCR | S: Daily 11 am R: Next day |
Z853 | Dengue & Chikungunya Viruses, PCR Qualitatative | 3 mL EDTA Whole Blood / Plasma or 2 mL Serum or 2 mL CSF | R 72 hrs F Unacceptable | Real Time PCR | S: Daily 11 am R: Next day |
RW058 | Deoxycorticosterone | 3 mL SERUM No Additive Tube | R 7 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
RW059 | Desipramine | 4 mL SERUM No Additive Tube Draw sample >12 hrs post oral dose | R 5 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
S099 | Desmoglein (DSG) 1 & 3 Antibody | 2 mL SERUM | R 1 week F 2 weeks | IFA | S: Mon 9 am R: Wed 6 pm |
RW060 | Dexamethasone | 2 mL SERUM No Additive Tube Draw sample between 8-10 a.m | R 1 week F 6 weeks | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
R044 | DHEA Sulphate; Dehydroepiandrosterone Sulphate | 2 mL SERUM | R 1 week F 2 months | CMIA | Daily |
Z022 Y046 Basal Y047 90 min Y049 Customized | DHEA Stimulation by ACTH | 2 mL SERUM for each timed specimen; Draw fasting baseline sample; Administer 250 ug synthetic ACTH IV; draw additional sample at 90 min | R 1 week F 2 weeks | EIA | S:Tue / Fri 9 am R:Same day |
R100 | DHEA; Dehydroepiandrosterone | 2 mL SERUM | R 1 week F 2 weeks | EIA | S:Tue / Fri 9 am R:Same day |
Z285 | Diabetes Panel 1 *Glucose F + PP * Cholesterol * Triglycerides* HbA1c *Urea * Creatinine | 2 mL Fluoride PLASMA + 3 mL SERUM + 3 mL EDTA WB | R 24 hrs F Unacceptable | Spectrophotometry, HPLC | Daily |
Z286 | Diabetes Panel 2 *Glucose F + PP* HbA1c* Uric Acid * Creatinine * Cholesterol * HDL * LDL Calculated * Triglyceride * Microalbumin * Urine R/E | 2 mL Fluoride PLASMA + 3 mL SERUM + 3 mL EDTA WB + 10 mL aliquot of first morning URINE | R 24 hrs F Unacceptable | Spectrophotometry, HPLC, Dipstick | Daily |
Z312 | Diabetes Panel Basic *Glucose F / PP / R *HbA1c | 2 mL Fluoride PLASMA + 3 mL EDTA WB | R 24 hrs F Unacceptable | Hexokinase,HPLC | Daily |
Z359 | Diabetes Screen *Glucose F + PP * Urine Glucose | 2 mL Fluoride PLASMA + 10 mL aliquot of first morning URINE | R 24 hrs F Unacceptable | Hexokinase,Dipstick | Daily |
Z833 | Diabetes Type 1, Autoimmune Profile *GAD-65* Anti-IA2* Insulin Autoantibody* Islet Cell Antibody | 5 mL SERUM | R 1 week F 2 weeks | EIA, IFA | S:Fri 9 am R:Next day |
RW061 | Diazepam Includes metabolite Nordiazepam | 2 mL SERUM No Additive Tube Draw sample just before next dose | R 5 days F 14 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
RW062 | Digitoxin | 2 mL SERUM No Additive Tube Draw sample just before next dose | R 1 week F 6 weeks | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
D008 | Digoxin | 2 mL SERUM No Additive Tube Draw sample just before next dose (Trough) or 6-8 hrs post dose (Peak) | R 48 hrs F 2 weeks | CLIA | Daily |
R103 | 5a- Dihydrotestosterone; 5a- DHT | 2 mL SERUM | R 1 week F 2 weeks | EIA | S:Thu 9 am R: Same day |
RW063 | Dihydrotestosterone (DHT), Free | 5 mL SERUM | R 7 days F 6 weeks | LC-MS/MS, Equilibrium Dialysis | S: By 7th of Month R: 2 - 3 weeks |
RW064 | Disopyramide | 2 mL SERUM No Additive Tube | R 14 days F 35 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
H245 | Disseminated Intravascular Coagulation (DIC) Profile *CBC *Prothrombin studies *APTT *Fibrinogen * D-Dimer | 6 mL Citrated PPP Separate plasma & freeze immediately + 3 mL EDTA WB | R 48 hrs (WB) F 2 weeks (PPP) | Photo-optical clot detection, Electrical Impedence | Daily |
P084 | DLC (Differential Leukocyte Count), Fluid | 2 mL FLUID | R 24 hrs F Unacceptable | Manual Count | Daily |
H023 | DLC (Differential Leukocyte Count), Automated | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electronic cell cytometry, VCS & Microscopy | Daily |
N106 | DNA Profiling / Finger printingFor Establishing Paternity / Kinship / Lineage studies | 3 mL EDTA WB for each individual | R 1 week F Unacceptable | PCR, STR Analysis | S: Daily 11 am R: 5 days |
G140 | DNPH, Urine | 10 mL aliquot of first morning or post feed URINE | R 1 week F 2 weeks | Biochemical | S: Daily 5 pm R: Same day |
RW065 | Doxepin Includes metabolite Nordoxepin & Total | 3 mL SERUM No Additive Tube Draw sample >12 hrs post oral dose | R 7 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
OS130 | DPD Gene Mutations (5-FU toxicity) Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Daily by 11 am R: 13 days |
R122 | DPYD (Deoxypridinoline), Urine | 10 mL aliquot of first morning URINE Wrap in aluminium foil to protect from light | R 1 week F 4 weeks | Chemiluminesce nt Immunoassay | S: Mon 4 pm R: Same day |
OS132 | DRPLA Gene Analysis | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Fragment analysis | S: Mon 11 am R: 12 days |
V617 | Drugs of Abuse, 7 Drugs Urine Screen * Opiates *Benzodiazepine *Cannabinoids *Cocaine & metabolites *Amphetamine * Barbiturate * Phencyclidine (PCP) | 10 mL aliquot of random URINE | R 1 week F 2 weeks | Lateral Flow Immunoassay | Daily |
N116 | Duchenne / Becker Muscular Dystrophy (DMD / BMD) Gene Mutation | 3 mL EDTA WB | R 72 hrs F Unacceptable | MLPA | S: Mon 11 am R: Sat |
S036 | Echinococcus (Hydatid Serology), IgG, Serum | 2 mL SERUM | R 72 hrs F 2 weeks | EIA | S:Tue / Sat 9 am R:Same day |
P096 | Echinococcus detection for scolices in Hydatid Cyst fluid | 1 mL CYST FLUID | R 1 week F 2 weeks | Microscopy | S: Daily 6 pm R: Next day |
Z218 | Echovirus Antibodies Panel, IgG & IgM | 2 mL SERUM | R 1 week F 4 weeks | EIA | S:Mon 9 am R:Same day |
S125 | Echovirus Antibody, IgG | 2 mL SERUM | R 1 week F 4 weeks | EIA | S:Mon 9 am R:Same day |
S177 | Echovirus Antibody, IgM | 2 mL SERUM | R 1 week F 4 weeks | EIA | S:Mon 9 am R:Same day |
N072 | EGFR, Mutational Analysis | Paraffin BLOCK | NA | PCR, Fragment Analysis, Sequencing | S:Mon / Thu 9 am R:Fri / Tue |
Z383 | Electrolytes, 24 Hour Urine *Sodium *Potassium *Chloride | 10 mL aliquot of 24 hr URINE | R 1 week F 2 weeks | Indirect ISE | Daily |
Z380 | Electrolytes, Random Urine *Sodium *Potassium *Chloride | 10 mL aliquot of random URINE | R 1 week F 2 weeks | Indirect ISE | Daily |
Z020 | Electrolytes, Serum *Sodium *Potassium *Chloride | 3 mL SERUM | R 1 week F 2 weeks | Indirect ISE | Daily |
J154 | Electron Microscopy (EM) | Kidney or Muscle or Nerve or Other tissue BIOPSY in 3% Buffered Glutaraldehyde solution | R 1 week F Unacceptable | Transmission Electron Microscopy | S: Daily 6 pm R: 10 days |
S078 | Endomysial Antibody, IgA, IFA | 2 mL SERUM | R 1 week F 4 weeks | IFA | S: Daily 11 am R: Same day |
S105 | Endomysial Antibody, IgA, IFA in dilutions | 3 mL SERUM | R 1 week F 4 weeks | IFA | S: Daily 11 am R: Next day |
Z819 | Enhanced Liver Fibrosis (ELF) Panel *Hyaluronic acid (HA) * Amino terminal Propeptide type III Procollagen (PIIINP) *Tissue inhibitor Metalloproteinase 1 (TIMP-1) * ELF score | 3 mL SERUM Overnight fasting mandatory | R 1 week F 4 weeks | CMIA | S: Mon / Thu 4 pm R: Next day |
N125 | Enterovirus, Qualitative PCR | 3 mL CSF / 3 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R:Wed / Sat |
M210 | Enterovirus Antigen, Stool | 5 g fresh STOOL | R 48 hrs F Unacceptable | ICT | S: Daily 1 pm R: Same day |
M204 | Enterohemorrhagic E.coli, Verotoxin 1 & 2 Antigen | 5 g fresh STOOL | R 24 hrs F Unacceptable | ICT | S: Daily 1 pm R: Same day |
S195 | Epidermal (Pemphigus) Antibody, IFA | 2 mL SERUM | R 1 week F 4 weeks | IFA | S: Daily 11 am R: Same day |
S198 | Epidermal (Pemphigus) Antibody, IFA in dilutions | 3 mL SERUM | R 1 week F 4 weeks | IFA | S: Daily 11 am R: Next day |
Z172 | Epstein Barr Virus Antibodies to Viral Capsid Antigen (VCA), IgG & IgM | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S: Wed / Sat 9 am R:Same day |
RW067 | Epstein Barr Virus Antibody to Early Antigen (D), IgG | 2 mL SERUM | R 7 days F 30 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
S069 | Epstein Barr Virus Antiody to Viral Capsid Antigen (VCA), IgG | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Wed / Sat 9 am R:Same day |
S070 | Epstein Barr Virus Antiody to Viral Capsid Antigen (VCA), IgM | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Wed / Sat 9 am R:Same day |
RW068 | Epstein Barr Virus Antibody to Nuclear Antigen (EBNA), IgG | 2 mL SERUM | R 7 days F 30 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
J185 | Epstein Barr Virus Early RNA (EBER-ISH), In Situ Hybridization | Paraffin BLOCK or BIOPSY | NA | In Situ Hybridization | S: Daily 6 pm R: 5 days (Block / ; 7 days (Biopsy) |
N127 | Epstein Barr Virus (EBV), Qualitative PCR | 3 mL EDTA WB or 2 mL CSF | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R:Wed / Sat |
R018 | Erythropoietin; EPO | 2 mL SERUM | R 1 week F 2 months | CLIA | S:Mon / Thu 4 pm R:Same day |
H009 | ESR; Erythrocyte Sedimentation Rate | 3 mL EDTA WB | R 72 hrs F Unacceptable | Capillary Photometry / Westergren | Daily |
R019 | Estradiol (E2) Serum | 3 mL SERUM | R 48 hrs F 6 months | CLIA | Daily |
R101 | Estriol Unconjugated / Free (µE3) | 2 mL SERUM | R 1 week F 6 months | CLIA | Daily |
RW069 | Estrogen Total, Serum | 2 mL SERUM No Additive Tube | R 14 days F 28 days | Extraction, RIA | S: By 7th of Month R: 2 - 3 weeks |
RW070 | Ethosuximide | 2 mL SERUM drawn just before next dose No Additive Tube | R 14 days F 35 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
G161 | Everolimus | 3 mL EDTA WB drawn 1 hr before next dose | R 7 days F Unacceptable | LC-MS / MS | S:Daily 5 pm R:Same day |
Z011 | Executive Officers Panel *Glucose (F) *Creatinine *Uric Acid *Cholesterol *Triglycerides *SGOT *SGPT *GGTP *Bilirubin, Total *Protein, Total *Albumin *A:G Ratio *Alkaline Phosphatase *CBC *Blood Group & Rh factor * TSH Ultrasensitive | 2 mL FLUORIDE PLASMA + 4 mL SERUM + 3 mL EDTA WB 12 hrs overnight fasting mandatory | R 48 hrs F Unacceptable | Spectrophotometry, Electrical Impedence, VCS, EMT | Daily |
S118 | Extractable Nuclear Antigens (ENA), Qualitative profileCombined group screening test for 15 antigens | 2 mL SERUM | R 72 hrs F 4 weeks | Immunoblot | S: Mon through Sat 9 am R:Same day |
Z101 | Extractable Nuclear Antigens (ENA), Quantitative profile Individual antibodies to *Sm *U1RNP *SS-A/Ro *SS-B/La *Jo-1 *Scl-70 *Centromere | 3 mL SERUM | R 72 hrs F 4 weeks | EIA | S: Tue / Fri 9 am R:Same day |
G127 | Fabry Disease Quantitative, Blood This tests deficiency of enzyme Alpha Galactosidase A | 10 mL EDTA or Heparinized WB | R 48 hrs F Unacceptable | Enzyme assay | S: Daily 4 pm R: 4 days |
H173 | Factor II, Functional | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Photo-optical clot detection | S: Thu 9 am R: Next day |
H174 | Factor V, Functional | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Electromechanical clot detection | S: Thu 9 am R: Next day |
H209 | Factor V Leiden Mutation Analysis *Factor V Leiden Mutation *Prothrombin Gene Mutation *MTHFR Gene Mutation | 3 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R:Wed / Sat |
H178 | Factor VII, Functional | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Photo-optical clot detection | S: Thu 9 am R: Next day |
H240 | Factor VIII, Functional / Activity | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Electromechanical clot detection | S: Daily 11 am R: Same day |
H175 | Factor IX Functional | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Photo-optical clot detection | S: Wed / Sat 9 am R: Fri / Tue |
H176 | Factor X Functional | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Electromechanical clot detection | S: Thu 9 am R: Next day |
H177 | Factor XI Functional | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Photo-optical clot detection | S: Thu 9 am R: Next day |
H179 | Factor XII Functional | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Photo-optical clot detection | S: Thu 9 am R: Next day |
H041 | Factor XIII (Clot Solubility) Functional, Qualitative | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Clot dissolution with 5M Urea | S: Daily 1 pm R: Next day |
XX025 | Fanconi's anemia, Stress Cytogenetics | 5 mL Heparinized WB | 18 -22°C within 48 hrs | Stress Cytogenetics | S: Daily 6 pm R: 7 days |
Z837 | Fatty Liver Index *GGTP *Triglycerides | 2 mL SERUM Overnight fasting mandatory Record patient height, weight, waist circumference (highest point of hip bone) on test request form. | R 72 hrs F 1 week | IFCC,GPO-POD | S: Mon through Sat 9 am R: Same day |
Z124 | Febrile Agglutinins Panel Combined Brucella, Widal and Weil Felix tests panel *Brucella abortus *Brucella melitensis *Salmonella paratyphi Type AH and Type BH *Salmonella typhi H & O *OX2 *OXK *OX19 | 3 mL SERUM | R 48 hrs F 72 hrs | Latex & Tube agglutination | S: Daily 6 pm R: Next day |
S231 | Fecal Calprotectin | 5g STOOL | R 6 days F Unacceptable | EIA | S: Mon / Thu 9 am R: Same day |
S247 | Fecal Elastase | 5g STOOL | R 1 week F 1 year | EIA | S: Mon 9 am R: Same day |
RW071 | Felbamate | 2 mL SERUM drawn 1 hr before next dose No Additive Tube | R 5 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
G141 | Ferric Chloride Test, Urine | 10 mL aliquot of random URINE | R 1 week F 2 weeks | Chemical | S: Daily 5 pm R: Same day |
H060 | Ferritin | 2 mL SERUM | R 48 hrs F 4 weeks | CLIA | Daily |
Z390 | Fever Panel 1 *Hemogram *MP * Widal * Urine R/E | 3 mL EDTA WB + 2 mL SERUM + 10 mL aliquot of random URINE | R 48 hrs F Unacceptable | Electrical impedence, VCS, Microscopy, Agglutination, Dipstick | Daily |
Z391 | Fever Panel 2 *Hemogram *MP * Widal * Urine R/E * SGPT * Aerobic Blood Culture | 3 mL EDTA WB + 2 mL SERUM + 10 mL WB in Special Plus Aerobic Blood Culture bottle + 10 mL aliquot of random URINE | 18 -22°C within 48 hrs | Electrical impedence, VCS, Microscopy, Agglutination, Dipstick, IFCC, Conventional culture & Automated sensitivity | S: Daily 6 pm R: Interim: 24 hrs & 48 hrs Final : 6 days |
H026 | Fibrinogen Degradation Products (FDP), Blood | 3 mL CITRATED PLASMA Separate plasma and freeze immediately | F 2 weeks | Latex Agglutination | Daily |
B088 | Fibrinogen Clotting Activity | 3 mL CITRATED PLASMA Separate plasma and freeze immediately | F 2 weeks | Photo-optical clot detection | Daily |
RW206 | Fibroblast Growth Factor; FGF2 | 2 mL EDTA PLASMA Separate plasma and freeze immediately | F 28 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
Z800 | Fibromyalgia Panel *CMV, IgG *Selenium, Serum * RA factor * Anti Nuclear Antibody (ANA) * Creatine Phosphokinase (CPK), TSH, Ultrasensitive *C- Reactive Protein | 4 mL SERUM + 2 mL (Z-No Additive) SERUM If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS, CLIA, Immunoturbidimetry, IFCC, EIA | S: Daily 6 pm R: Next day |
S170 | Filaria Antigen | 2 mL Heparinized WB or 2 mL SERUM | R 72 hrs F Unacceptable | ICT | Daily |
OS135 | FIP 1L1-PGDFRA Gene Rearrangement Detection | 4 mL EDTA WB or BONE MARROW | R 72 hrs F Unacceptable | PCR | S: Mon 11 am R: 12 days |
XX003 | FISH - t (8;21) or LSI ETO / AML1 | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX007 | FISH - 11q 23 or LSI MLL Gene Breakapart | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX009 | FISH - 14q 32.3 or LSI IGH Gene Breakapart | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX026 | FISH - 17p | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX013 | FISH- 1p and 19q Codeletion | Paraffin BLOCK | NA | FISH | S: Daily 4 pm R: 7 Days |
XX014 | FISH - 22q deletion of LSI Di George / VCFS | 5 mL Heparinized WB | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX031 | FISH - ALK-1 Breakapart Rearrangement | Paraffin BLOCK | NA | FISH | S: Daily 4 pm R: 7 Days |
XX015 | FISH - Amino one probe (Trisomy 21) / Down Syndrome | 5 mL Amniotic FLUID Consent form mandatory | R 48 hrs F Unacceptable | FISH | S: Daily 4 pm R: 7 Days |
XX017 | FISH- Amino three probes (Trisomy 18, X, Y) | 5 mL Amniotic FLUID Consent form mandatory | R 48 hrs F Unacceptable | FISH | S: Daily 4 pm R: 7 Days |
XX016 | FISH - Amino two probes (Trisomy 13 & 21) | 5 mL Amniotic FLUID Consent form mandatory | R 48 hrs F Unacceptable | FISH | S: Daily 4 pm R: 7 Days |
XX036 | FISH - Aneuploidy detection, Products of conception (POC) using Chromsomes 13, 18, 21, X & Y | TISSUE from Placenta or Fascia lata or Diaphragm or Tendon or skin or Chest wall cartilage in normal saline | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX001 | FISH - BCR / ABL or Philadelphia translocation | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX023 | FISH - CLL Panel *del11q23(ATM) *del17p13.1(TP53) *del13q14.3 *del13q34 *trisomy 12 *IGH Gene breakapart | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX029 | FISH - C-Myc | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX005 | FISH - del 13q or LSI D13S319 | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX012 | FISH - EGFR Gene Amplification | Paraffin BLOCK | NA | FISH | S: Daily 4 pm R: 7 Days |
XX051 | FISH - Equivocal HER2 (ERBB2) Amplification | Paraffin BLOCK | NA | FISH | S: Daily 4 pm R: 5 Days |
XX048 | FISH - Ewing Sarcoma (EWS), 22q12 (EWSR1) Rearrangement | Paraffin BLOCK | NA | FISH | S: Daily 4 pm R: 7 Days |
XX011 | FISH - HER2 (ERBB2) Amplification | Paraffin BLOCK | NA | FISH | S: Daily 4 pm R: 7 Days |
XX004 | FISH - inv (16) or LSI CBFB | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX022 | FISH - MDS Panel - Chromosomes 5q, 7q, 8q & 20q | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX050 | FISH - MET (7q31) Amplification | Paraffin BLOCK | NA | FISH | S: Daily 4 pm R: 7 Days |
XX038 | FISH - Microdeletion detection for Williams syndrome | 5 mL Heparinized WB | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX032 | FISH - Multiple Myeloma with CD138 Positive Selection cells (5 Probes) *Del 13q14.3,del 17p13.1 *t(11;14) CCND1/IGH *t(4;14) FGFR3/IGH *t(14;16) IGH/MAF | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX027 | FISH - Multiple Myeloma (5 Probes) *Del 13q14.3,del 17p13.1 *t(11;14) CCND1/IGH *t(4;14) FGFR3/IGH *t(14;16) IGH/MAF | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
Z787 | FISH - NSCLC (Non Small Cell Lung Cancer) ALK1 & ROS1 | Paraffin BLOCK | NA | FISH | S: Daily 4 pm R: 10 Days |
XX010 | FISH - Opposite Sex BMT (XX / XY) | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX018 | FISH - Prader-Wili Syndrome SNRPN | 5 mL Heparined WB | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX030 | FISH - Prenatal Screeing Panel (13, 18, 21, X & Y) | 6 mL Amniotic FLUID Consent form mandatory | R 48 hrs F Unacceptable | FISH | S: Daily 4 pm R: 7 Days |
XX049 | FISH - ROS1 (6q22) Rearrangement | Paraffin BLOCK | NA | FISH | S: Daily 4 pm R: 7 Days |
XX028 | FISH - SRY Gene | 5 mL Heparinized WB | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX006 | FISH - t(11;14) or LSI IGH / CCNDI | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX008 | FISH - t(12;21) or LSI TEL / AML1 | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX002 | FISH- t(15;17) or LSI PML / RARA | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX039 | FISH - t(8:14) or MYC / IGH for Burkitt's & Non - Hodgkin Lymphoma | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX037 | FISH -Trisomy 21 / Down Syndrome | 5 mL Heparinized WB or CORD BLOOD or 5 mL Amniotic FLUID or 2g Chorionic villus BIOPSY Consent form mandatory | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX045 | FISH - Eosinophilic Leukemia Panel (PDGFRA, PDGFRB, FGFR1 and CBFB) | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX044 | FISH - FGFR1 (8p12) Gene Rearrangement | 5 mL Heparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX052 | FISH - Follicular Lymphoma (IGH / BCL2) t(14;18) | 5 mL Heparinized WB or BONE MARROW or 5 x 5 mm Lymph node BIOPSY in normal saline or Paraffin BLOCK | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX046 | FISH - MYCN Amplification | Paraffin BLOCK | NA | FISH | S: Daily 4 pm R: 7 Days |
XX042 | FISH - PDGFR Alpha (4q12) Gene Rearrangement | 5 mLHeparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX043 | FISH - PDGFR Beta (5q33) Gene Rearrangement | 5 mLHeparinized WB or BONE MARROW | 18 -22°C within 48 hrs | FISH | S: Daily 4 pm R: 7 Days |
XX047 | FISH - Synovial Sarcoma (SS18 / SYT ) 18q11.2, Gene Rearrangement | Paraffin BLOCK | NA | FISH | S: Daily 4 pm R: 7 Days |
RW072 | Flecainide | 3 mL SERUM drawn 1 hr before next dose No Additive tube | R 7 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
Flow Cytometry, Individual Markers | 3 mL EDTA WB + 3 mL Heparinized WB or BONE MARROW | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day | |
H234 H135 H136 Z219A H138 H139 Z147A H141 H142 H143 H144 H145 Z166A H147 H148 H149 H150 H151 H153 | CD1aCD2 CD3 CD4 CD5 CD7 CD8 CD10 (CALLA) CD11c CD13 CD14 CD15 CD16 + 56 D19 CD20 CD22 CD23 CD25 CD33 CD34 CD34 - Stem cell enumeration CD36 CD38 CD41a CD45 CD61 CD64 CD79a CD79b CD103 | 3 mL EDTA WB + 3 mL Heparinized WB or BONE MARROW | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
H223 H232 H229 H203 H160 H161 H162 H167 H168 H169 H170 H171 H172 H228 | CD123 CD138 CD MPO FMC-7 Glycophorin HLA DR IgG Heavy chain (Cytoplasmic) IgG Heavy chain (Surface) IgM Heavy chain (Cytoplasmic) IgM Heavy chain (Surface) Kappa & Lambda Light chains TdT ZAP-70 | 3 mL EDTA WB + 3 mL Heparinized WB or BONE MARROW | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
N052 | FLT3 Gene Mutation | 5 mL EDTA WB or BONE MARROW | R 72 hrs F Unacceptable | Real Time PCR, Fragment Analysis | S:Mon / Thu 11 am R: Wed / Sat |
P012 | Fluid Examination, Routine, CSF / Nasal Fluid | 2 mL CSF or NASAL FLUID | R 48 hrs F Unacceptable | Biochemistry & Microscopy of Giemsa stained smears | Daily |
P013 | Fluid Examination, Routine, Body Fluids Includes Ascitic / Peritoneal / Pericardial / Pleural / Bronchial washings / Prostatic /Synovial / CAPD fluid | 2 mL FLUID | R 48 hrs F Unacceptable | Biochemistry & Microscopy of Giemsa stained smears | Daily |
RW073 | Fluoxetine Includes metabolite Norfluoxetine & Total | 3 mL SERUM No Additive Tube Draw sample >12 hrs post oral dose | R 5 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
Z781 | FMF- First Trimester Screen | 2 mL SERUM Provide maternal Date of Birth (ddormmoryy), LMP, USG report between 11-13 weeks gestation including CRL, NT & Nasal Bone, number of fetuses; Diabetic status, body weight; IVF, Smoking & Previous horo Trisomy 21. Enclose Patient demographic details in Maternal Serum Screen Request Form. Valid between 9-13 weeks gestation (Ideal 10-13 weeks). | R 3 days F 12 weeks | ECLIA | S: Tue / Thu / Sat 9 am R: Same day |
R048 | Folate (Folic Acid), RBC Includes serum Folate 2 mL EDTA WB + 2 mL SERUM No Additive Tube Protect from light State PCV | 2 mL EDTA WB + 2 mL SERUM No Additive Tube Protect from light | R 24 hrs F 6 weeks | CLIA | S: Daily 2 pm R: Same day |
R046 | Folate (Folic Acid), Serum | 2 mL SERUM No Additive Tube Protect from light | R 48 hrs F 4 weeks | CLIA | Daily |
A110 | Food Intolerance Test | 2 mL SERUM | R 1 week F 2 weeks | Protein Microarray | S: Daily 1 pm R: 2 days |
B191 | Fractional Excretion of Sodium *Creatinine, serum * Creatinine, urine *Sodium, serum *Sodium, urine | 3 mL SERUM + 10 mL aliquot of random URINE | R 1 week F 1 week | Jaffe's reaction, Indirect ISE | Daily |
OS137 | Fragile X (FMR1) Mutation Screen | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Sat 11 am R: 15 days |
B151 | Free Beta HCG | 2 mL SERUM | R 1 week F 2 weeks | CLIA | Daily |
OS138 | Friedreich's Ataxia Mutation Analysis | 4 mL EDTA WB | R 1 week F Unacceptable | PCR. Fragment Analysis | S: Mon / Fri 11 am R: 10 days |
B071 | Fructosamine | 2 mL SERUM | R 2 weeks F 2 months | Spectrophotome try | Daily |
Z126 | FSH & LH | 3 mL SERUM Prefered sampling time in females is Day 2 or Day 3 of menstrual cycle | R 48 hrs F 4 weeks | CLIA | Daily |
Z079 Y050 Basal Y051 30 min Y052 45 min Y053 60 min Y054 Customized | FSH & LH Stimulation by Gonadotropin Releasing Hormone (GnRH) | 2 mL SERUM for each timed specimen; Draw fasting baseline sample; Administer 2.5 ug or Kg body weight (100 ug maximum) as IV bolus; draw additional samples at 30, 45 & 60 min | R 48 hrs F 4 weeks | CLIA | Daily |
R080 | FSH; Follicle Stimulating Hormone | 2 mL SERUM Prefered sampling time in females is Day 2 or Day 3 of menstrual cycle | R 48 hrs F 4 weeks | CLIA | Daily |
P021 | Fungus Examination Routin, KOH Calcofluor white preparation | Skin or Nail Scrapings or Hair or CSF or Body Fluids or Sputum or Bronchial washings or Tissue in a sterile container or 2 mL Heparinized WB or BONE MARROW or Oral or Genital or Wound SWABS in 0.5 mL sterile normal saline | 18 -22°C within 72 hrs | FluorescentMicroscopy | S: Daily 3.30 pm R:Same day |
OS139 | G-6-PD Gene Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Mon 11 am R: 10 days |
R158 | G-6- PD Newborn Screen Heel prick blood on filter paper | 1 drop heel prick blood each on 3 spots of filter paper | R 1 week F 1 week | Fluoroimmunoassay | S: Tue /Thu / Sat 5 pm R: 2 days |
H018 | G-6- PD Quantitative | 3 mL EDTA WB | R 3 weeks F Unacceptable | Kinetic UV | S: Mon through Sat 4 pm R: Same day |
RW074 | Gabapentin | 2 mL SERUM No Additive tube Draw sample 2 hrs after last dose | R 12 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
B150 | GAD 65 (Glutamic Acid Decarboxylase-65), IgG | 2 mL SERUM | R 2 weeks F 2 weeks | EIA | S: Wed / Sat 9 am R: Same day |
S242 | Galactomannan (Aspergillus antigen), Serum | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S: Mon through Sat 12 noon R: Same day |
G115 | Galactose - 1 Phosphate, Quantitative, Blood | 4 mL heparinized WB Keep sample on ice | R 48 hrs F Unacceptable | Fluorometry | S: Daily 4 pm R: 5 Days |
G116 | Galactose Quantitative, Plasma | 2 mL Heparinized PLASMA | R 48 hrs F 1 week | Fluorometry | S: Daily 4 pm R: 3 Days |
G114 | Galactosemia Screening, Blood | 4 mL Heparinized WB from Patient & Control subject who is not a blood relative | R 48 hrs F Unacceptable | Beutler Fluorescence Spot test | S: Daily 4 pm R: Next day |
G118 | Galactosemia (Epimerase) Quantitative, Blood | 4 mL Heparinized WB Avoid sample collection for 60 days post transfusion | R 48 hrs F Unacceptable | Enzyme Assay | S: Daily 4 pm R: 5 Days |
OS140 | Galactosemia (GALT) Gene Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S: Daily 11 am R: 15 Days |
G117 | Galactosemia Classical (Transferase), Quantitative, Blood | 4 mL Heparinized WB Avoid sample collection for 60 days post transfusion | R 48 hrs F Unacceptable | Enzyme Assay | S: Daily 4 pm R: 5 Days |
G119 | Galactosemia Panel 1 *Galactosemia Screening * Galactosemia Classical (Transferase) | 4 mL Heparinized WB from Patient & Control subject who is not a blood relative | R 48 hrs F Unacceptable | Spot test, Enzyme assay | S: Daily 4 pm R: 5 Days |
G120 | Galactosemia Panel 2 **Galactosemia Screening * Galactosemia Classical (Transferase) * Galactose Plasma | 4 mL Heparinized WB from Patient & Control subject who is not a blood relative + 2 mL Heparinized PLASMA Avoid sample collection for 60 days post transfusion | R 48 hrs F Unacceptable | Spot test, Enzyme assay | S: Daily 4 pm R: 5 Days |
G121 | Galactosemia Panel 3 *Galactosemia Classical (Transferase) *Galactosemia (Epimerase) | 4 mL Heparinized WB Avoid sample collection for 60 days post transfusion | R 48 hrs F Unacceptable | Spot test, Enzyme assay | S: Daily 4 pm R: 5 Days |
R164 | Galactosemia, Newborn Screen | 1 drop heel prick blood each on 3 spots of filter paper | R 1 week F 1 week | Fluoroimmunoassay | S: Tue / Thu / Sat 5 pm R: 2 days |
OS141 | Ganciclovir Resistance Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S: Mon11 am R: 10 days |
RW075 | Ganglioside GD 1a Antibody, IgG | 2 mL SERUM | R 7 days F 30 days | EIA | S: By 7th of Month R: 2 - 3 weeks |
RW076 | Ganglioside GD 1a Antibody, IgM | 2 mL SERUM | R 7 days F 30 days | EIA | S: By 7th of Month R: 2 - 3 weeks |
RW077 | Ganglioside GD 1b Antibody, IgG | 2 mL SERUM | R 7 days F 30 days | EIA | S: By 7th of Month R: 2 - 3 weeks |
RW078 | Ganglioside GD 1b Antibody, IgM | 2 mL SERUM | R 14 days F 30 days | EIA | S: By 7th of Month R: 2 - 3 weeks |
RW080 | Ganglioside GQ1B Antibody IgG | 2 mL SERUM | R 14 days F 21 days | EIA | S: By 7th of Month R: 2 - 3 weeks |
RW079 | Ganglioside GM-1 Antibodies, IgG & IgM | 2 mL SERUM | R 14 days F 30 days | Imunoassay | S: By 7th of Month R: 2 - 3 weeks |
S233 | Ganglioside Antibody Profile, IgG *GM1 *GM2 *GM3 *GD1a *GD1b *GT1b *GQ1b | 2 mL SERUM | R 2 weeks F 2 weeks | Immunoblot | S: Tue 9 am R: Same day |
S234 | Ganglioside Antibody Profile, IgM *GM1 *GM2 *GM3 *GD1a *GD1b *GT1b *GQ1b | 2 mL SERUM | R 2 weeks F 2 weeks | Immunoblot | S: Tue 9 am R: Same day |
R020 | Gastrin | 2 mL SERUM Overnight fasting mandatory. It is recommended that patient discontinues proton pump inhibitor drugs like Omeprazole, Esomeprazole, Pantoprazole, Lansoprazole & Rabeprazole for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician | F 4 weeks | CLIA | S: Mon / Thu 4 pm R: Same day |
Z061 Y058 Basal Y059 5 min. Y060 10 min. Y061 15 min. Y062 20 min. Y122 25 min. Y123 30 min. Y063 Customized | Gastrin Stimulation by Secretin | 2 mL SERUM for each timed specimen ; Draw fasting baseline sample; Administer Secretin 2 U or kg body weight IV as a bolus ; draw additional samples at 5,10, 15, 20, 25 & 30 min. Overnight fasting mandatory | F 4 weeks | CLIA | S: Mon / Thu 4 pm R: Same day |
G125 | Gaucher Disease Quantitative, BloodTests deficiency of Beta Glucosidase | 10 mL EDTA or Heparinsed WB | R 72 hrs F Unacceptable | Enzyme Assay | S: Daily 4 pm R: 4 days |
G173 | Genetic Counselling | Patient & relative to report to LPL laboratories | NA | Counselling | Daily |
N078 | Genetic Mapping for Cardiovascular Disorders | 3 mL EDTA WB | R 72 hrs F Unacceptable | SNP Genotyping using Microarray | S: Daily 9 am R: 8 Weeks |
N079 | Genetic Mapping for Gynecological Disorders | 3 mL EDTA WB | R 72 hrs F Unacceptable | SNP Genotyping using Microarray | S: Daily 9 am R: 8 Weeks |
N077 | Genetic Mapping for Oncology / Cancer | 3 mL EDTA WB | R 72 hrs F Unacceptable | SNP Genotyping using Microarray | S: Daily 9 am R: 8 Weeks |
N076 | Genetic Mapping for Whole Genome | 3 mL EDTA WB | R 72 hrs F Unacceptable | SNP Genotyping using Microarray | S: Daily 9 am R: 8 Weeks |
N061 | Genexpert MTB with Rifampicin resistance, Qualitative PCR | 3 mL SPUTUM or 3 mL BAL FLUID or 2 mL CSF or 5 mL BODY FLUIDS or PUS or fresh TISSUE | R 1 week F Unacceptable | Real Time PCR | S: Daily 11 am R: Same day |
Z518 | Genexpert.com *Genexpert with Rifampicin resistance * Culture AFB, Rapid | 6 mL SPUTUM or 6 mL BAL FLUID or 2 mL CSF or 6 mL BODY FLUIDS or PUS or fresh TISSUE | R 24 hrs F Unacceptable | Real Time PCR, Automated fluorescent, ICT | S: Daily 3:30 pm R: Interim: 1 day, 14 days & 4 weeks Final: 6 weeks |
Z813 | Germ Cell Tumor Panel *AFP * HCG, Total *LDH | 3 mL SERUM | R 1 week F 2 weeks | CMIA, Spectrophoto metry | Daily |
B168 | GFR (Glomerular Filtration Rate) Calculated by MDRD formula | 2 mL SERUM GFR calculation by this formula is not applicable for <18 yrs age | R 1 week F 4 weeks | Spectrophoto metry, Calculation | Daily |
B034 | GGTP (Gamma Glutamyl transpeptidase) | 2 mL SERUM | R 72 hrs F 1 week | IFCC | Daily |
P211 | Giemsa Stain, Body Fluids | BODY FLUIDS or PUS or EXUDATES or FNA ASPIRATES or SMEARS fixed in Absolute alcohol | R 72 hrs F Unacceptable | Microscopy | S: Daily 6 pm R: Next day |
H211 | Giemsa Stain, Peripheral Blood / Bone marrow | PERIPHERAL BLOOD or BONE MARROW or SMEARS fixed in Absolute alcohol | R 72 hrs F Unacceptable | Microscopy | S: Daily 6 pm R: Next day |
Z204 | Gliadin Deamidated Antibodies Panel, IgA & IgG | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Thu 9 am R:Same day |
S159 | Gliadin Deamidated Antibody, IgG | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Thu 9 am R:Same day |
S158 | Gliadin Deamidated Antibody, IgA | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Thu 9 am R:Same day |
S098 | Glomerular Basement Membrane (GBM), Antibody, IFA | 2 mL SERUM | R 1 week F 2 weeks | IFA | S:Daily 11 am R:Same day |
RW081 | Glucagon | 3 mL EDTA PLASMA Separate plasma and freeze immediately Overnight fasting mandatory | F 28 days | Extraction, RIA | S: By 7th of Month R: 2 - 3 weeks |
G004 | Glucose Challenge Test (GCT) ; Glucose 1 hr Obstetrical | 2 mL Fluoride PLASMA drawn 1 hr after 55 g glucose monohydrate (equivalent to 50 g anhydrous) Oral Glucose | R 72 hrs F 1 week | Hexokinase | Daily |
B195 | Glucose Challenge Test (GCT), Pregnancy, 75g Glucose | 2 mL Fluoride PLASMA drawn 2 hrs after 82.5 g glucose monohydrate (equivalent to 75 g anhydrous glucose) Oral Glucose. | R 72 hrs F 1 week | Hexokinase | Daily |
G001 Y064 Basal Y065 0.5 hr Y066 1.0 hr Y067 1.5 hr Y068 2.0 hr Y069 2.5 hr Y073 Customized | 2 mL Fluoride PLASMA + 10 mL aliquot of corresponding URINE for each timed specimen Draw fasting baseline sample; Dissolve 82.5 g glucose monohydrate (equivalent to 75 g anhydrous glucose) in adults or 1.92 g / Kg body wt in children in 300 mL water. Draw additional plasma & urine samples at 0.5, 1.0, 1.5, 2.0 & 2.5 hrs. Overnight fasting mandatory | R 72 hrs F 1 week | Hexokinase,Strip test | Daily | |
G002 Y064 Basal Y065 0.5 hr Y066 1.0 hr Y067 1.5 hr Y068 2.0 hr Y069 2.5 hr Y070 3.0 hr Y071 4.0 hr Y072 5.0 hr Y073 Customized | Glucose Estimation Extended, 5 hrs | 2 mL Fluoride PLASMA + 10 mL aliquot of corresponding URINE for each timed specimen Draw fasting baseline sample; Dissolve 82.5g glucose monohydrate (equivalent to 75 g anhydrous glucose) in adults or 1.92g / Kg body wt in children in 300 mL water. Draw additional plasma & urine samples at 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0 & 5.0 hrs. Overnight fasting mandatory | R 72 hrs F 1 week | Hexokinase,Strip test | Daily |
G009 Y124 Basal Y125 1 hr Y126 2 hrs | Glucose Tolerance Test (GTT), Pregnancy, 75 g glucose | 2 mL Fluoride PLASMA for each timed specimen Draw fasting baseline sample; Dissolve 82.5g glucose monohydrate (equivalent to 75 g anhydrous glucose) in 300 mL water. Draw additional plasma samples at 1.0 & 2.0 hrs Overnight fasting mandatory | R 72 hrs F 1 week | Hexokinase | Daily |
B196 | Glucose Tolerance Test (GTT), Pregnancy, 100 g glucose | 2 mL Fluoride PLASMA for each timed specimen Draw fasting baseline sample; Dissolve 110 g of glucose monohydrate (equivalent to 100 g anhydrous glucose) in 300 mL water. Draw additional plasma samples at 1.0, 2.0 & 3.0 hrs Overnight fasting mandatory | R 72 hrs F 1 week | Hexokinase | Daily |
G010 | Glucose Tolerance Test, Oral (OGTT) | 2 mL Fluoride PLASMA for each fasting & post glucose specimens Draw fasting baseline sample; Disssolve 82.5g Glucose monohydrate in adults (equivalent to 75 g anhydrous glucose) / 1.92 g / Kg body weight in children in 300 mL water. Draw post glucose sample exactly after 2.0 hrs Overnight fasting mandatory | R 72 hrs F 1 week | Hexokinase | Daily |
B001 | Glucose, Fasting (F) | 2 mL Fluoride PLASMA Overnight fasting mandatory | R 72 hrs F 1 week | Hexokinase | Daily |
Z131 | Glucose, Fasting (F) & Post meal (PP), 2 hrs | 2 mL Fluoride PLASMA for each fasting & post prandial specimens Overnight fasting mandatory | R 72 hrs F 1 week | Hexokinase | Daily |
P085 | Glucose, Fluid | 2 mL BODY FLUID | R 48 hrs F Unacceptable | Hexokinase | Daily |
B002 | GLUCOSE, POST PRANDIAL (PP) 2.0 Hours post meal | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Collect sample exactly 2 hours after starting meal. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B187 | GLUCOSE POST LOAD 0.5 Hour post 75 g glucose | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Dissolve 82.5g glucose monohydrate (equivalent to 75 g anhydrous glucose) in 300 mL water. Collect sample exactly 0.5 hours after starting intake of glucose. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B143 | GLUCOSE POST LOAD 1 Hour post 75 g glucose | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Dissolve 82.5g glucose monohydrate (equivalent to 75 g anhydrous glucose) in 300 mL water. Collect sample exactly 1.0 hour after starting intake of glucose. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B006 | GLUCOSE POST LOAD 1.5 Hours post 75 g glucose | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Dissolve 82.5g glucose monohydrate (equivalent to 75 g anhydrous glucose) in 300 mL water. Collect sample exactly 1.5 hours after starting intake of glucose. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B007 | GLUCOSE POST LOAD 2.0 Hours post 75 g glucose | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Dissolve 82.5g glucose monohydrate (equivalent to 75 g anhydrous glucose) in 300 mL water. Collect sample exactly 2.0 hours after starting intake of glucose. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B188 | GLUCOSE POST LOAD 2.5 Hours post 75 g glucose | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Dissolve 82.5g glucose monohydrate (equivalent to 75 g anhydrous glucose) in 300 mL water. Collect sample exactly 2.5 hours after starting intake of glucose. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B144 | GLUCOSE POST LOAD 3.0 Hours post 75 g glucose | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Dissolve 82.5g glucose monohydrate (equivalent to 75 g anhydrous glucose) in 300 mL water. Collect sample exactly 3.0 hours after starting intake of glucose. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
Y373 | GLUCOSE POST LOAD 1.0 Hour post 100 g glucose | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Dissolve 110 g of glucose monohydrate (equivalent to 100 g anhydrous glucose) in 300 mL water. Collect sample exactly 1.0 hour after starting intake of glucose. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B014 | GLUCOSE POST LOAD 1.5 Hour post 100 g glucose | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Dissolve 110 g of glucose monohydrate (equivalent to 100 g anhydrous glucose) in 300 mL water. Collect sample exactly 1.5 hours after starting intake of glucose. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B015 | GLUCOSE POST LOAD 2.0 Hour post 100 g glucose | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Dissolve 110 g of glucose monohydrate (equivalent to 100 g anhydrous glucose) in 300 mL water. Collect sample exactly 2.0 hours after starting intake of glucose. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
Y374 | GLUCOSE POST LOAD 3.0 Hour post 100 g glucose | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Dissolve 110 g of glucose monohydrate (equivalent to 100 g anhydrous glucose) in 300 mL water. Collect sample exactly 3.0 hours after starting intake of glucose. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B126 | GLUCOSE POST MEAL 2.0 Hour post Lunch | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Collect sample exactly 2 hrs after starting meal. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B127 | GLUCOSE PRE MEAL Dinner | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Collect sample exactly before starting meal. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B189 | GLUCOSE CUSTOMIZED POST LOAD 75 g glucose | 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Dissolve 82.5g glucose monohydrate (equivalent to 75 g anhydrous glucose) in 300 mL water. Collect sample as per clinician's instruction. Ship refrigerated or frozen. | R 72 hrs F 1 week | Hexokinase | Daily |
B003 | Glucose, Random (R) | 2 mL Fluoride PLASMA | R 72 hrs F 1 week | Hexokinase | Daily |
B198 | Glycemark (1,5 Anhydroglucitol) | 2 mL SERUM | R 1 week F 4 weeks | Enzymatic Colorimetric | S:Mon / Thu 9 am R: Same day |
G123 | GM 1 Gangliosidosis, Quantitative, BloodTests deficiency of Beta Galactosidase | 10 mL EDTA or Heparinized WB | R 48 hrs F Unacceptable | Enzyme Assay | S: Daily 4 pm R: 4 Days |
G124 | GM 2 Gangliosidosis, Quantitative, Blood; Tay Sachs & Sandhoff disease Tests deficiency of Hexosaminidase, Total, A & B | 10 mL EDTA or Heparinized WB | R 48 hrs F Unacceptable | Enzyme Assay | S: Daily 4 pm R: 4 Days |
Z200 | Goodpasture's Syndrome Panel *Glomerular Basement Membrane Antibody *ANCA-PR3 / c-ANCA | 3 mL SERUM | R 72 hrs F 2 weeks | EIA, IFA | S: Mon / Wed 9 am R: Next day |
P025 | Gram Stain | SPECIMENS or SMEARS | R 72 hrs F Unacceptable | Microscopy | Daily |
M214 | Group A Streptococcal Antigen | Throat SWAB | R 24 hrs F Unacceptable | ICT | S: Daily 1 pm R: Same day |
Z208 | Growth Disorder Panel *Growth Hormone *IGFBP-3 *IGF- I | 3 mL SERUM Patient should rest for 30 min. prior to sample collection | R Unacceptable F 4 weeks | CLIA | S: Mon / Thu 4 pm R: Same day |
RW082 | Growth Hormone Antibody | 2 mL SERUM No Additive Tube | R 14 days F 6 weeks | Radiobinding Assay | S: By 7th of Month R: 2 - 3 weeks |
RW083 | Growth Hormone Releasing Hormone (GHRH) | 3 mL SERUM No Additive Tube | R Unacceptable F 2 months | Extraction, RIA | S: By 7th of Month R: 2 - 3 weeks |
Z300 Y094 Basal Y095 30 min. Y096 60 min. Y097 90 min. Y099 Exercise Y098 Customized | Growth Hormone Stimulation Test | 2 mL SERUM for each timed specimen. Draw fasting baseline specimen after resting for 30 min.; Administer stimulating agent Clonidine (Arkamine) 300 ug or 5ug / Kg body wt. orally. Draw additional specimens at 30, 60 & 90 mins. Other stimulating agents that can be used are: Insulin (0.10 - 0.15 U or Kg body weight IV followed by additional samples at 30, 60 & 90 min). Exercise (20 min. vigorous exercise followed by immediate sampling) | R 8 hrs F 2 months | CLIA | Daily |
Z069 Y100 Basal Y102 60 min. Y104 120 min. Y105 Customized | Growth Hormone Suppression by Glucose | 2 mL SERUM for each timed specimen. Draw fasting baseline specimen after resting for 30 min; .Administer Glucose orally 1.75 g / kg body wt (maximum 75g). Draw additional specimens at 60 & 120 min. | R 8 hrs F 2 months | CLIA | Daily |
R031 | Growth Hormone (GH) | 2 mL SERUM Overnight fasting mandatory Patient should rest for 30 min. before sample collection | R 8 hrs F 2 months | CLIA | Daily |
N034 | H1N1 (Swine Flu) Qualitative, Real Time PCR | Nasal or Throat or Nasopharyngeal SWAB in Special viral transport medium | R 48 hrs F Unacceptable | Real Time PCR | S: Daily 11 am R: Same day (except Sundays) |
N068 | Hains Mycobacterium Tuberculosis First Line Drug resistance profile | 2 mL SPUTUM or BAL or Pleural ASPIRATE or CSF or BODY FLUID or cultured GROWTH | R 72 hrs F Unacceptable | PCR, Line probe assay | S: Tue / Fri 11 am R: Thu / Mon |
N117 | Hains Mycobacterium Tuberculosis Second Line Drug resistance profile | 2 mL SPUTUM or BAL or Bronchial ASPIRATE or cultured GROWTH | R 72 hrs F Unacceptable | PCR, Line probe assay | S: Sat 11 am R: Fri |
Z835 | Hains Mycobacterium Tuberculosis First & Second Line Drug resistance profile | 2 mL SPUTUM or BAL or Bronchial ASPIRATE or cultured GROWTH | R 72 hrs F Unacceptable | PCR, Line probe assay | S: Sat 11 am R: Fri |
RW084 | Haloperidol | 2 mL SERUM No Additive tube Draw sample11-17 hrs after last dose | R 7 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
H119 | Ham Test; Paroxysmal Nocturnal Hemoglobinuria (PNH) Screening Test | 3 mL EDTA WB | R 24 hrs F Unacceptable | Gel Technique | S: Daily 9 am R: Same day |
B100 | Haptoglobin | 2 ml SERUM | R 4 weeks F 4 weeks | Immunoturbidim etry | Daily |
OS144 | Haptoglobin Genotyping | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Tue / Sat 11 am R: 8 days |
B080 | HbA1c; Glycosylated hemoglobin | 3 mL EDTA WB | R 1 week F Unacceptable | HPLC | Daily |
B030 | HBDH; Alpha - Hydroxy Butyrate Dehydrogenase | 2 mL SERUM | R 4 days F 2 weeks | GSCC | Daily |
U022 | HCG, Beta, Total, Quantitative, 24 Hour Urine | 10 mL aliquot of 24 hr URINE | R 1 week F 2 weeks | CMIA | Daily |
R021 | HCG, Beta, Total, Quantitative, Maternal | 2 mL SERUM | R 1 week F 4 weeks | CMIA | Daily |
U075 | HCG, Beta, Total, Quantitative, Random Urine | 10 mL aliquot of random URINE | R 1 week F 2 weeks | CMIA | Daily |
F002 | HCG, Beta, Total, Quantitative, Tumor Marker | 2 mL SERUM | R 1 week F 4 weeks | CMIA | Daily |
RW085 | HDL Cholesterol Subclasses * HDL-2 * HDL-3 | 4 mL SERUM No Additive Tube | R 7 days F 6 weeks | Precipitation, Colorimetric,Enzymatic | S: By 7th of Month R: 2 - 3 weeks |
B128 | HDL Cholesterol, Direct | 2 mL SERUM | R 1 week F 2 weeks | Enzymatic Immunoinhibitio n | Daily |
F024 | HE4; Human Epididymis Protein 4 | 2 mL SERUM | R 4 days F 4 weeks | CMIA | S: Mon / Thu 4 pm R:Same day |
Z615 | Heart Screen *hsCRP *Uric acid *Glucose Fasting *Lipid profile basic *Homocysteine | 3 mL SERUM + 2 mL fluoride PLASMA 12 hrs overnight fasting mandatory | R 72 hrs F 2 weeks | Immunoturbidim etry, Hexokinase, Spectrophotome try, CMIA | Daily |
H204 | Heinz Bodies, Periperal blood | 2 air dried peripheral blood SMEARS | NA | Microscopy | Daily |
Z121 | Helicobacter pylori Antibodies Panel, IgA & IgG | 3 mL SERUM | R 48 hrs F 2 weeks | EIA | S:Thu 9 am R:Same day |
S227 | Helicobacter pylori Antigen, Stool | 5 g STOOL | R 72 hrs F 4 weeks | EIA | S:Mon 9 am R:Same day |
S083 | Helicobacter pylori, IgA | 2 mL SERUM | R 48 hrs F 2 weeks | EIA | S:Thu 9 am R:Same day |
S082 | Helicobacter pylori, IgG | 2 mL SERUM | R 48 hrs F 2 weeks | EIA | S:Thu 9 am R:Same day |
OS143 | Hemochromatosis 2 Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S:Daily 11 am R:30 days |
OS146 | Hemoglobin D Iran Mutation Analysis | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S:Mon / Wed 11 am R:10 days |
OS147 | Hemoglobin D Punjab Mutation Analysis | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S:Mon / Wed 11 am R:10 days |
OS148 | Hemoglobin E (GLU 26LYS) Mutation Analysis | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S:Mon / Wed 11 am R:10 days |
E002 | Hemoglobin HPLC / Electrophoresis Includes Hematological indices | 4 mL EDTA WB Indicate age, sex, race & religion | R 48 hrs F Unacceptable | HPLC, Electrophoresis | S Daily 10 am R: Same day |
U047 | Hemoglobin, Free, Urine | 10 mL aliquot of random URINE | R 72 hrs F Unacceptable | Strip Test | Daily |
H001 | Hemoglobin; Hb | 3 mL EDTA WB | R 48 hrs F Unacceptable | Photometry | Daily |
Z019 | Hemogram *Hemoglobin *PCV *TLC *RBC Count *MCV *MCH *MCHC *Platelet Count *Automated DLC *Absolute Differential counts *RDW *ESR | 4 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence, VCS, Capillary Photometry / Westergren | Daily |
H241 | Hemophilia A Carrier Detection *Factor VIII *vWF Antigen * Factor VIII / vWF Ratio | 3 mL CITRATED PPP Separate plasma & freeze immediately | F 2 weeks | Electromechanical Clot Detection, EIA | S: 1st & 3rd Mon 11 am R: Next day |
Z374 | Hemophilia Panel *APTT * Factor VIII * Factor IX | 3 mL CITRATED PPP Separate plasma & freeze immediately | F 2 weeks | Electromechanical & Photo- optical Clot Detection | S: Wed / Sat 9 am R: Fri / Tue |
U046 | Hemosiderin, Urine | 10 mL aliquot of random URINE | R 72 hrs F Unacceptable | Prussian Blue Reaction | S: Daily 9 am R: Same day |
RW086 | Heparin, Anti Xa Assay | 2 mL CITRATED PPP Separate plasma & freeze immediately | F 30 days | Chromogenic | S: By 7th of Month R: 2 - 3 weeks |
S090 | Hepatitis A Antibody (Anti- HAV), IgG | 2 mL SERUM | R 2 weeks F 2 weeks | CMIA | Daily |
S061 | Hepatitis A Antibody (Anti- HAV), IgM | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
OS145 | Hepatitis A virus RNA Detection, PCR | 4 mL EDTA PLASMA | R 72 hrs F 4 weeks | PCR | S: Daily 11 am R: 10 days |
S058 | Hepatitis B Core Antibody (Anti- HBc), IgM | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
S115 | Hepatitis B Core Antibody (Anti- HBc), Total | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
Z135 | Hepatitis B Immunity Screen *Anti-HBc Total *Anti-HBs *HBsAg | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
Z017 | Hepatitis B Profile *HBsAg *Anti-HBs *HBeAg *Anti- HBe *Anti-HBc IgM *Anti-HBc Total | 4 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
S057 | Hepatitis B Surface Antibody; Anti-HBs | 2 mL SERUM | R 2 weeks F 2 weeks | CMIA | Daily |
S116 | Hepatitis B Surface Antigen (HBsAg) ConfirmationNeutralization Procedure | 2 mL SERUM Indicate HBsAg positivity | R 2 weeks F 2 weeks | CMIA | Daily |
S215 | Hepatitis B Surface Antigen (HBsAg), Quantitative | 2 mL SERUM | R 2 weeks F 2 weeks | CMIA | Daily |
S056 | Hepatitis B Surface Antigen; HBsAg; Australia Antigen Screening only | 2 mL SERUM | R 2 weeks F 2 weeks | CMIA | Daily |
N027 | Hepatitis B Viral DNA (HBV DNA) Quantitative, Real Time PCR | 3 mL EDTA PLASMA or 2 mL SERUM Separate plasma or serum aseptically within 2 hrs of collection Avoid freeze thaw cycles | R 72 hrs F 6 months | Real Time PCR | S: Tue / Thu / Sat 11 am R: Wed / Fri / Mon |
N041 | Hepatitis B Viral Drug Resistance & Genotyping | 3 mL EDTA PLASMA Separate plasma aseptically within 2 hrs of collection Minimum viral load required is 2000 IU/mL | R 72 hrs F 6 months | Sequencing | S: Daily 11 am R: 7 days |
Z602 | Hepatitis B Virus Genotyping, Drug Resistance & Quantitative PCR | 3 mL EDTA PLASMA Separate plasma aseptically within 2 hrs of collection Avoid freeze thaw cycles | R 72 hrs F 6 months | Sequencing, Real Time PCR | S: Daily 11 am R: 7 days |
Z877 | Hepatitis B Monitoring Panel *SGPT * SGOT * Creatinine, serum * Bilirubin Direct * Bilirubin, Total * Urea, serum * CBC * Hepatitis B Viral DNA Quantitative, Real Time PCR | 3 mL EDTA WB + 3 mL EDTA PLASMA + 3 mL SERUM | R 48 hrs F unacceptable | DPD, Electrical Impedence, VCS, IFCC, Real Time PCR , Compensated Jaffe's Reaction IDMS Traceable, Urease UV | S: Tue / Thu / Sat 11 am R: Wed / Fri / Mon |
N011 | Hepatitis B Virus PCR Qualitative; HBV DNA PCR, Qualitative | 3 mL EDTA PLASMA Separate plasma aseptically within 2 hrs of collection | R 72 hrs F 6 months | PCR | S: Tue / Thu / Sat 11 am R: Wed / Fri / Mon |
S060 | Hepatitis Be Antibody; Anti- HBe | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
S059 | Hepatitis Be Antigen; HBeAg | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
Z137 | Hepatitis Be Panel *HBeAg * Anti-HBe | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
S062 | Hepatitis C Antibody (Anti- HCV) | 2 mL SERUM | R 1 week F 2 weeks | CMIA | Daily |
Z511 | Hepatitis C Viral Combo *HCV RNA Quantitative Real Time PCR * HCV Genotype | 6 mL EDTA PLASMA or 6 mL SERUM Separate plasma or serum aseptically within 2 hrs of collection | R 72 hrs F 4 weeks | Real Time PCR | S: Tue / Fri 11 am R: Thu / Mon |
N028 | Hepatitis C Viral RNA (HCV RNA) Quantitative | 3 mL EDTA PLASMA or 3 mL SERUM Separate plasma or serum aseptically within 2 hrs of collection Avoid freeze thaw cycles | R 72 hrs F 6 months | Real Time PCR | S: Tue / Fri 11 am R: Thu / Mon |
N147 | Hepatitis C Viral RNA (HCV RNA) Quantitative, Ultra | 3 mL SERUM or 3 mL EDTA PLASMA | R 72 hrs F 6 months | Real Time PCR | S: Tue / Fri 11 am R: Thu / Mon |
N032 | Hepatitis C Viral RNA, Genotype | 2 mL EDTA PLASMA or 2 mL SERUM Separate plasma or serum aseptically within 2 hrs of collection | R 72 hrs F 4 weeks | Real Time PCR | S: Tue / Fri 11 am R: Thu / Mon |
N004 | Hepatitis C Viral PCR Qualitative; HCV RNA PCR, Qualitative | 2 mL EDTA PLASMA or 2 mL SERUM Separate plasma or serum aseptically within 2 hrs of collection Avoid freeze thaw cycles | R 72 hrs F 6 months | PCR | S: Tue / Fri 11 am R: Thu / Mon |
Z878 | Hepatitis C Monitoring Panel *SGPT * SGOT * Creatinine, serum * Bilirubin Direct * Bilirubin, Total * Urea, serum * CBC * Hepatitis C Viral DNA Quantitative, Real Time PCR | 3 mL EDTA WB + 3 mL EDTA PLASMA + 3 mL SERUM Separate plasma or serum aseptically within 2 hrs of collection Avoid freeze thaw cycles | R 48 hrs F unacceptable | DPD, Electrical Impedence, VCS, IFCC, Real Time PCR , Compensated Jaffe's Reaction IDMS Traceable, Urease UV | S: Tue / Fri 11 am Report: Thu / Mon |
RW273 | Hepatitis C Viral RNA Genotype 1NS5a Drug Resistance * HCV NS5a Subtype *Daclatasvir Resistance * Ledipasvir Resistance * Ombitasvir Resistance | 2 mL EDTA or 2 mL SERUM Separate plasma or serum aseptically within 24 hrs of collection Avoid freeze thaw cycles | R 14 days F 42 days | Polymerase Chain Reaction (PCR) • Sequencing | S: By 7th of Month R: 2 - 3 weeks |
OS149 | Hepatitis D Virus Detection, PCR | 4 mL EDTA PLASMA Separate plasma aseptically within 2 hrs of collection | R 1 week F 4 weeks | PCR | S: Daily 11 am R: 13 days |
S117 | Hepatitis Delta Antibody (Anti HDV), IgM | 2 mL SERUM | R 1 week F 2 weeks | EIA | S:Wed 11 am R:Same day |
S202 | Hepatitis E Antibody (Anti- HEV), IgG | 2 mL SERUM | R 1 week F 2 weeks | EIA | S:Mon / Wed / Fri 9 am R:Same day |
S051 | Hepatitis E Antibody (Anti- HEV), IgM | 2 mL SERUM | R 1 week F 2 weeks | EIA | S:Mon through Sat 9 am R:Same day |
N109 | Hepatitis E Virus Detection, PCR | 2 mL EDTA PLASMA or 2 mL SERUM Separate plasma or serum aseptically within 4 hrs of collection | R 72 hrs F 6 months | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
OS150 | Hepatitis G Virus RNA Detection, PCR | 4 mL EDTA PLASMA Separate plasma or serum aseptically within 2 hrs | R 1 week F 4 weeks | PCR | S: Daily 11 am R: 18 days |
Z556 | Herpes Simplex Virus (HSV) 1 Antibodies Panel, IgG & IgM, Serum | 3 mL SERUM | R 4 days F 4 weeks | EIA, CLIA | S: Tue / Fri 9 am R: Same day |
S211 | Herpes Simplex Virus (HSV) 1 IgG, Serum | 2 mL SERUM | R 4 days F 4 weeks | CLIA | S: Tue / Fri 9 am R: Same day |
S213 | Herpes Simplex Virus (HSV) 1 IgM, Serum | 2 mL SERUM | R 4 days F 4 weeks | EIA | S: Tue / Fri 9 am R: Same day |
Z205 | Herpes Simplex Virus (HSV) 1 + 2 Antibodies Panel, IgG & IgM, Serum | 2 mL SERUM | R 4 days F 4 weeks | CLIA | Daily |
S021 | Herpes Simplex Virus (HSV) 1 + 2, IgG, Serum | 2 mL SERUM | R 4 days F 4 weeks | CLIA | Daily |
S071 | Herpes Simplex Virus (HSV) 1 + 2, IgM, Serum | 2 mL SERUM | R 4 days F 4 weeks | CLIA | Daily |
Z557 | Herpes Simplex Virus (HSV) 2 Antibodies Panel, IgG & IgM, Serum | 3 mL SERUM | R 4 days F 4 weeks | CLIA | S: Tue / Fri 9 am R: Same day |
S212 | Herpes Simplex Virus (HSV) 2 IgG, Serum | 2 mL SERUM | R 4 days F 4 weeks | CLIA | S: Tue / Fri 9 am R: Same day |
S214 | Herpes Simplex Virus (HSV) 2 IgM, Serum | 2 mL SERUM | R 4 days F 4 weeks | EIA | S: Tue / Fri 9 am R: Same day |
Z303 | Herpes Simplex Virus (HSV) Type 1 & 2, PCR, Qualitative | 2 mL CSF or EDTA PLASMA or Blister Fluid or Swab or Scrapings or Fresh Tissue in 1 mL normal saline or Paraffin embedded tissue | R 48 hrs F 4 weeks | PCR, Amplification | S: Mon / Thu 11 am R: Wed / Sat |
N013 | Herpes Simplex Virus (HSV) Type 2, PCR, Qualitative | 2 mL CSF or EDTA PLASMA or Blister Fluid or Swab or Scrapings or Fresh Tissue in 1 mL normal saline or Paraffin embedded tissue | R 48 hrs F 4 weeks | PCR, Amplification | S: Mon / Thu 11 am R: Wed / Sat |
N012 | Herpes Simplex Virus (HSV) Type I, PCR, Qualitative | 2 mL CSF or EDTA PLASMA or Blister Fluid or Swab or Scrapings or Fresh Tissue in 1 mL normal saline or Paraffin embedded tissue | R 48 hrs F 4 weeks | PCR, Amplification | S: Mon / Thu 11 am R: Wed / Sat |
RW088 | Herpes Virus 6 (HHV-6) Antibodies Panel, IgG & IgM | 2 mL SERUM No Additive Tube | R 14 days F 30 days | IFA | S: By 7th of Month R: 2 - 3 weeks |
G185 | HHH Syndrome; Hyperornithinemia- Hyperammonemia- Homocitrullinuria Syndrome | 15 mL aliquot of random URINE | R 72 hrs F 4 weeks | LC-MS/MS, GC- MS | S: Daily 5 pm R:5 days |
U034 | 5-HIAA (5-Hydroxy Indole Acetic Acid), 24 Hour Urine | 50 mL aliquot of 24 hr URINE Preservative 50% HCl State Total Volume Avoidbanana, kiwi, walnut, avocado, brinjal, pineapple, plum, tomato & drugs like Fluorouracil, Melphalan, Paracetamol & Acetaminophen, Heparin, L-dopa, Reserpine, Salicylates, Chlorpromazine, Imipramine, Isoniazid, MAO inhibitors, Phenothiazines, Promethazine, alcoholic beverages, caffeine, teaorcoffee, tobacco and strenuous exercise at least 72 hrs before and during specimen collection | R 7 days F 30 days | HPLC | S: Wed / Sat 9 am R: Fri / Tue |
U038 | 5-HIAA (5-Hydroxy Indole Acetic Acid), Random Urine | 50 mL aliquot of random URINE Preservative 50% HCl State Total Volume Avoidbanana, kiwi, walnut, avocado, brinjal, pineapple, plum, tomato & drugs like Fluorouracil, Melphalan, Paracetamol & Acetaminophen, Heparin, L-dopa, Reserpine, Salicylates, Chlorpromazine, Imipramine, Isoniazid, MAO inhibitors, Phenothiazines, Promethazine, alcoholic beverages, caffeine, teaorcoffee, tobacco and strenuous exercise at least 72 hrs before and during specimen collection | R 7 days F 30 days | HPLC | S: Wed / Sat 9 am R: Fri / Tue |
Z040 | Hirsutism Panel *Androstenedione * DHEA Sulphate * Free Testosterone | 5 mL SERUM | R 24 hrs F 4 weeks | CLIA, CMIA, RIA | S: Mon / Thu 9 am R: Same day |
RW089 | Histamine, 24 Hour Urine Includes creatinine | 5 mL aliquot of 24 hr URINE Preservative 10 mL 50% 6N HCl Avoid direct sunlight, antihistamines, oral corticosteroids and H2 receptor blockers, 24 hours prior to specimen collection. | R 14 days F 14 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
S019 | Histone Antibodies | 2 mL SERUM | R 1 week F 2 weeks | EIA | S:Thu 9 am R:Same day |
J113 | Histo / Cytopathology / Immunohistochemistry (IHC), Photomicrograph | Stained SECTIONS or SMEARS or IHC stained sections | NA | Digital Photography | S: Daily 6 pm R: Next day |
J119 | Histo / Cytopathology, Slide(s) / Block(s), Issue | Written requisition | NA | NA | 72 hrs |
Z829 | Histopathology Direct Immunofluorescence (DIF), Kidney Biopsy *Complement C3 *Complement C1q *IgA * IgG *IgM *Kappa Light Chains *Lambda Light Chains | Kidney BIOPSY in buffered normal saline Biopsy should measure minimum 1 cm | R 24 hrs F Unacceptable | Cryoprocessing, Fluorescence microscopy | S: Daily 6 pm R:3 days |
J025 J026 J027 J040 J024 Z158 | Histopathology Direct Immunofluorescence (DIF), Skin / Conjunctival Biopsy IgA IgG IgM Complement C1q Complement C3 Panel-IgA,IgG,IgM, Complement C1q & C3 | Skin or Conjunctival BIOPSY in buffered normal saline Biopsy should measure minimum 3 mm | R 24 hrs F Unacceptable | Cryoprocessing, Fluorescence microscopy | S: Daily 6 pm R: 4 days |
J007 | Histopathology, Biopsy - Second Opinion | Stained SECTIONS or Paraffin BLOCKS | NA | Microscopy | S: Daily 6 pm R: 3 days |
J118 | Histopathology, Biopsy, Bone *Small biopsy *Medium biopsy | BIOPSY in 10% Formal - saline | NA | Processing,Staining, Microscopy | S: Daily 6 pm R: maximum 12 days |
J116 | Histopathology Biopsy Large Complex / Cancer Specimen *Esophagectomy *Gastrectomy *Mastectomy *Hemi / Total Colectomy *Large Bone Resection *Ovarian Tumor Resection *Radical Nephrectomy for Cancer *Radical Neck Dissection *Radical Hysterectomy *Radical Orchidectomy *Soft tissue tumor resections *Head & Neck resection *Eyeball (Tumorous) | BIOPSY in 10% Formal - saline | NA | Processing,Staining, Microscopy | S: Daily 6 pm R: 5 days Bone specimens maximum 14-16 days |
J012 | Histopathology Biopsy, Large Specimen *Uterus with cervix *Uterus with cervix and adnexae / fibroids *Ovarian tumors / Large cysts *Eyeball (tumorous) *Non tumorous conditions of Thyroid gland / Testes / Kidney - nephrectomy / Intestinal resection *Lymph node (Block dissection) *Placenta *Eye ball (Non- tumorous) | BIOPSY in 10% Formal - saline | NA | Processing,Staining, Microscopy | S: Daily 6 pm R: 4 days |
J092 | Histopathology Biopsy, Medium Specimen *Breast lump *Pilonidal sinus *Fistula / Sinus *Lymph node *Ovarian cyst *Gall bladder *Prostate (TURP / Enucleation) *Superficial lumps *Brain & Spinal cord tumors * Small excision biopsies *Fibroids (Enucleated) *Products of conception | BIOPSY in 10% Formal - saline | NA | Processing,Staining, Microscopy | S: Daily 6 pm R: 3 days |
J001 | Histopathology Biopsy, Small Specimen *Endometrium *Cervical biopsy *Endoscopic biopsies *Trucut biopsies *Appendix *Fallopian Tubes *Conjunctival biopsy *Small diagnostic / Incision biopsies | BIOPSY in 10% Formal - saline | NA | Processing,Staining, Microscopy | Sample: Daily by 11 am; Report Next day Sample: Daily 11 am to 6 pm; Report 2 days |
Z353 | Histopathology Kidney Biopsy Panel 1Histopathology *Special Stains *DIF for IgG, IgA, IgM, C3 & C1q *IHC for C4d & SV40 (Transplant biopsy) *Photomicrograph | 2 Kidney BIOPSY tissue cores one each in buffered normal saline & 10% Formal-saline | R 24 hrs F Unacceptable | Cryoprocessing, Fluorescence & Light Microscopy, IHC, Digital Photography | S: Daily 6 pm R: 5 days |
Z355 | Histopathology Kidney Biopsy Panel 2 *Histopathology *Special Stains *IHC for C4d & SV40 (Transplant biopsy) *Photomicrograph | 1 Kidney BIOPSY tissue core in 10% Formal-saline | NA | Light Microscopy, IHC, Digital Photography | S: Daily 6 pm R: 5 days |
Z830 | Histopathology Kidney Biopsy Panel 3Histopathology *Special Stains *DIF for IgG, IgA, IgM, C3 & C1q *IHC for C4d & SV40 (Transplant biopsy) *Photomicrograph *Electron Microscopy | 3 Kidney BIOPSY tissue cores one each in buffered normal saline, 10% Formal-saline & 3% buffered Glutaraldehyde solution | R 24 hrs F Unacceptable | Cryoprocessing, Fluorescence & Light Microscopy, IHC, Digital Photography, Transmission Electron Microscopy | S: Daily 6 pm R: 10 days |
Z850 | Histopathology, Kidney Biopsy Second Opinion | BLOCK / SLIDES | NA | Light Microscopy | S: Daily 6 pm R: 4 days |
Z386 | Histopathology, Liver Biopsy Panel *Histopathology *Special Stains *Photomicrograph | 1 Liver Biopsy tissue core in 10% Formal-saline | NA | Light Microscopy, Digital Photography | S: Daily 6 pm R: 5 days |
J114 | Histopathology, Polarizing Microscopy | SECTIONS or Paraffin BLOCKS | R 72 hrs F Unacceptable | Polarizing Microscopy | S: Daily 6 pm R: Next day |
J050 J084 J052 J095 J078 J079 J053 J081 J080 J055 J054 J082 J059 J083 | Histopathology Special Stains Acid Fast (ZN) Alcian Blue Amyloid (Congo Red) Copper (Rhodanine) Fontanna Masson Gomori's Silver Methenamine Iron (Perl's) Masson Trichrome Mucicarmine Myeloperoxidase PAS PTAH Reticulin Van Giesons | TISSUE in 10% Formal-saline or Paraffin BLOCKS or Alcohol fixed FNA Aspirate SMEARS | NA | Special Stain, Microscopy | S: Daily 6 pm R: 3 Days |
Z701 | Histopathology, Skin Biopsy Panel *Histopathology examination *Special stains *Photomicrograph | BIOPSY in 10% Formal - saline | NA | Processing,Staining, Microscopy | S: Daily 6 pm R: 5 Days |
RW269 | Histoplasma Antibody, Immunodiffusion | 2 mL SERUM No Additive Tube | R 14 days F 30 days | Immunodiffusion | S: By 7th of Month R: 2 - 3 weeks |
S010 | HIV 1 & 2 Antibodies, Screening TestIncludes p24 Antigen | 2 mL SERUM HIV Consent form mandatory | R 1 week F 4 weeks | CMIA | Daily |
S203 | HIV Rapid Screening Test | 2 mL SERUM HIV Consent form mandatory | R 1 week F 4 weeks | Immunochromat ography | Daily |
S063 | HIV 1 & 2 Antibodies, Western Blot | 2 mL SERUM | R 1 week F 4 weeks | Western Blot | S: Tue / Thu / Sat 9 am R: Same day |
N060 | HIV 1 Genotyping & Drug Resistance | 2 mL EDTA PLASMA Separate plasma within 6 hrs & freeze immediately | F 4 weeks | Reverse transcriptase PCR, DNA Sequencing | S: 1st / 15th of every month R: 15th / 30th of every month |
N029 | HIV 1 RNA, Quantitative, Real Time PCR | 3 mL EDTA PLASMA Separate plasma within 2 hrs & freeze immediately | R 5 days F 6 months | Real Time PCR | S: Wed / Sat 11 am R: Fri / Tue |
H215 | HIV 1 RNA, Quantitative, Real Time PCR with CD3 / CD4 (Immune Deficiency Panel 4) Markers | 3 mL EDTA PLASMA + 4 mL Heparinized WB + 4 mL EDTA WB | 18 - 22°C within 24 hrs | Real Time PCR, Flow Cytometry | S: Wed / Sat 11 am R: Fri / Tue |
H216 | HIV 1 RNA, Quantitative, Real Time PCR with CD3, CD4 / CD8 (Immune Deficiency Panel 2) Markers | 3 mL EDTA PLASMA + 4 mL Heparinized WB + 4 mL EDTA WB | 18 - 22°C within 24 hrs | Real Time PCR, Flow Cytometry | S: Wed / Sat 11 am R: Fri / Tue |
OS151 | HIV 2 Detection, PCR | 4 mL EDTA PLASMA Separate plasma within 2 hrs of collection | R 1 week F 6 months | PCR | S: Daily 11 am R: 6 days |
L021 | HLA-A2 (A*02) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L005 | HLA - AB (Class 1) Typing | 4 mL EDTA WB or 6 mL ACD WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient or donor is mandatory. | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L025 | HLA - ABC (Class 1) Typing | 4 mL EDTA WB or 6 mL ACD WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient or donor is mandatory. | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L010 | HLA - B15 (B*15) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L019 | HLA - B22 (B*22) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
N044 | HLA- B27 Qualitative PCR | 3 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR | S: Daily 9 am R: Same day |
L009 | HLA - B38 (B*38) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L008 | HLA - B5 (B*51/52) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L026 | HLA - B7(B*07) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L007 | HLA - B8 (B*08) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L032 | HLA- C Locus Typing, Any Antigen | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L017 | HLA-Celiac Disease (DR- DQB1- DQA1 Haplotype Association including DQ2,DQ8) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L020 | HLA-Cw6 (C*06) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L036 | HLA-DQB1 Typing | 4 mL EDTA WB or 6 mL ACD WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient or donor is mandatory. | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L018 | HLA-DR & DQB1 (Class II) Typing | 4 mL EDTA WB or 6 mL ACD WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient or donor is mandatory. | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L006 | HLA-DR (Class II) Typing | 4 mL EDTA WB or 6 mL ACD WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient or donor is mandatory. | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L011 | HLA-DR2 (DRB1*02) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L012 | HLA-DR3 (DRB1*03) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L013 | HLA-DR4 (DRB1*04) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L014 | HLA-DR5 (DRB1*11/12) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L016 | HLA-DR7 (DRB1*07) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
L027 | HLA-Narcolepsy (DRB1*15, DQB1*06:02, DQA1*01:02) | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Sequencing Based Typing (SBT) | S: Daily 9 am R:7 days |
L023 | HLA- Panel Reactive IgG Antibodies (PRA), Class I, Quamtitative | 3 mL SERUM Collect preferably 48 hrs after Dialysis | R 1 week F 4 weeks | Luminex X-Map Technology | S: Daily by 9 am R: 2 days |
L024 | HLA- Panel Reactive IgG Antibodies (PRA), Class II, Quamtitative | 3 mL SERUM Collect preferably 48 hrs after Dialysis | R 1 week F 4 weeks | Luminex X-Map Technology | S: Daily by 9 am R: 2 days |
L003 | HLA- Panel Reactive IgG Antibodies (PRA), Screen *Class I *Class II | 3 mL SERUM Collect preferably 48 hrs after Dialysis | R 1 week F 4 weeks | Luminex X-Map Technology | S: Daily by 9 am R: Next day |
L028 | HLA-B Locus Typing, Any Antigen | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R: Next day |
N086 | HLA DNA High Resolution Typing - A Locus | 4 mL EDTA WB or 6 mL ACD WB or Buccal SWAB | R 96 hrs F Unacceptable | PCR, Sequencing | S: Daily 9 am R: 7 days |
N087 | HLA DNA High Resolution Typing - B Locus | 4 mL EDTA WB or 6 mL ACD WB or Buccal SWAB | R 96 hrs F Unacceptable | PCR, Sequencing | S: Daily 9 am R: 7 days |
N083 | HLA DNA High Resolution Typing - C Locus | 4 mL EDTA WB or 6 mL ACD WB or Buccal SWAB | R 96 hrs F Unacceptable | PCR, Sequencing | S: Daily 9 am R: 7 days |
N085 | HLA DNA High Resolution Typing - DQB1 Locus | 4 mL EDTA WB or 6 mL ACD WB or Buccal SWAB | R 96 hrs F Unacceptable | PCR, Sequencing | S: Daily 9 am R: 7 days |
N084 | HLA DNA High Resolution Typing - DRB1 Locus | 4 mL EDTA WB or 6 mL ACD WB or Buccal SWAB | R 96 hrs F Unacceptable | PCR, Sequencing | S: Daily 9 am R: 7 days |
N070 | HLA DNA High Resolution Typing *A, B, C, DR & DQ | 4 mL EDTA WB or 6 mL ACD WB or Buccal SWAB | R 96 hrs F Unacceptable | PCR, Sequencing | S: Daily 9 am R: 8 days |
N024 | HLA DNA Typing for Bone Marrow Transplant, 10 Antigens, PCR *A, B, C, DR & DQ Low Resolution Typing | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | SSP-PCR | S: Daily 9 am R:2 Days |
N025 | HLA DNA Typing for Bone Marrow Transplant, 6 Antigens, PCR *A, B & DR Low Resolution Typing | 4 mL EDTA WB or 6 mL ACD WB | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R:2 Days |
N023 | HLA DNA Typing for Kidney / Liver Transplant, PCR *A, B & DR Low Resolution Typing | 4 mL EDTA WB or 6 mL ACD WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient or donor is mandatory. | R 96 hrs F Unacceptable | Reverse SSOP - Luminex | S: Daily 9 am R:2 Days |
L022 | HLA DSA (Donor Specific IgG Antibodies), Class I & II | Recipient:3 mL SERUM Collect preferably 48 hrs after Dialysis Donor: 12 mL ACD WB | R 48 hrs F Unacceptable | Luminex X-Map Technology | S: Mon / Wed / Fri 9 am R:Wed / Fri / Mon |
L029 | HLA Hypersensitivity to Abacavir (B*57:01) | 4 mL EDTA WB or 6 mL ACD WB or Buccal SWAB | R 96 hrs F Unacceptable | PCR, Sequencing | S: Daily 9 am R: 7 Days |
L031 | HLA Hypersensitivity to Allopurinol (B*58:01) | 4 mL EDTA WB or 6 mL ACD WB or Buccal SWAB | R 96 hrs F Unacceptable | PCR, Sequencing | S: Daily 9 am R: 7 Days |
L030 | HLA Hypersensitivity to Carbamazepine & Phenytoin (B*15:02) | 4 mL EDTA WB or 6 mL ACD WB or Buccal SWAB | R 96 hrs F Unacceptable | PCR, Sequencing | S: Daily 9 am R: 7 Days |
L034 | HLA Single Antigen Bead Assay for Class I IgG Antibodies | 2 mL SERUM | R 72 hrs F 1 week | Luminex X-Map Technology | S: Daily 9 am R: 2 Days |
L035 | HLA Single Antigen Bead Assay for Class II IgG Antibodies | 2 mL SERUM | R 72 hrs F 1 week | Luminex X-Map Technology | S: Daily 9 am R: 2 Days |
L033 | HLA T & B Cell Flow Cytometry, Cross Match | Recipient:2 mL SERUM + 4 mL Heparinized WB Collect preferably 48 hrs after Dialysis Donor: 3 mL Heparinized WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient or donor is mandatory. | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Next day |
L002 | HLA T & B Cell Lymphocyte Cross Match | Recipient:6 mL ACD WB + 3 mL SERUM Collect preferably 48 hrs after Dialysis Donor: 12 mL ACD WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient or donor is mandatory. | R 48 hrs F Unacceptable | Complement Dependent Cytotoxicity with DTT Treatment | S: Daily 1 pm R: Next day |
L038 | HLA Cadaveric Cross Match | Recipient:6 mL ACD WB + 3 mL SERUM Collect preferably 48 hrs after Dialysis Donor: 12 mL ACD WB Doctor's prescription on the letter head with stamp AND photograph of recipient is mandatory. | R 48 hrs F Unacceptable | Complement Dependent Cytotoxicity with DTT Treatment | S: Daily R: 8 hrs |
Z855 | HLA Pretransplant Workup Non Sensitized Recipient Panel 1 Recipient :*HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex * HLA T & B cell lymphocyte cross match vs potential donor * HLA Panel Reactive IgG antibodies (PRA) Screen Luminex Donor:*HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex | Recipient:6 mL ACD WB + 3 mL SERUM + 4 mL EDTA WB Collect preferably 48 hrs after Dialysis Donor: 12 mL ACD WB + 4 mL EDTA WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient & donor is mandatory. | R 48 hrs F Unacceptable | Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP - Luminex, Luminex X-Map technology | S: Mon / Wed / Fri 9 am R: Wed / Fri / Mon |
Z857 | HLA Pre transplant Workup Panel 2 Recipient :*HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex * HLA T & B cell lymphocyte cross match vs potential donor * HLA T & B cell lymphocyte flow cytometry cross match vs potential donor * HLA Panel Reactive IgG antibodies (PRA) Screen Luminex * Donor specific IgG antibodies Class I & II Luminex Donor:*HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex | Recipient:6 mL ACD WB + 9 mL SERUM + 4 mL EDTA WB + 4 mL Heparinized WB Collect preferably 48 hrs after Dialysis Donor: 12 mL ACD WB + 4 mL EDTA WB + 4 mL Heparinized WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient & donor is mandatory. | 18 -22°C within 24 hrs | Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP - Luminex, Luminex X-Map technology, Flow cytometry | S: Mon / Wed / Fri 9 am; R: Wed / Fri / Mon |
Z873 | HLA Pretransplant Workup Sensitized Recipient Panel 3 Recipient :*HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex * HLA T & B cell lymphocyte cross match vs potential donor * HLA Panel Reactive IgG antibodies Class I & ClassII quantitative Luminex * Donor specific IgG antibodies Class I & II Luminex Donor:*HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex | Recipient:6 mL ACD WB + 9 mL SERUM + 4 mL EDTA WB Collect preferably 48 hrs after Dialysis Donor: 12 mL ACD WB + 4 mL EDTA WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient & donor is mandatory. | R 48 hrs F Unacceptable | Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP - Luminex, Luminex X-Map technology | S: Mon / Wed / Fri 9 am; R: Wed / Fri / Mon |
Z858 | HLA Pretransplant Workup Sensitized Recipient Panel 4 Recipient :*HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex * HLA T & B cell lymphocyte cross match vs potential donor * HLA T & B cell lymphocyte flow cytometry cross match vs potential donor * HLA Panel Reactive IgG antibodies (PRA) Screen Luminex *Single antigen bead (SAB) IgG Class I & II Luminex Donor:*HLA DNA High resolution Typing A, B, C, DR & DQ (SBT) | Recipient:6 mL ACD WB + 9 mL SERUM + 4 mL EDTA WB + 4 mL Heparinized WB Collect preferably 48 hrs after Dialysis Donor: 12 mL ACD WB + 4 mL EDTA WB + 4 mL Heparinized WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient & donor is mandatory. | 18 -22°C within 24 hrs | Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP - Luminex, Luminex X-Map technology, Flow cytometry, Sequence based Typing (SBT) | S: Mon 9 am R: Sat |
Z860 | HLA Pretransplant Workup Sensitized Recipient Panel 5 Recipient :*HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex * HLA T & B cell lymphocyte flow cytometry cross match vs potential donor *Single antigen bead (SAB) IgG Class I & II Luminex Donor:*HLA DNA Typing 10 antigens, Low resolution, Luminex | Recipient: 9 mL SERUM + 4 mL EDTA WB + 4 mL Heparinized WB Collect preferably 48 hrs after Dialysis Donor: 4 mL EDTA WB + 4 mL Heparinized WB Doctor's prescription on the letter head with stamp AND 1 photograph of recipient & donor is mandatory. | 18 -22°C within 24 hrs | Reverse SSOP - Luminex, Luminex X-Map technology, Flow cytometry | S: Mon / Wed / Fri 9 am; R: Wed / Fri / Mon |
L004 | HLA - B 27, Flow Cytometry | 4 mL EDTA or Heparanized WB | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
Z827 | HOMA-IR: Insulin Resistance Index *Glucose,Fasting *Insulin,Fasting *Beta cell function *Insulin sensitivity *HOMA-IR index | 2 mL Fluoride PLASMA + 2 mL SERUM Overnight fasting mandatory | R 24 hrs F 1 week | Hexokinase,CMIA | S: Daily 4 pm R: Same day |
Z828 | HOMA-IR: Insulin Resistance Index, C-peptide model *Glucose, Fasting *C-Peptide, Fasting *Beta cell function *Insulin sensitivity *HOMA-IR index | 2 mL Fluoride PLASMA + 2 mL SERUM Overnight fasting mandatory | R 24 hrs F 1 week | Hexokinase,CLIA | S: Daily 4 pm R: Same day |
R143 | Homocysteine, Quantitative Serum | 2 mL SERUM Collect sample on ice and separate serum within 1 hr | R 2 weeks F 4 weeks | CMIA | Daily |
U036 | Homovanillic Acid (HVA), 24 hr Urine | 50 mL aliquot of 24 hr URINE Preservative 50% HCl State Total volume AvoidL-Dopa at least 72 hrs before and during collection. | R 7 days F 30 days | HPLC | S: Wed / Sat 9 am R: Fri / Tue |
U049 | Homovanillic Acid (HVA), Random Urine | 50 mL aliquot of random URINE Preservative 50% HCl State Total volume AvoidL-Dopa at least 72 hrs before and during collection. | R 7 days F 30 days | HPLC | S: Wed / Sat 9 am R: Fri / Tue |
N040 | HPV (Human Papilloma Virus) Detection & Genotyping, Qualitative PCR | Cervical or Oral SWAB or Paraffin BLOCK or Fresh TISSUE in Normal Saline | R 72 hrs F Unacceptable | Real Time PCR | S: Wed / Sat 11 am R: Fri / Tue |
Z794 | HPV, Chlamydia trachomatis & Neisseria gonorrhea PCR Panel, Qualitative | Cervical SWAB | R 72 hrs F Unacceptable | Real Time PCR | S: Wed / Sat 11 am R: Fri / Tue |
RW097 | HTLV - I / II, Antibody Confirmation | 2 mL SERUM Do not use glass tubes | R 7 days F 30 days | Line Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
N130 | Human Herpes virus 6 (HHV6), Qualitative PCR | 3 mL EDTA WB / 3 mL CSF | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N123 | Human Herpes virus 7 (HHV7), Qualitative PCR | 3 mL EDTA WB / 3 mL CSF | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N129 | Human Parechovirus, Qualitative PCR | 3 mL EDTA WB / 3 mL CSF | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N118 | Huntington Disease Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Fragment Analysis | S: Tue 11 am R: 10 days |
Z086 | 17 - Hydroxycorticosteroids & 17 - Ketosteroids, 24 Hour Urine | 20 mL aliquot of 24 hr URINE Preservative 50% HCl State Total volume | R 4 weeks F 2 months | Column Chromatography | S: Daily 4 pm R: 3 days |
U032 | 17 - Hydroxycorticosteroids (17- OHCS), 24 Hour Urine | 20 mL aliquot of 24 hr URINE Preservative 50% HCl State Total volume | R 4 weeks F 2 months | Column Chromatography | S: Daily 4 pm R: 3 days |
RW100 | 17 - Hydroxypregnenolone | 2 mL SERUM No Additive tube | R 5 days F 28 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
R053 | 17 - Hydroxyprogesterone (17- OHP) | 2 mL SERUM | R 4 days F 4 weeks | RIA | S Tue / Sat 9 am R:Same day |
R163 | 17 - Hydroxyprogesterone, Newborn Screen; CAH Screen | 1 drop heel prick blood each on 3 spots of filter paper | R 1 week F 1 week | Fluoroimmunoassay | S: Tue / Thu / Sat 5 pm R: 2 days |
Z024 Y106 Basal Y108 60 min Y109 Customized | 17 - Hydroxyprogesterone (17- OHP) Stimulation by ACTH | 2 mL SERUM for each timed specimen; Draw fasting baseline sample; Administer 250 ug synthetic ACTH IV; draw additional sample at 60 min | R 4 days F 4 weeks | RIA | S Tue / Sat 9 am R:Same day |
G186 | Hydroxyproline, Plasma | 2 mL Heparinized PLASMA Overnight fasting mandatory | R 48 hrs F 2 weeks | LC / MS | S Mon / Wed 5 pm R:3 days |
Z175 | Hypercalcemia Panel 1 *PTH (Intact) *Calcium, Serum *Calcium 24-hour Urine | 10 mL aliquot of 24 hr URINE + 3 mL SERUM Urine:Preservative 10 mL 50 % HCl State Total volume Serum : Collect sample between 8 - 10 am. Separate serum & freeze immediately. | F 4 weeks | CMIA, Arsenazo III | Daily |
Z165 | Hypercalcemia Panel 2 *PTH (Intact) *Calcium, Serum *Phosphorus, Serum * Vitamin D 25 Hydroxy | 6 mL SERUM Collect sample between 8 - 10 am. Separate serum & freeze immediately. | F 4 weeks | CMIA, Arsenazo III, CLIA, Molybdate UV | Daily |
RW102 | Hypersensitivity Pneumonitis Screen *Aspergillus fumigatus *Micropolyspora faeni *Pigeon serum *S.viridis *Thermoactinomyces candidus *Thermoactinomyces vulgaris | 2 mL SERUM | R 14 days F 6 weeks | Immunodiffusion | S: By 7th of Month R: 2 - 3 weeks |
Z311 | Hypertension Panel *Urea* Creatinine* Glucose,fasting* Electrolytes, Serum * Lipid profile, Basic | 2 mL Fluoride PLASMA + 2 mL SERUM Minimum 12 hrs fasting mandatory | R 1 week F 2 weeks | Hexoknase, Spectrophotome try, Indirect ISE | Daily |
Z798 | Hyperthyroid / Grave's Disease Panel *Free T4 * TSH * Total T3 *TSH Receptor Antibody | 4 mL SERUM | R 72 hrs F 4 weeks | CLIA, ECLIA | S: Daily 4 pm R: Same day |
Z797 | Hypothyroidism / Hashimoto's Disease Panel *Free T4 * TSH *Anti TPO | 4 mL SERUM | R 48 hrs F 2 weeks | CLIA | Daily |
G201 | Hypogonadism Panel, Males *FSH *LH *Testosterone - LC- MS/MS | 2 mL SERUM No Additive tube Morning sample preferred . | R 48 hrs F 7 weeks | CLIA, LC- MS/MS | S: Daily 4 pm R: 2 days |
G202 | Hypogonadism Panel, Females *FSH *LH *Estradiol- LC-MS/MS | 2 mL SERUM No Additive tube Morning sample preferred Prefered sampling time in females is Day 2 or Day 3 of menstrual cycle . | R 48 hrs F 7 weeks | CLIA, LC- MS/MS | S: Daily 4 pm R: 2 days |
OS154 | IgVH Gene Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequecing | S: Tue 11 am R: 10 days |
RW103 | IgA Subclasses *IgA1 * IgA2 * Total IgA | 2 mL SERUM | R 14 days F 6 weeks | Nephelometry | S: By 7th of Month R: 2 - 3 weeks |
Z176 | IGF-1 & Growth Hormone Panel | 3 mL SERUM Separate serum & freeze immediately Overnight fasting mandatory | F 4 weeks | CLIA | Daily |
R106 | IGF-1; Somatomedin - C | 2 mL SERUM Separate serum & freeze immediately | F 4 weeks | CLIA | Daily |
RW105 | IGF Binding Protein 2; IGFBP-2 | 2 mL SERUM No Additive Tube | R 4 days F 28 days | RIA | S: By 7th of Month R: 2 - 3 weeks |
R105 | IGF Binding Protein 3; IGFBP-3 | 2 mL SERUM Separate serum & freeze immediately | F 4 weeks | CLIA | S: Mon / Thu 4 pm R: Same day |
RW104 | IGF Binding Protein 1; IGFBP-1 | 2 mL SERUM No Additive Tube Overnight fasting mandatory | R 7 days F 28 days | RIA | S: By 7th of Month R: 2 - 3 weeks |
N073 | Imatinib Resistance Mutation Analysis; IRMA | 4 mL EDTA WB Submit latest BCR-ABL Quantitative report | R 48 hrs F Unacceptable | PCR Sequecing | S: Mon 11 am R: Sat |
G135 | IMD Panel, Quantitative, Blood *Amino Acids * Organic Acids * Fatty Acids | 1 drop heel prick blood each on 3 spots of filter paper | R 1 week F 1 week | TMS | S: Mon / Wed / Fri 4 pm R: 2 days |
RW107 | Imipramine Includes metabolite Desipramine & Total | 3 mL SERUM No Additive Tube Draw sample >12 hrs post oral dose | R 5 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
H250 | Immature Platelet Fraction (IPF) | 3 mL EDTA WB | R 12 hrs F Unacceptable | Fluorescent Flow Cytometry | Daily |
Z879 | Immigration / Immunization Check Panel, Basic *Rubella (German Measles) Antibody, IgG * Measles (Rubeola) Antibody, IgG * Mumps Virus Antibody, IgG * Quantiferon-TB Gold ; Gamma Interferon | 4 mL SERUM + 1 mL WB from set of Special QuantiFERON-TB Gold tubes Shake tubes to ensure thorough mixing Do not centrifuge if sending within 16 hrs OR incubate at 37 C for 16-24 hrs & centrifuge. | R 48 hrs F Unacceptable | CLIA , Enzyme Immunoassay | S: Mon 9 am R: Next day |
Z880 | Immigration / Immunization Check Panel, Advanced *Rubella (German Measles) Antibody, IgG * Measles (Rubeola) Antibody, IgG * Mumps Virus Antibody, IgG * Quantiferon-TB Gold ; Gamma Interferon * Hepatitis A Antibody (Anti-HAV), IgG * Hepatitis B Surface Antibody; Anti HBs * Bacterial Meningitis Screen | 4 mL SERUM + 1 mL WB from set of Special QuantiFERON-TB Gold tubes Shake tubes to ensure thorough mixing Do not centrifuge if sending within 16 hrs OR incubate at 37 C for 16-24 hrs & centrifuge. | R 48 hrs F Unacceptable | CLIA , Enzyme Immunoassay | S: Mon 9 am R: Next day |
RW108 | Immune Complex Detection by C1q Binding | 2 mL SERUM No Additive Tube Separate serum within 1 hr Do not use glass tubes | F 6 weeks | EIA | S: By 7th of Month R: 2 - 3 weeks |
Z146 | Immune Deficiency Panel 1 Includes % and Absolute Counts *CD3 * CD4* CD8 * CD19 * CD 16+/CD56 | 3 mL EDTA WB + 3 mL Heparinized WB | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
Z147 | Immune Deficiency Panel 2; CD4/CD8 Counts Includes % and Absolute Counts *CD3 * CD4* CD8 | 3 mL EDTA WB + 3 mL Heparinized WB | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
Z148 | Immune Deficiency Panel 3; CD3 Count Includes % and Absolute Counts | 3 mL EDTA WB + 3 mL Heparinized WB | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
Z219 | Immune Deficiency Panel 4; CD4 Counts Includes % and Absolute Counts *CD3 * CD4 | 3 mL EDTA WB + 3 mL Heparinized WB | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
Z220 | Immune Deficiency Panel 5 Includes % and Absolute Counts *CD3 * CD19 | 3 mL EDTA WB + 3 mL Heparinized WB | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
E006 | Immunofixation Electrophoresis (IFE), 24 Hour Urine | 50 mL aliquot of 24 hr URINE State Total Volume | R 1 week F 2 weeks | Agarose gel electrophoresis, Immunofixation | S: Daily 9 am R: 4 days |
E005 | Immunofixation Electrophoresis (IFE), Serum | 2 mL SERUM Separate serum within 1 hr | R 2 weeks F 6 months | Agarose gel electrophoresis, Immunofixation | S: Daily 9 am R: Next day |
B078 | Immunoglobulin IgA, Serum | 2 mL SERUM | R 72 hrs F 6 weeks | Immunoturbidimetry | Daily |
E012 | Immunoglobulin IgD & IgE Typing, Serum | 2 mL SERUM Separate serum within 1 hr | R 1 week F 2 weeks | Agarose gel electrophoresis, Immunofixation | S: Daily 9 am R:Next day |
E013 | Immunoglobulin IgD & IgE Typing, Urine | 20 mL aliquot of 24 hr URINE State Total Volume | R 1 week F 2 weeks | Agarose gel electrophoresis, Immunofixation | S: Daily 9 am R: 4 Days |
RW244 | Immunoglobulin IgD, Serum | 2 mL SERUM No Additive Tube | R 7 days F 21 days | Nephelometry | S: By 7th of Month R: 2 - 3 weeks |
S028 | Immunoglobulin IgE, Serum | 2 mL SERUM | R 72 hrs F 3 months | ImmunoCAP | Daily |
B190 | Immunoglobulin IgG Subclass 4 | 2 mL SERUM | R 8 days F 30 days | Nephelometry | S: Mon / Thu 4 pm R: Same day |
RW109 | Immunoglobulin IgG Subclasses *IgG Subclasses 1, 2, 3, 4 * Total IgG | 3 mL SERUM | R 7 days F 6 weeks | Nephelometry | S: By 7th of Month R: 2 - 3 weeks |
Z180 | Immunoglobulin IgG Synthesis Index & Rate | 2 mL CSF + 2 mL SERUM Collection date & time to be same for both specimens | R 72 hrs F 4 weeks | BCG, Nephelometry, Immunoturbidim etry | S: Daily 4 pm R: Next day |
B091 | Immunoglobulin IgG, CSF | 2 mL CSF | R 1 week F 4 weeks | Nephelometry | S: Mon through Sat 4 pm R: Same day |
B077 | Immunoglobulin IgG, Serum | 2 mL SERUM | R 72 hrs F 6 weeks | Immunoturbidim etry | Daily |
RW110 | Immunoglobulin IgM, CSF | 2 mL CSF | R 72 hrs F 30 days | Rate Nephelometry | S: By 7th of Month R: 2 - 3 weeks |
B079 | Immunoglobulin IgM, Serum | 2 mL SERUM | R 72 hrs F 6 weeks | Immunoturbidimetry | Daily |
RW111 | Immunoglobulin Profile, CSF *IgG * IgA *IgM | 2 mL CSF | R 72 hrs F 30 days | Fixed time Nephelometry | S: By 7th of Month R: 2 - 3 weeks |
Z178 | Immunoglobulin Profile, Serum *IgG * IgA *IgM | 2 mL SERUM | R 72 hrs F 6 weeks | Immunoturbidimetry | Daily |
J150 | Immunohistochemistry, Any 3 markers | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
J151 | Immunohistochemistry, Any 5 markers | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
Z700 | Immunohistochemistry,Custom Panel | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
Immunohistochemistry,Individual Markers | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
|
J108 J076 J137 J147 J180 J143 J194 J196 J094 J178 J158 J186 J141 J041 J132 | ACTH Actin (Smooth Muscle Actin) AFP (Alpha Feto Protein) ALK-1 AMACR 34-BETA E12 Beta Catenin Ber-Ep4 (EpCAM) BCL-2 BCL-6 Calcitonin Caldesmon Calretinin Cathepsin D C4d | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
J153 J066 J163 J096 J203 J162 J097 J061 J062 | CD1a CD3 CD4 CD5 CD7 CD8 CD10 CD15 CD20 | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
J174 J098 J063 J099 J100 J175 J029 J037 J161 J064 J065 J102 J101 J146 J145 | CD21 CD23 CD30 CD31 CD34 CD35 CD45 (LCA) CD45Ro (Pan T) CD56 CD68 CD79a CD99 (MIC-2) CD117 CD138 CEA | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
J111 J157 J187 J195 J130 J017 J126 J188 J127 J167 J018 J173 | Chromogranin A CK5/6 CDX-2 c-MYC Cyclin-D1 Cytokeratin (Pancytokeratin) Cytokeratin 7 Cytokeratin 19 Cytokeratin 20 Cytomegalovirus (CMV) Desmin DOG-1 | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
J077 J030 J009 J107 J197 J034 J199 J105 J160 J043 J103 J191 | Epidermal Growth Factor Receptor (EGFR) Epithelial Membrane Antigen (EMA) Estrogen Receptor (ER) FSH GATA-3 Glial Fibrillary Acidic Protein (GFAP) Glypican-3 Growth Hormone Hepatocyte Specific Antigen (HSA) HER2 / ERBB2 HMB 45 Human Chorionic Gonadotropin (HCG) | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
J209 J171 J172 J140 J192 J139 J046 J138 J189 J142 J190 J198 J033 J036 | IDH1 IgA IgG Inhibin INI-1 Kappa Light Chains Ki67 Lambda Light Chains Melan-A Myeloperoxidase Myogenin Napsin-A Neurofilament Polypeptide Neuron Specific Enolase (NSE) | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
J181 J044 J159 J179 J202 J207 J148 J010 J104 J093 J045 J166 J125 J031 | Oct.2 p53 p63 PAX-5 PAX-8 PDL1 Polyoma BK Virus Progesterone Receptor (PR) Prolactin Prostate Specific Antigen (PSA) pS2 Serum Associated Amyloid (SAA) Synaptophysin S100 | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
J128 J067 J144 J193 J032 J136 | TdT Thyroglobulin TTF-1 Uroplakin II Vimentin WT-1 | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
J200 J201 J202 J203 J204 J205 J206 | TLE1 Galectin-3 PAX8 CD7 IgG4 TFE3 SALL4 | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
Z680 | Immunohistochemistry, Microsatellite Instability Panel for Colorectal Cancer *MLH-1 *MSH-2 *MSH-6 *PMS-2 | Tumor TISSUE in 10% Formal saline or Paraffin BLOCK | NA | IHC | S: Daily 6 pm R: Block : 5 days Tissues : 7 days |
G169 | Immunosuppressant Drug Profile 1 *Tacrolimus *Sirolimus | 3 mL EDTA WB drawn just before next dose | R 1 week F Unacceptable | LC-MS/MS | S:Daily 5 pm R:Same day |
G166 | Immunosuppressant Drug Profile 2 *Cyclosporine *Sirolimus | 3 mL EDTA WB drawn just before next dose | R 1 week F Unacceptable | LC-MS/MS | S:Daily 5 pm R:Same day |
G167 | Immunosuppressant Drug Profile 3 *Cyclosporine *Tacrolimus | 3 mL EDTA WB drawn just before next dose | R 1 week F Unacceptable | LC-MS/MS | S:Daily 5 pm R:Same day |
G168 | Immunosuppressant Drug Profile 4 *Tacrolimus *Everolimus | 3 mL EDTA WB drawn just before next dose | R 1 week F Unacceptable | LC-MS/MS | S:Daily 5 pm R:Same day |
P051 | India Ink Preparation, CSF | 1 mL CSF | 18 -22°C within 48 hrs | Light Microscopy | Daily |
P068 | India Ink Preparation, Fluid | 1 mL FLUID | 18 -22°C within 48 hrs | Light Microscopy | Daily |
Z812 | Infertility Comprehensive Panel, Females *FSH *LH *Prolactin *Testosterone, Total * TSH Ultrasensitive * Estradiol *Anti Mullerian Hormone (AMH) | 4 mL SERUM Draw sample 4 hrs after patient has awakened Preferred sampling time: Day 2 or Day 3 of menstrual cycle | R 24 hrs F 2 weeks | CLIA, EIA | S:Daily 9 am R:Same day |
Z605 | Infertility Panel, Males *FSH *LH *Testosterone, Total *TSH Ultrasensitive | 3 mL SERUM | R 48 hrs F 4 weeks | CLIA | Daily |
Z179 | Infertility Screening Panel, Females *FSH * LH * Prolactin * Testosterone, Total *TSH Ultrasensitive | 3 mL SERUM Draw sample 4 hrs after patient has awakened Preferred sampling time: Day 2 or Day 3 of menstrual cycle | R 24 hrs F 2 weeks | CLIA | Daily |
F021 | Inhibin A, Pregnancy | 2 mL SERUM | R 48 hrs F 4 weeks | CLIA | S:Daily 9 am R:Same day |
F022 | Inhibin A, Reproductive Marker | 2 mL SERUM | R 48 hrs F 4 weeks | CLIA | S:Daily 9 am R:Same day |
F025 | Inhibin B | 2 mL SERUM Preferred sampling time: Day 2 or Day 3 of menstrual cycle | R 24 hrs F 4 weeks | EIA | S:Mon 9 am R:Same day |
S133 | Insulin Antibodies | 2 mL SERUM | R 1 week F 4 weeks | EIA | S:Sat 9 am R:Same day |
RW112 | Insulin Antibodies, Highly Sensitive | 2 mL SERUM No Additive Tube Separate serum within 1 hr | R 28 days F 28 days | Radiobinding Assay | S: By 7th of Month R: 2 - 3 weeks |
Z084 Y084 Basal Y085 0.5 hr Y086 1.0 hr Y087 1.5 hr Y088 2.0 hr Y089 2.5 hr Y090 3.0 hr Y091 4.0 hr Y092 5.0 hr Y093 Customized | Insulin Response to Glucose, 5 Hours | 2 mL Fluoride PLASMA + 2 mL SERUM for each timed specimen Draw fasting baseline sample; Dissolve 82.5 g glucose monohydrate (equivalent to 75 g anhydrous glucose) in adults or 1.92 g / Kg body wt in children in 300 mL water. Draw additional samples at 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0 & 5.0 hrs. Overnight fasting mandatory. | R 24 hrs F 1 week | CMIA, Hexokinase | Daily |
R039 | Insulin, Fasting | 2 mL SERUM Overnight fasting mandatory. | R 24 hrs F 4 weeks | CMIA | Daily |
Z385 | Insulin Fasting (F) & Post Prandial (PP) Panel | 2 mL SERUM each for F & PP sample. Overnight fasting mandatory. | R 24 hrs F 4 weeks | CMIA | Daily |
RW113 | Insulin, Free (Bioactive) | 2 mL SERUM No Additive Tube Overnight fasting mandatory Recommended for patients with detectable insulin antibodies. | R 7 days F 28 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
R042 | Insulin PP | 2 mL SERUM 2 hrs post meal | R 24 hrs F 4 weeks | CMIA | Daily |
R041 | Insulin Random | 2 mL SERUM | R 24 hrs F 4 weeks | CMIA | Daily |
RW256 | Intereron - Beta IgG, MAID | 2 mL SERUM collected 8 hrs after Interferon injection No Additive Tube Provide dose & duration of therapy. | R 14 days F 30 days | Multianalyte Immunodetectio n (MAID) | S: By 7th of Month R: 2 - 3 weeks |
RW114 | Interleukin - 2 Receptor; IL-2R | 2 mL SERUM No Additive Tube Separate serum within 1 hr | F 30 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
RW115 | Interleukin - 6; IL-6 | 2 mL SERUM in No Additive Tube or 2 mL EDTA PLASMA Separate serum or plasma within 2 hrs | F 2 months | EIA | S: By 7th of Month R: 2 - 3 weeks |
N050 | Interleukin 28B rs12979860 & rs 8099917 Genotyping, Qualitative PCR | 3 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR | S:Thu / Mon 9 am R: Sat / Wed |
S244 | Intrinsic Factor Antibody | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S: Mon 9 am R: Same day |
N046 | Inv 16 (p13q22) / t(16;16)(p13;q22) Gene Rearrangement, Qualitative PCR | 3 mL EDTA WB or BONE MARROW | R 72 hrs F Unacceptable | Real Time PCR | S:Mon / Thu 11 am R: Wed / Sat |
H020 | Iron Studies *Serum Iron * Total Iron Binding Capacity *Transferrin Saturation | 3 mL SERUM Avoidiron supplements for minimum 7 days prior to specimen collection. | R 3 weeks F 4 weeks | Spectrophotometry | Daily |
Z783 | Iron Studies Monitoring Panel *Serum Iron * Total Iron Binding Capacity *Transferrin Saturation * Ferritin | 4 mL SERUM Avoidiron supplements for minimum 7 days prior to specimen collection. | R 48 hrs F 4 weeks | Spectrophotometry, CLIA | Daily |
S134 | Islet Cell Antibody | 2 mL SERUM | R 1 week F 4 weeks | Indirect IFA | S:Daily 11 am R: Same day |
S186 | Islet Cell Antibody in dilutions | 2 mL SERUM | R 1 week F 4 weeks | Indirect IFA | S:Daily 11 am R: Next day |
N039 | JAK2 Mutation Detection, Qualitative PCR | 3 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR | S:Mon / Thu 11 am R: Wed / Sat |
N122 | JAK2 Exon 12 Mutation | 3 mL EDTA WB | R 72 hrs F Unacceptable | PCR, Fragment analysis | S:Mon / Thu 11 am R: Wed / Sat |
Z839 | JAK 2 V617F Reflex to JAK 2 EXON 12, Mutation Detection | 3 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR, Fragment analysis | S: Mon 11 am R: Sat |
Z840 | JAK 2 V617F, CALR & MPL, Mutation Detection Profile | 3 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR, Sequencing, Fragment analysis | S: Mon 11 am R: Sat |
N148 | Japanese Encephalitis Virus Detection , PCR | 3 mL CSF | R 72 hrs F 1 week | Real Time PCR | S: Thu 11 am R: Sat |
OS156 | JC/BK Virus Detection, PCR | 4 mL SERUM / 4 mL EDTA PLASMA / 3 mL CSF / URINE / TISSUE in normal saline | R 72 hrs F 1 week | PCR | S:Daily 11 am R: 10 days |
S080 | Jo-1 Antibody | 2 mL SERUM | R 72 hrs F 2 weeks | EIA | S:Tue / Fri 9 am R:Same day |
B148 | Kappa / Lambda Light Chains, Free, Serum *Kappa Light Chains *Lambda Light chains *Kappa Lambda Ratio | 2 mL SERUM | R 1 week F 4 weeks | Nephelometry | S:Mon through Sat 4 pm R:Same day |
U079 | Kappa / Lambda Light Chains, Free, Urine *Kappa Light Chains *Lambda Light chains | 10 mL aliquot of random URINE | R 1 week F 4 weeks | Nephelometry | S:Mon through Sat 4 pm R:Same day |
B199 | Ketone Body (Beta Hydroxybutyrate), Serum | 2 mL SERUM | R 12 hrs F 4 weeks | Enzymatic | S: Daily 4 pm R: Same day |
U005 | 17-Ketosteroids, 24 Hour Urine | 20 mL aliquot of 24 hr URINE Preservative 50% HCl State Total Volume | R 4 weeks F 2 months | Column Chromatography | S: Daily 4 pm R: 3 days |
Z379 | Kidney Dialysis Panel *Glucose R *Creatinine *Uric Acid *Cholesterol *Protein Total *Albumin *A:G Ratio *Alkaline Phosphatase *Calcium *Phosphorus *Electrolytes, serum *BUN *CBC *Urine R/E | 3 mL SERUM + 2 mLFluoride PLASMA + 3 mL EDTA WB + 10 mL aliquot of first morning URINE | R 24 hrs F Unacceptable | Spectrophotometry,Indirect ISE, Hexokinase | Daily |
Z784 | Kidney Panel Extended *Urea *Creatinine *Uric Acid *Protein Total *Albumin *A:G Ratio *Alkaline Phosphatase *Calcium *Phosphorus *Electrolytes, serum *Bicarbonate *Glucose Random | 4 mL SERUM + 2 mLFluoride PLASMA | R 24 hrs F 4 weeks | Spectrophotometry, Indirect ISE, Hexokinase | Daily |
Z007 | Kidney Panel; KFT *Urea *Creatinine *Uric Acid *Protein Total *Albumin *A:G Ratio *Alkaline Phosphatase *Calcium *Phosphorus *Electrolytes, serum | 3 mL SERUM | R 24 hrs F 4 weeks | Spectrophotometry,Indirect ISE | Daily |
Z230 | Kidney Stone Formation Diagnostic Panel *pH *Creatinine *Calcium *Magnesium *Citrate *Oxalate *Osmolality *Electrolytes, urine *Uric Acid *Phosphorus | Day 1: 50 mL alilquot of 24 hr URINE No preservative Day 2: 50 mL alilquot of 24 hr URINE Preservative 50% HCl State Total Volume Record patient weight | F 4 weeks | Spectrophotometry, Enzymatic, Indirect ISE | S: Wed / Sat 9 am R: Same day |
Z231 | Kidney Stone Formation Therapeutic Monitoring Panel *pH *Creatinine *Calcium *Magnesium *Citrate *Oxalate *Osmolality *Sodium *Uric Acid *Phosphorus | Day 1: 50 mL alilquot of 24 hr URINE No preservative Day 2: 50 mL alilquot of 24 hr URINE Preservative 50% HCl State Total Volume Record patient weight | F 4 weeks | Spectrophotometry, Enzymatic, Indirect ISE | S: Wed / Sat 9 am R: Same day |
Z816 | KRAS & NRAS Mutation Analysis Panel | Paraffin BLOCK | NA | PCR, Fragment Analysis & Sequencing | S: Tue 11 am R: Mon |
OS158 | KRAS Codon 61 Mutation Detection | TISSUE or Paraffin BLOCK | R 72 hrs F Unacceptable | PCR | S: Sat 11 am R: 15 days |
N067 | KRAS Mutation Codon 12 & 13 Fragment Analysis | Paraffin BLOCK | NA | PCR Fragment Analysis | S: Tue 11 am R: Mon |
B098 | Lactate, CSF 1 mL CSF | 1 mL CSF | R 24 hrs F 4 weeks | Spectrophotometry | Daily |
B099 | Lactate, Plasma | 2 mL Fluoride PLASMA without tourniquet | R 2 weeks F 4 weeks | Spectrophotometry | Daily |
B113 | Lactate, Plasma, Post Exercise | 2 mL Fluoride PLASMA without tourniquet Separation of plasma at source is mandatory | R 2 weeks F 4 weeks | Spectrophotometry | Daily |
RW118 | Lamotrigine | 2 mL SERUM No Additive Tube Draw 0.5 - 1 hr before next dose | R 5 days F 14 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
P052 | LDH (Lactate Dehydrogenase) Fluid | 5 mL FLUID | R 1 week F Unacceptable | IFCC | Daily |
B031 | LDH; Lactate Dehydrogenase | 2 mL SERUM | R 4 days F Unacceptable | IFCC | Daily |
B129 | LDL Cholesterol, Direct | 2 mL SERUM | R 1 week F 2 weeks | Enzymatic selective protection | Daily |
E014 | LDL Subfractions | 2 mL SERUM 12 hrs fasting mandatory | R 1 week F Unacceptable | Polyacrylamidegel electrophoresis | S: Fri 9 am R: Same day |
H036 | LE Cell Phenomenon | 10 mL WB in plastic container with glass beads Rotate for 30 min. to defibrinate | R 48 hrs F Unacceptable | Romanowsky staining | S: Daily 6 pm R: Next day |
Z038 | Lead Poisoning Panel * 5-Amino Levulinic Acid (5-ALA) * Lead Blood | 10 mL aliquot of 24 hr URINE in dark colored container + 4 mL K2EDTA (Metal Free) PLASMA Use powderless gloves during collection. Record total volume. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 72 hrs F Unacceptable | Column Chromatography , AAS with Zeeman correction | S: Tue / Fri 9 am R: Next day |
C021 | Lead, 24 Hour Urine | 10 mL aliquot of 24 hr URINE in Metal free container. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 72 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
C020 | Lead, Blood | 4 mL K2EDTA (Metal Free) PLASMA Use powderless gloves during collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 72 hrs F Unacceptable | AAS with Zeeman correction | S: Daily 6 pm R: Next day |
C022 | Lead, Random Urine | 10 mL aliquot of random URINE in Metal free container. Use powderless gloves during collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 72 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
M217 | Legionella Antigen, Urine | 5 mL aliquot of random URINE. | R 48 hrs F Unacceptable | ICT | S: Daily 1 pm R: Same day |
RW119 | Legionella pneumophila Antibodies IgG & IgM, SerumSerogroups 1-6 | 2 mL SERUM | R 7 days F 60 days | IFA | S: By 7th of Month R: 2 - 3 weeks |
S025 | Leishmania (Kala Azar) Antibody, IgG | 2 mL SERUM | R 1 week F 4 weeks | EIA | S:Sat 9 am R:Same day |
M231 | Leishmania (Kala Azar) rK-39 Antibody, Serum | 2 mL SERUM | R 72 Hrs F Unacceptable | Immunochromat ography | S: Daily 3.30 pm R:Same day |
B164 | Leptin | 2 mL SERUM | R 1 week F 4 weeks | EIA | S:Sat 9 am R:Same day |
Z302 | Leptospira Antibodies Panel, IgG & IgM | 2 mL SERUM | R 1 week F 4 weeks | EIA | S:Tue / Sat 9 am R:Same day |
S157 | Leptospira Antibody, IgG | 2 mL SERUM | R 1 week F 4 weeks | EIA | S:Tue / Sat 9 am R:Same day |
S197 | Leptospira Antibody, IgM | 2 mL SERUM | R 1 week F 4 weeks | EIA | S:Tue / Sat 9 am R:Same day |
OS159 | Leptospira Detection, PCR | 4 mL EDTA WB or 10 mL URINE | R 1 week F Unacceptable | PCR | S:Wed / Sat 11 am R:Mon / Thu |
H253 | Leucocyte Adhesion Deficiency (LAD I & II) *CD11a *CD11b *CD18 *CD15s | 3 mL EDTA WB + 3 mL Heparinized WB Clinical history & CBC report mandatory | 18 -22°C within 72 hrs | Flow Cytometry | S: Daily 9 am R: Next day |
H050 | Leukocyte Alkaline Phosphatase (LAP) Score | 5 fresh peripheral blood SMEARS Fixative 95% Ethanol for 30 mins | NA | Cytochemistry | S: Daily 9 am R: Next day |
Z151 | Leukemia / Lymphoma Diagnostic Panel: Chronic Lymphoproliferative disorders, T & B cell | 3 mL EDTA WB + 3 mL Heparinized WB or BONE MARROW + Aspirate SMEAR | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
Z538 | Leukemia Diagnostic Comprehensive Profile (Any 3 Markers) *Leukemia diagnostic panel, Acute Leukemia - T, B or Myeloid, *Chromosome analysis for hematological malignancy, *Leukemia Genetic Profile - any 3 markers, PCR | 2 mL Heparinized BONE MARROW + 3 mL EDTA WB or Bone Marrow | 18 -22°C within 24 hrs | Flow Cytometry, Culture, Microscopy, Karyotype, Real Time PCR | S: Daily 11 am R: 7 days |
Z663 | Leukemia Diagnostic Comprehensive Profile (Any 6 Markers) *Leukemia diagnostic panel, Acute Leukemia - T, B or Myeloid, *Chromosome analysis for hematological malignancy, *Leukemia Genetic Profile - any 6 markers, PCR | 2 mL Heparinized BONE MARROW + 3 mL EDTA WB or Bone Marrow | 18 -22°C within 24 hrs | Flow Cytometry, Culture, Microscopy, Karyotype, Real Time PCR | S: Daily 11 am R: 7 days |
Z512 | Leukemia Diagnostic Panel, Customized (Any 10 Markers) | 3 mL EDTA WB + 3 mL Heparinized WB or 2 mL Heparinized BONE MARROW + Aspirate SMEAR | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
Z282 | Leukemia Diagnostic Panel: CLL / HCL / SLL (Basic) | 3 mL EDTA WB + 3 mL Heparinized WB or 2 mL Heparinized BONE MARROW + Aspirate SMEAR | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
Z780 | Leukemia Diagnostic Panel: Plasma Cell Dyscrasias | 3 mL EDTA WB + 3 mL Heparinized WB or 2 mL Heparinized BONE MARROW + Aspirate SMEAR | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
Z268 | Leukemia Diagnostic Panel : Acute Leukemia - T, B or Myeloid | 3 mL EDTA WB + 3 mL Heparinized WB or 2 mL Heparinized BONE MARROW + Aspirate SMEAR | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
Z269 | Leukemia Diagnostic Panel: AML Characterization | 3 mL EDTA WB + 3 mL Heparinized WB or 2 mL Heparinized BONE MARROW + Aspirate SMEAR | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
Z662 | Leukemia Genetic Profile - Any 6 Markers, PCR, Qualitative | 3 mL EDTA WB or BONE MARROW | R 48 hrs F Unacceptable | Real Time PCR | S: Tue / Fri 11 am R: Thu / Mon |
Z154 | Leukemia Monitoring Panel: Hairy Cell | 3 mL EDTA WB + 3 mL Heparinized WB or 2 mL Heparinized BONE MARROW + Aspirate SMEAR | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
RW205 | Levetiracetam | 3 mL SERUM drawn just before next dose No Additive tube | R 28 days F 60 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
Z207 | LH & Testosterone, Total | 3 mL SERUM Preferred sampling time in females is Day 2 or Day 3 of menstrual cycle | R 48 hrs F 4 weeks | CLIA | Daily |
R081 | LH; Luteinising Hormone | 2 mL SERUM Preferred sampling time in females is Day 2 or Day 3 of menstrual cycle | R 48 hrs F 4 weeks | CLIA | Daily |
B059 | Lipase | 2 mL SERUM | R 1 week F 4 weeks | Spectrophotome try | Daily |
B131 | Lipid Profile, Basic *Cholesterol * Triglycerides * HDL Direct * LDL Direct * VLDL, Calculated *Non HDL Cholesterol | 3 mL SERUM 12 hrs fasting mandatory | R 1 week F 2 weeks | Spectrophotometry | Daily |
E017 | Lipid Profile, Complete *Cholesterol *Triglycerides *HDL / LDL / VLDL - Electrophoretic *Cholesterol / HDL Ratio *Chylomicrons *Non HDL Cholesterol | 3 mL SERUM 12 hrs fasting mandatory | R 1 week F 2 weeks | Spectrophotometry, Electrophoresis | S: Daily 9 am R:3 days |
Z279 | Lipid Profile, Comprehensive *Apolipoproteins A1, B & Ratio *Lipoprotein (a) *Cholesterol *Triglycerides *LDL Cholesterol *HDL Cholesterol *Cholesterol / HDL Ratio *Non HDL Cholesterol *Homocysteine *Fibrinogen *Cardio CRP | 4 mL SERUM + 3 mL CITRATED PPP Separate plasma & freeze immediately 12 hrs fasting mandatory | F 72 hrs | Spectrophotometry, CMIA , Imunoturbidimet ry & Photo optical clot detection | S: Mon through Sat 4 pm R: Same day |
Z060 | Lipid Profile Extended *Apolipoproteins A1, B & Ratio *Lipoprotein (a) *Cholesterol *Triglycerides *HDL/VLDL/LDL Electrophoretic *Cholesterol / HDL Ratio*Chylomicrons *Non HDL Cholesterol * Cardio CRP | 3 mL SERUM 12 hrs fasting mandatory | R 1 week F 2 weeks | Spectrophotometry, Electrophoresis, Immunoturbidim etry | S: Daily 9 am R: 3 days |
B101 | Lipoprotein (a); Lp (a) | 2 mL SERUM | R 1 week F 4 weeks | Immunoturbidim etry | Daily |
RW123 | Lipoprotein Fractionation, Ultracentrifugation | 4 mL SERUM No Additive tube 12 hrs fasting mandatory | R 7 days F 6 weeks | Ultracentrifugati on,Colorimetric, Enzymatic | S: By 7th of Month R: 2 - 3 weeks |
N150 | Liquid Biopsy, cfDNA, EGFR For Colorectal & Lung cancer *p.E746_A750 deletion *p.T790M mutation *p.L858R mutation | 10 mL Whole blood in 1 Streck tube | R 1 week F Unacceptable | Droplet Digital PCR | S: Mon / Thu 9 am R: Fri / Tue |
M203 | Listeria Antigen, Stool | 5 g fresh STOOL | R 24 hrs F Unacceptable | ICT | S: Daily 1 pm R: Same day |
B069 | Lithium | 2 mL SERUM drawn just before next dose | R 1 week F 4 weeks | Colorimetric | Daily |
Z025 | Liver & Kidney Panel *LFT *KFT | 3 mL SERUM | R 24 hrs F 1 week | Spectrophotometry, Indirect ISE | Daily |
Z618 | Liver Fibrosis Panel *SGOT *SGPT *GGTP *Bilirubin *Protein, Total * Alkaline Phosphatase * Prothrombin Time * Protein Electrophoresis, Serum | 3 mL SERUM + 3 mL Citrated PPP Separate plasma & freeze immediately | F 2 weeks | Spectrophotometry,Electromech anical Clot Detection, Capillary Electrophoresis | S: Daily 9 am; R: Same day |
S165 | Liver Kidney Microsomal (LKM) Antibody in Dilutions, IFA | 3 mL SERUM | R 1 week F 4 weeks | IFA | S:Daily 11 am R: Next day |
S164 | Liver Kidney Microsomal (LKM) Antibody, IFA | 2 mL SERUM | R 1 week F 4 weeks | IFA | S:Daily 11 am R: Same day |
Z005 | Liver Panel 1; LFT *SGOT *SGPT *GGTP *Bilirubin *Protein,Total *Alkaline Phosphatase | 2 mL SERUM | R 24 hrs F 1 week | Spectrophotometry | Daily |
Z004 | Liver Panel 2 *SGOT *SGPT *GGTP *Bilirubin *Protein,Total *Alkaline Phosphatase *Prothrombin Time *HBsAg | 3 mL SERUM + 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day & Oral Anticoagulants for 7 days prior to sampling with consent from treating Physician. | F 2 weeks | Spectrophotome try, CMIA, Electromechanic al Clot Detection | Daily |
B192 | Lp-PLA2 (Lipoprotein Associated Phospholipase A2), Activity | 2 mL SERUM | R 1 week F 3 months | Enzymatic | S: Tue / Fri 9 am ; R: Same day |
RW124 | LSD, Urine, Quantitative | 20 mL aliquot of random URINE Protect from light | R 14 days F 30 days | GC / MS | S: By 7th of Month R: 2 - 3 weeks |
Z789 | Lung Cancer Mutation Panel *ALK-1 *EGFR | Paraffin BLOCK or Coated SLIDES | NA | FISH, PCR | S:Tue 11 am R: Mon |
H124 | Lupus Anticoagulant by APTT; PTT-LA | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day & Oral Anticoagulants for 7 days prior to sampling with consent from treating Physician. | F 2 weeks | Electromechanical Clot Detection | S: Daily 3 pm R: Next day |
H123 | Lupus Anticoagulant by dRVVT | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day & Oral Anticoagulants for 7 days prior to sampling with consent from treating Physician. | F 2 weeks | Electromechanical Clot Detection | S: Daily 3 pm R: Next day |
Z168 | Lupus Anticoagulant Panel; LAC Panel *APTT * PTT-LA * dRVVT | 3 mL Citrated PPP Separate plasma & freeze immediately Recommended to discontinue Heparin for 1 day & Oral Anticoagulants for 7 days prior to sampling with consent from treating Physician. | F 2 weeks | Electromechanical Clot Detection | S: Daily 3 pm R: Next day |
S092 | Lyme Disease (Borrelia burgdorferi) Antibodies, IgG & IgM | 2 mL SERUM | R 1 week F 4 weeks | EIA | S: Sat 9 am R:Same day |
RW024 | Lyme Disease (Borrelia burgdorferi) DNA, Qualitative Real Time PCR | 2 mL CSF or Synovial FLUID | R 7 days F 30 days | Real Time PCR | S: By 7th of Month R: 2 - 3 weeks |
RW125 | Lyme Disease (Borrelia burgdorferi), IgG & IgM Immunoblot | 2 mL SERUM | R 14 days F 30 days | Immunoblot | S: By 7th of Month R: 2 - 3 weeks |
RW126 | Lyme Disease (Borrelia burgdorferi), IgG Immunoblot | 2 mL SERUM | R 14 days F 30 days | Immunoblot | S: By 7th of Month R: 2 - 3 weeks |
Z149 | Lymphoma Diagnostic Panel | 3 mL EDTA WB or 3 mL Heparinized BONE MARROW or 50 mL BODY FLUIDS or Lymph Node ASPIRATE in normal saline. | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
RW127 | Lysozyme; Muramidase | 2 mL SERUM No Additive tube Separate serum within 1 hr | R 15 days F 18 days | Enzymatic | S: By 7th of Month R: 2 - 3 weeks |
Z125 | Macrocytic Anemia Panel Folate, serum * Vitamin B12 | 3 mL SERUM No Additive tube Protect from light Overnight fasting mandatory | R 48 hrs F 4 weeks | CLIA | Daily |
RW249 | Macroprolactin | 2 mL SERUM | R 2 weeks F 6 weeks | PEG, ECLIA | S: By 7th of Month R: 2 - 3 weeks |
U019 | Magnesium, 24 Hour Urine | 10 mL aliquot of 24 hr URINE State Total Volume | R 1 week F 4 weeks | Xylidyl Blue | Daily |
U060 | Magnesium, Random Urine | 10 mL aliquot of random URINE | R 1 week F 4 weeks | Xylidyl Blue | Daily |
B066 | Magnesium, Serum | 2 mL SERUM | R 1 week F 4 weeks | Xylidyl Blue | Daily |
S189 | Malaria Antibody | 2 mL SERUM | R 1 week F 4 weeks | ICT | S:Tue / Fri 9 am R:Same day |
OS160 | Malaria Detection, PCR | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S:Daily by 11 am R:6 days |
H030 | Malaria Parasite / Blood Parasite Identification | 2 Thick & Thin peripheral blood SMEARS | NA | Microscopic Examination | Daily |
H249 | Malaria Parasite Confirmation | 3 mL EDTA WB | R 48 hrs F Unacceptable | Digital Cytometry | Daily |
S153 | Malaria Vivax & Falciparum Antigen | 3 mL EDTA WB | R 48 hrs F Unacceptable | ICT | Daily |
M184 | Malditof - MS Mycobacterium Speciation | Pure GROWTH | R 48 hrs F Unacceptable | Malditof - MS | S: Daily 9 am R:Same day |
M188 | Malditof - MS Yeast Identification | Pure GROWTH | R 48 hrs F Unacceptable | Malditof - MS | S: Daily 9 am R:Same day |
M189 | Malditof - MS Bacteria Identification | Pure GROWTH | R 48 hrs F Unacceptable | Malditof - MS | S: Daily 9 am R:Same day |
M190 | Malditof - MS Mold Identification | Pure GROWTH | R 48 hrs F Unacceptable | Malditof - MS | S: Daily 9 am R:Same day |
C058 | Manganese, 24 Hour Urine | 10 mL aliquot of 24 hr URINE in metal free container Avoidvitamins, mineral or herbal supplements one week prior to specimen collection. Use powderless gloves. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
C064 | Manganese, Blood | 4 mL K2EDTA WB Metal free tube Avoidvitamins, mineral or herbal supplements one week prior to specimen collection. Use powderless gloves. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F Unacceptable | ICPMS | S: Daily 6 pm R: Next day |
C059 | Manganese, Random Urine | 10 mL aliquot of random URINE in metal free container Avoidvitamins, mineral or herbal supplements one week prior to specimen collection. Use powderless gloves. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
P007 | Mantoux Test; Tuberculin Skin Test | Conducted on patient Patient to come on Day 1 & Day 3 of the test | NA | Intradermal Skin Test | S: Daily R: 48 Hrs Post injection |
N075 | Maternal Blood for Fetal DNA *Trisomy detection for 13, 18 & 21 Chromosomes | 10 mL WB in Special Tube Valid between 10-24 weeks gestation | R 72 hrs F Unacceptable | DNA Sequencing | S: Tue 9 am R: Next Tue |
Z397 | Maternal Serum Screen 2; Dual Test *Free Beta HCG * PAPP-A * Risk Evaluation | 3 mL SERUM Provide maternal Date of birth (ddormmoryy); LMP or Ultrasound; Number of Fetuses (SingleorTwins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy in Maternal Serum Screen Form. Valid between 9-13 weeks gestation (Ideal 10-13 weeks). | R 24 hrs F 2 months | CLIA | S: Mon through Sat 9 am R: Same day |
Z875 | Maternal Serum Screen 2, Advanced Reflex To Maternal Blood For Fetal DNA (MBFD) Chromosome 21 *PAPP-A *Free BETA HCG *Risk Evaluation * MBFD-21 | 3 mL SERUM Provide maternal Date of birth (ddormmoryy); LMP or Ultrasound; Number of Fetuses (SingleorTwins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy in Maternal Serum Screen Form. Valid between 9-13 weeks gestation (Ideal 10-13 weeks).All positive results to submit 10 mL WB in a Special tube available from LPL for MBFD-21. Ship refrigerated. DO NOT FREEZE. | R 24 hrs F 2 months | CLIA, DNA Sequencing | Dual test - S: Mon through Sat 9 am; R: Same day MBFD-21- S:Tue 9 am R: Next Tue |
Z884 | Maternal & Pre-Eclampsia Screening Panel, First Trimester *Free Beta HCG * Pregnancy Associated Plasma Protein A (PAPP-A) * Placental Growth Factor (PlGF) Done on FMF accredited (Roche) | 3 mL SERUM Provide maternal Date of birth (dd/mm/yy); Height, weight, IVF, Smoking,History of blood pressure, Diabetes and Preeclampsia in previous pregnancy, Previous h/o trisomy birth, Blood pressure | R 8 hrs F 12 weeks | ECLIA | S: Tue / Thu / Sat 9 am R: Same day |
Z266 | Maternal Serum Screen 3; Triple Test *AFP * Beta HCG * Free Estriol * Risk Evaluation | 3 mL SERUM Provide maternal Date of birth (ddormmoryy); LMP or Ultrasound; IVF, Number of Fetuses (Singleor Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy in Maternal Serum Screen Form. Valid between 14- 22 weeks gestation (Ideal 15-20 weeks). | R 1 week F 4 weeks | CLIA | S: Mon through Sat 9 am R: Same day |
Z514 | Maternal Serum Screen 4; Quadruple Test *AFP * Beta HCG * Free Estriol *Inhibin A * Risk Evaluation | 3 mL SERUM Provide maternal Date of birth (ddormmoryy); LMP or Ultrasound; IVF, Number of Fetuses (Singleor Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy in Maternal Serum Screen Form. Valid between 14- 22 weeks gestation (Ideal 15-20 weeks). | R 1 week F 4 weeks | CLIA | S: Mon through Sat 9 am R: Same day |
H007 | Mean Corpuscular Hemoglobin Concentration; MCHC | 3 mL EDTA WB | R 48 hrs F Unacceptable | Calculated | Daily |
H006 | Mean Corpuscular Hemoglobin; MCH | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electronic Cell Cytometry,Calculated | Daily |
H005 | Mean Corpuscular Volume; MCV | 3 mL EDTA WB | R 48 hrs F Unacceptable | Calculated | Daily |
H033 | Mean Platelet Volume; MPV | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence | Daily |
Z191 | Measles (Rubeola) Antibodies Panel, IgG & IgM | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Mon 9 am R:Same day |
S072 | Measles (Rubeola) Antibody, IgG | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Mon 9 am R:Same day |
S073 | Measles (Rubeola) Antibody, IgM | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Mon 9 am R:Same day |
OS161 | Medullary Thyroid Carcinoma, Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S:Daily 11 am R:10 days |
OS162 | MELAS (Mitochondrial Encephalopathy & Lactic Acidosis with Stroke like Syndrome), Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S:Daily 11 am R:10 days |
H244 | Menorrhagia Screen *Prothrombin Time *APTT *Factor VIII Functional *Factor IX | 6 mL Citrated PPP. Separate plasma & freeze immediately | F 2 weeks | Electromechanical & Photo- optical Clot Detection | S:Thu 11 am R:Next day |
Z808 | Menopausal Screening Panel *Estradiol (E2) *TSH, Ultrasensitive * FSH *Anti Mullerian hormone (AMH) | 5 mL SERUM | R 24 hrs F 2 weeks | CLIA, EIA | S:Daily 9 am R:Same day |
C028 | Mercury, 24 Hour Urine | 10 mL aliquot of 24 hr URINE Metal Free container Avoidpredatory fish like Sword Fish, Tuna & Shark at least 3 days prior to specimen collection. Use powderless gloves during specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S:Daily 6 pm R:Next day |
C029 | Mercury, Random Urine | 10 mL aliquot of random URINE Metal Free container Avoidpredatory fish like Sword Fish, Tuna & Shark at least 3 days prior to specimen collection. Use powderless gloves during specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S:Daily 6 pm R:Next day |
OS163 | MERRF (Myoclonic Epilepsy Associated with Ragged Red Fibres), Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S:Daily 11 am R: 10 days |
G108 | Metabolic Screen Comprehensive, Urine *Metabolic Screen Basic *Amino Acids Qualitative | 10 mL aliquot of first morning URINE For infants on breast milk, feed the child and then collect urine | R 24 hrs F 1 week | Chemical, TLC | S: Mon / Wed / Fri 4 pm R: 2 days |
G101 | Metabolic Screen Basic, Urine *Reducing Substances * Ferric Chloride Test * DNPH Test * Nitrosonaphthol Test* Nitroprusside Test * Silver Nitroprusside Test | 10 mL aliquot of first morning URINE For infants on breast milk, feed the child and then collect urine | R 1 week F 2 weeks | Chemical | S: Daily 4 pm R: Same day |
G122 | Metachromatic Leukodystrophy, Quantitative, Blood Tests deficiency of Aryl Sulphatase A | 10 mL EDTA or Heparinized WB | R 48 hrs F Unacceptable | Spectrophotometry | S: Daily 4 pm R: 4 days |
Z822 | Metal Screen 1, Serum *Aluminium * Copper * Zinc *Selenium | 3 mL SERUM (Z-No Additive) tube Avoidantacids, Aluminium containing medications, seaorfresh water fish atleast 3 days prior to specimen collection. Use powderless gloves during specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
Z820 | Metal Screen 2, Whole Blood *Arsenic * Cadmium *Chromium *Cobalt *Lead *Manganese *Thallium | 4 mL K2EDTA WB Metal free tube Avoideating seafood, herbal supplements, mineral supplements, vitamin B12 or vitamin B complex for 3 days prior to specimen collection. Use powderless gloves. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F Unacceptable | ICPMS, AAS with Zeeman correction | S: Daily 6 pm R: Next day |
Z821 | Metal Screen 3, Urine *Arsenic * Cadmium *Chromium *Cobalt *Lead *Manganese *Thallium * Copper * Zinc *Selenium *Nickel *Mercury | 10 mL aliquot of random URINE Metal Free container Avoideating seafood, herbal supplements, mineral supplements, vitamin B12 or vitamin B complex, seaorfresh water fish for atleast 3 days prior to specimen collection. Use powderless gloves during specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
U035 | Metanephrines, 24 Hour URINE *Metanephrines * Normetanephrines | 50 mL aliquot of 24 hr URINE Preservative 50% HCl State Total Volume AvoidAlpha- Methyldopa, Buspirone, Codeine, Isoproterenol metabolite, Mandelamine, L-dopa, Parcetamol, Metoclopramide, pepper, alcoholic beverages, teaorcoffee, tobacco and strenuous exercise at least 72 hrs before & during specimen collection. | R 5 days F 30 days | HPLC | S: Wed / Sat 9 am R: Fri / Tue |
U052 | Metanephrines, Random URINE *Metanephrines * Normetanephrines | 50 mL aliquot of random URINE Preservative 50% HCl Avoid Alpha Methyldopa, Buspirone, Codeine, Isoproterenol metabolite, Mandelamine, L-dopa, Parcetamol, Metoclopramide, pepper, alcoholic beverages, teaorcoffee, tobacco and strenuous exercise at least 72 hrs before & during specimen collection. | R 5 days F 30 days | HPLC | S: Wed / Sat 9 am R: Fri / Tue |
K022 | Methadone Screen, Urine | 10 mL aliquot of random URINE | R 72 hrs F 4 weeks | Lateral Flow Immunoassay | S: Daily 4 pm R: Same day |
K019 | Methamphetamine Screen, Urine | 10 mL aliquot of random URINE | R 72 hrs F 4 weeks | Lateral Flow Immunoassay | S: Daily 4 pm R: Same day |
K021 | Methaqualone Screen, Urine | 10 mL aliquot of random URINE | R 24 hrs F 4 weeks | Lateral Flow Immunoassay | S: Daily 4 pm R: Same day |
D052 | Methotrexate | 2 mL SERUM No Additive Tube Protect from light | R 24 hrs F 4 weeks | EMIT | S: Mon / Wed / Fri 2 pm R: Same day |
OS164 | Methylguanine Methyltransferase (MGMT) | TISSUE in normal saline | R 72 hrs F Unacceptable | PCR | S: Mon 11 am R: 13 days |
G103 | Methylmalonic Acid, Qualitative, Urine | 10 mL aliquot of first morning URINE | R 1 week F 2 weeks | Chemical | S: Daily 4 pm R: Same day |
G188 | Methylmalonic Acid, Quantitative, Urine | 10 mL aliquot of first morning URINE | R 1 week F 2 weeks | LC-MS / MS | S: Daily 4 pm R: Next day |
G189 | Methylmalonic Acid, Quantitative, Serum | 2 mL SERUM Separate serum within 1 hr | R 1 week F 6 weeks | LC-MS / MS | S: Daily 4 pm R: Next day |
OS165 | MICM (Maternally Inherited Cardiomyopathy), Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Daily 11 am R: 10 days |
B142 | Microalbumin Creatinine Ratio, Urine | 15 mL aliquot of random URINE | R 1 week F Unacceptable | Immunoturbidim etry, Spectrophotome try | Daily |
U031 | Microalbumin, 24 Hour Urine | 10 mL aliquot of 24 Hour URINE Record Total volume | R 1 week F Unacceptable | Immunoturbidimetry | Daily |
U027 | Microalbumin, 1st Morning / Random Urine | 10 mL aliquot of 1st morning or random URINE | R 1 week F Unacceptable | Immunoturbidimetry | Daily |
H024 | Microfilaria Detection | Thick & Thin smears of peripheral BLOOD / Hydrocele FLUID smears | R 72 hrs F Unacceptable | Microscopy | Daily |
Z831 | Minimal Residual Disease (MRD) Analysis for B-ALL *CD10 *CD13 *CD15 *CD19 *CD20 *CD33 *CD34 *CD38 *CD45 *CD58 *CD73 *CD86 *CD123 *CD200 *SYTO-16 | 3 mL Heparinized BONE MARROW | R 24 hrs F Unacceptable | Flow Cytometry | S: Daily 9 am R: Next day |
S046 | Mitochondrial Antibody (AMA), IFA | 2 mL SERUM | R 1 week F 2 weeks | IFA | S:Daily 11 am R:Same day |
S085 | Mitochondrial Antibody (AMA), IFA in dilutions | 2 mL SERUM | R 1 week F 2 weeks | IFA | S:Daily 11 am R:Next day |
OS166 | MITOCHONDRIAL MUTATION DETECTION PANEL 1 *MALAS *MERRF *MM *MMC *ME *PEM *EI | 4 mL EDTA WB. | R 72 hrs F Unacceptable | PCR | S: Daily 11 am R: 10 days |
OS167 | MITOCHONDRIAL MUTATION DETECTION PANEL 2 *LHON *NARP *CPEO *SNHL *DEAF *AMDF | 4 mL EDTA WB. | R 72 hrs F Unacceptable | PCR | S: Daily 11 am R: 10 days |
OS168 | MITOCHONDRIAL MUTATION DETECTION COMPREHENSIVE PANEL *MALAS *MERRF *MM *MMC *ME *PEM *EI *LHON *NARP *CPEO *SNHL *DEAF *AMDF | 4 mL EDTA WB. | R 72 hrs F Unacceptable | PCR | S: Daily 11 am R: 10 days |
H184 | MIXING STUDIES - APTT *Fibrinogen *Thrombin Time *APTT *Mixing studies | 6 mL Citrated PPP Separate plasma & freeze immediately | F 2 weeks | Photo-optical Clot detection | S: Wed / Sat 11 am R: Next day |
H242 | MIXING STUDIES - APTT with Prothrombin Time studies *Prothrombin Time *APTT *Thrombin Time *Fibrinogen * Mixing studies | 6 mL Citrated PPP Separate plasma & freeze immediately | F 2 weeks | Photo-optical Clot detection | S: Wed / Sat 11 am R: Thu / Mon |
OS170 | MM (Mitochondrial myopathy), Mutation detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Daily 11 am R: 10 days |
OS169 | MMC (Maternal myopathy with Cardiomyopathy), Mutation detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Daily 11 am R: 10 days |
M187 | Modified Acid Fast stain for Leprosy *Modified ZN Stain | Slit -skin or Nasal or Ear lobe or Tissue or other secretions SMEARS | 18 - 22°C within 48 hrs | Light microscopy | S: Daily 9 am R: Same day |
S004 | Mono Test (Infectious Mononucleosis) | 2 mL SERUM | F 4 weeks | Latex Agglutination | Daily |
N121 | MPL (Myeloproliferative Leukemia), Gene Mutation | 3 ml EDTA WB | R 72 hrs F Unacceptable | PCR, Fragment analysis | S: Mon / Thu 11 am R: Wed / Sat |
N049 | MTHFR (Methylene Tetrahydrofolate reductase) Gene Mutation, Qualitative PCR | 3 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
G110 | Mucopolysaccharidosis (MPS) Screen, Urine | 10 mL aliquot of first morning URINE | R 1 week F 2 weeks | Toluidine Blue Spot Test | S: Daily 4 pm R: Next day |
G112 | Mucopolysaccharidosis (MPS) Type I (Hurler) Quantitative, Blood Tests deficiency of Alpha Iduronidase | 10 mL EDTA or Heparinized WB | R 48 hrs F Unacceptable | Enzyme Assay | S: Daily 4 pm R: 4 Days |
G113 | Mucopolysaccharidosis (MPS) Type VI (Maroteaux Lamy) Quantitative, Blood Tests deficiency of Aryl Sulphatase B | 10 mL EDTA or Heparinized WB | R 48 hrs F Unacceptable | Enzyme Assay | S: Daily 4 pm R: 4 Days |
G111 | Mucopolysaccharidosis (MPS) Typing, 24 Hour Urine | 20 mL aliquot of 24 Hour URINE | R 1 week F 2 weeks | Two dimensional electrophoresis | S: Daily 4 pm R: 15 Days |
Z181 | Multiple sclerosis Panel 1 *IgG Synthesis Index & Rate *Oligoclonal Bands, CSF & Serum | 4 mL CSF + 2 mL SERUM | R 1 week F Unacceptable | BCG, Nephelometry, Immunoturbidim etry, Isoelectric focusing | S: Daily 9 am R: Next day |
Z182 | Multiple sclerosis Panel 2 *IgG Synthesis Index & Rate *Oligoclonal Bands, CSF & Serum * Myelin Basic Protein, CSF | 4 mL CSF + 2 mL SERUM | R 1 week F Unacceptable | BCG, Nephelometry, Immunoturbidim etry, Isoelectric focusing, RIA | LPL: S: Daily 9 am R: Next day USA: S: By 7th of Month R: 2 - 3 weeks |
Z842 | Multiple myeloma Monitoring panel *CBC * Urea * Creatinine * Calcium, total * Albumin *LDH * Beta 2 Microglobulin*Protein electrophoresis, serum * Immunofixation electrophoresis, serum * Kappa / Lambda Light Chains, Free, serum * Immunoglobulin Profile, serum | 5 mL SERUM | R 72 hrs F 6 weeks | Capillary electrophoresis, Agarose Gel Electrophoresis, Immunoturbidim etry | S:Daily 9 am R:Next day |
Z782 | Multiple myeloma Screening panel *Protein electrophoresis, serum * Immunofixation electrophoresis, serum * Kappa / Lambda Light Chains, Free, serum * Immunoglobulin Profile, serum | 5 mL SERUM | R 72 hrs F 6 weeks | Capillary electrophoresis, Agarose Gel Electrophoresis, Immunoturbidim etry | S:Daily 9 am R:Next day |
Z382 | Mumps Virus Antibodies Panel, IgG & IgM | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Mon 9 am R:Same day |
S037 | Mumps Virus Antibody, IgG | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Mon 9 am R:Same day |
S075 | Mumps Virus Antibody, IgM | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S:Mon 9 am R:Next day |
S243 | MuSK (Muscle specific Kinase) Antibody | 4 mL SERUM | R 1 week F 4 weeks | RIA | S:Tue 9 am R:Next day |
Z174 | Myasthenia Gravis Panel *Acetylcholine receptor Binding antibody *Striated / Skeletal muscle antibody in dilutions | 5 mL SERUM Patient should not have general anaesthetic or muscle relaxant drugs, 24 hrs prior to sampling. | R 1 week F 2 weeks | RIA, IFA | S: Tue / Sat 9 am R: 4 days |
Z277 | Mycobacterium Combined Panel; TB.COM *Mycobacterium Tuberculosis, PCR *Culture, AFB Rapid *Ziehl Neelson Stain | Sputum or Body Fluids or Aspirates or CSF or URINE or Tissue or Menstrual blood or 3 mL EDTA or ACD WB or BONE MARROW | R 72 hrs F Unacceptable | Real Time PCR, Automated fluorescent, ICT | S: Daily 3.30 pm R: Interim 14 Days & 4 weeks Final 6 weeks |
N001 | Mycobacterium Tuberculosis, PCR; Mycosure; TB PCR This test includes 4 Drug Sensitivity for MTB Complex if positive. Antitubercular Drug Sensitivity includes Rifampicin, Isoniazid, Ethambutol & Pyrazinamide | Sputum or Body Fluids or Aspirates or CSF or URINE or Tissue or Menstrual blood or 3 mL EDTA or ACD WB or BONE MARROW or Culture isolates | R 72 hrs F Unacceptable | Real Time PCR | S: Daily 11 am R: Next day if negative & 4 days if positive |
M094 | Mycobacterium tuberculosis, rRNA Detection, TMA | Sputum or Body Fluids or Aspirates or CSF or Tissue or Menstrual blood or 3 mL EDTA or WB or Culture isolates | R 72 hrs F 1 week | Transcription Mediated Amplification (TMA) and Hybridization Protection Assay (HPA) | S: Daily by 3.30 pm R: 15 days |
G187 | Mycophenolic Acid | 3 mL EDTA WB 1 hr before next dose Separate plasma within 2 hrs. | R 7 days F Unacceptable | LC-MS / MS | S: Daily 4 pm R:Same day |
Z677 | Mycoplasma pneumoniae IgG & IgM Antibodies Panel, Serum | 2 mL SERUM | R 48 hrs F 2 weeks | CLIA | S: Mon 9 am R:Same day |
S223 | Mycoplasma pneumoniae IgG, Serum | 2 mL SERUM | R 48 hrs F 2 weeks | CLIA | S: Mon 9 am R:Same day |
S224 | Mycoplasma pneumoniae IgM, Serum | 2 mL SERUM | R 48 hrs F 2 weeks | CLIA | S: Mon 9 am R:Same day |
RW135 | Myelin Basic Protein; MBP | 2 mL CSF Ideally submit 4th lumbar puncture collection tube to minimize contamination. | R 2 weeks F 6 weeks | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
RW133 | Myelin Associated Glycoprotein (MAG), IgM | 2 mL SERUM No Additive Tube | R 7 days F 30 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
RW134 | Myelin Associated Glycoprotein Sulfated Glucuronic Paragloboside Autoantibody (MAG-SGPG), IgM | 2 mL SERUM No Additive Tube | R 14 days F 30 days | Immunoassay,End point titer | S: By 7th of Month R: 2 - 3 weeks |
Z862 | Myeloproliferative Neoplasia With Eosinophilia *CBC * Peripheral Smear *Bone Marrow Panel 1 *FISH for PDGFRA, PDGFRB, FGFR1 | 2 mL EDTA WB + 2 mL EDTA BONE MARROW + 3 mL Heparinized BONE MARROW. Clinical history mandatory | 18 -22°C within 48 hrs | Electrical impedence, Microscopy, FISH | S: Daily 4 pm R. 7 days |
H225 | Myeloperoxidase (MPO) Stain, Blood / Bone marrow | 3 mL EDTA WB or 2 mL Heparinized BONE MARROW | R 72 hrs F Unacceptable | Cytochemical staining | S: Daily 6 pm R. 3 days |
B102 | Myoglobin, Serum | 2 mL SERUM | R 1 week F 3 months | Electrochemilum inescence | Daily |
S245 | Myositis Profile *Mi-2 *Ku* PM-SCL 100 * PM- SCL 75* Jo-1 * SRP* PL-7 * PL- 12* EJ* OJ* Ro-52 | 2 mL SERUM | R 2 weeks F 4 weeks | Immunoblot | S: Thu 9 am R.Same day |
Z836 | NAFLD (Non Alcoholic Fatty Liver Disease) Fibrosis Score *AST *ALT *Albumin* Glucose F & PP *Platelet Count | 2 mL SERUM + 3 mL EDTA WB + 2 mL Fluoride PLASMA each for Fasting & Post prandial. Overnight Fasting is mandatory. Patient's age, height & weight are mandatory. | R 48 hrs F 1 week | IFCC, Hexokinase, BCG, Electrical Impedence | S: Mon through Sat 9 am R: Same day |
Z166 | Natural Killer Cells *CD3 * CD 16/56 | 3 mL EDTA WB + 3 mL Heparinized WB or 2 mL Heparinized BONE MARROW | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
N088 | Neisseria gonorrhea, PCR Qualitative | 15 mL 1st morning URINE or Vaginal or Endocervical SWAB | R 7 days F Unacceptable | Real Time PCR | S: Daily 11 am R: Next day |
Z184 | Neuroblastoma Profile, 24 Hour Urine *Vanil Mandelic Acid (VMA) *Homovanilic Acid (HVA) | 50 mL aliquot of 24 Hour URINE Preservative 50% HCl State Total Volume AvoidL-Dopa, Theophylline, chocolate, vanilla, banana, alcoholic beverages, teaorcoffee, tobacco and strenuous exercise at least 72 hrs before and during specimen collection. | R 5 days F 30 days | HPLC | S: Wed / Sat 9 am R: Fri / Tue |
F019 | Neuron Specific Enolase (NSE), Serum | 2 mL SERUM | R 24 hrs F 3 months | Electrochemiluminescence | S: Mon 4 pm R: Same day |
S232 | Neuronal (Paraneoplastic) Autoantibodies Profile *Amphiphysin *CV2 *PNMA2 (Ma2 / Ta) *ANNA-1 / Hu *ANNA-2 / Ri *PCA-1 / Yo | 2 mL SERUM | R 2 weeks F 2 weeks | Immunoblot | S:Mon through Sat 9 am R: Same day |
Z851 | Neuroviruses Panel, Qualitative PCR *Adenovirus *Cytomegalovirus *Enteroviruses *Epstein Barr virus *Herpes simplex virus 1 & 2 *Varicella Zoster virus *Parechoviruses *HHV6 *HHV7 *Parvovirus B19 | 3 mL EDTA WB / 3 mL CSF | R 72 hrs F Unacceptable | Real Time PCR | S:Mon / Thu 11 am R: Wed / Sat |
Z335 | Newborn Screening *G6PD * TSH * Phenylalanine * Cystic Fibrosis * 17-OHP * Galactosemia *Biotinidase | 1 drop heel prick blood each on 3 spots of filter paper. Clinical Details and Drug history must accompany sample | R 1 week F 1 week | Fluoroimmunoassay | S: Tue / Thu / Sat 5 pm R: 2 days |
G146 | Newborn Screening, Extended *Biotinidase *Cystic Fibrosis *G6PD *Galactosemia *17- Hydroxy Progesterone *TSH *Tandem Mass Spectrometry - 30 Disorders | 1 drop heel prick blood each on 3 spots of filter paper. Clinical Details and Drug history must accompany sample | R 1 week F 1 week | TMS, Fluoroimmunoassay | S: Tue / Thu / Sat 5 pm R: 2 days |
G203 | New Born Screening, Panel 1 *TSH *G-6PD | 1 drop heel prick blood each on 3 spots of filter paper. Clinical Details and Drug history must accompany sample | R 1 week F 1 week | Fluoroimmunoassay | S: Tue / Thu / Sat 5 pm R: 2 days |
G204 | New Born Screening, Panel 2 *TSH *G-6PD *17-OHP | 1 drop heel prick blood each on 3 spots of filter paper. Clinical Details and Drug history must accompany sample | R 1 week F 1 week | Fluoroimmunoassay | S: Tue / Thu / Sat 5 pm R: 2 days |
G205 | New Born Screening, Panel 3 *TSH *G-6PD *Biotinidase *Phenylalaninine | 1 drop heel prick blood each on 3 spots of filter paper. Clinical Details and Drug history must accompany sample | R 1 week F 1 week | Fluoroimmunoassay | S: Tue / Thu / Sat 5 pm R: 2 days |
R167 | NGAL (Neutrophil Gelatinase - Associated Lipocalin), Urine | 10 mL aliquot of random URINE | R 1 week F 1 week | CMIA | S: Mon / Wed / Fri 4 pm R: Same day |
C051 | Nickel, 24 Hour Urine | 10 mL aliquot of 24 Hour URINE Metal Free container Use powderless gloves Avoidmineral supplements 3 days prior to specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
C056 | Nickel, Random Urine | 10 mL aliquot of random URINE Metal Free container Use powderless gloves Avoidmineral supplements 3 days prior to specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
RW138 | Nicotine & Cotinine, Urine | 10 mL aliquot of random URINE | R 14 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
K023 | Nicotine Screen, Urine | 15 mL aliquot of random URINE | R 48 hrs F 4 weeks | Lateral Flow Immunoassay | S: Mon through Sat by 4 pm R: Same day |
G126 | Niemann-Pick Disease, Quantitative, BloodTests deficiency of Sphingomyelinase | 10 mL EDTA or Heparinized WB | R 72 hrs F Unacceptable | Enzyme assay | S: Daily 4 pm R: 4 Days |
G143 | Nitroprusside Test, Urine | 10 mL aliquot of random URINE | R 1 week F 2 weeks | Chemical | S: Daily 4 pm R: Same day |
G142 | Nitrosonaphthol Urine | 10 mL aliquot of random URINE | R 1 week F 2 weeks | Chemical | S: Daily 4 pm R: Same day |
M185 | Nocardia, Stain *KOH Calcifluor * Gram stain *Modified ZN stain | Sputum or BAL or Pus or Endotracheal tube secretions or Culture growth or SWABS | 18 -22°C within 48 hrs | Light microscopy | S: Daily 9 am R: Same day |
RW140 | Nortriptyline | 3 mL SERUM >12 hrs post oral dose No Additive Tube | R 7 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
N051 | NPM1 Gene Mutation | 5 mL EDTA WB or BONE MARROW | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N108 | NRAS Mutation Codon 12, 13 & 61 | Paraffin BLOCK | NA | PCR, Sequencing | S: Tue 11 am R: Mon |
B185 | NT-PRO BNP (N-Terminal Pro B Type Natriuretic peptide) | 2 mL SERUM | R 1 week F 4 weeks | ECLIA | Daily |
B161 | NTx (Collagen Cross linked N- Telopeptide), Urine | 10 mL aliquot of 24 hr or Second void URINE State total volume | R 72 hrs F 2 weeks | EIA | S: Mon 9 am R: Same day |
Z321 | Obesity Panel * Sugar (F) *TSH *Lipid profile Basic *Leptin | 3 mL SERUM + 2 mL Fluoride PLASMA 12 hrs fasting mandatory | R 24 hrs F 1 week | Spectrophotometry, CLIA, EIA | S:Sat 9 am R:Same day |
Z292 | Obstetric Flow Panel * Natural Killer (NK) cells * CD 19 | 3 mL EDTA WB + 3 mL Heparinized WB | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
E018 | Oligoclonal bands IgG, CSF & Serum *CSF & Serum Isoelectric focusing * CSF & Serum IgG | 2 mL CSF + 2 mL SERUM | R 1 week F Unacceptable | Immunoturbidimetry, Nephelometry, Isoelectric focusing | S: Daily 9 am R: Next day |
E004 | Oligoclonal Bands, CSF Protein Electrophoresis | 2 mL CSF | R 1 week F Unacceptable | Agarose Gel Electrophoresis | S: Daily 9 am R: Next day |
Z818 | Oncogenic E6 / E7 mRNA | Cervical SWAB or CELLS in special container. Store at 2-8°C immediatley after collection. | R 2 weeks F Unacceptable | Flow Cytometry | S: Tue / Thu / Sat 9 am R: Wed / Fri / Mon |
K001 | Opiates, Screen, Random Urine | 15 mL aliquot of random URINE | R 48 hrs F 4 weeks | Lateral Flow Immunoasay | Daily |
G164 | Organic Acids Quantitative, Random Urine, Full Panel | 15 mL aliquot of random URINE | R 72 hrs F 4 weeks | GC / MS | S: Daily 5 pm R: 5 days |
G150 | Orotic Acid | 15 mL aliquot of random URINE Collect fasting or 2-3 hrs post- feed | R 72 hrs F 4 weeks | GC / MS | S: Daily 4 pm R: 2 days |
B184 | Osmolal Gap, Serum *Sodium *BUN *Glucose (R) *Osmolality | 3 mL SERUM + 2 mL Fluoride PLASMA | R 72 hrs F 1 week | Freezing Point Depression, Spectrophotome try, Calculated | S: Daily 4 pm R: Same day |
P064 | Osmolality, Serum | 2 mL SERUM | R 72 hrs F 1 week | Freezing Point Depression | S: Daily 4 pm R: Same day |
U040 | Osmolality, Urine | 5 mL aliquot of random URINE | R 1 week F Unacceptable | Freezing Point Depression | S: Daily 4 pm R: Same day |
U100 | Osmolality, Urine : Serum Ratio | 2 mL SERUM + 5 mL aliquot of random URINE | R 72 hrs F Unacceptable | Freezing Point Depression | S: Daily 4 pm R: Same day |
H012 | Osmotic Fragility Test; RBC Fragility Test | 3 mL Heparinized WB | R 72 hrs F Unacceptable | Parparts | S: Daily 12 Noon R: Next day |
R108 | Osteocalcin ; Bone Gla Protein (BGP) | 2 mL SERUM Separate serum within 1 hr & freeze | F 4 weeks | ECLIA | S: Mon 4 pm R: Same day |
Z159 | Osteoporosis Panel *Calcium *PTH-Intact *Vitamin D, 25-Hydroxy *Phosphorus * P1NP * Beta Crosslaps | 5 mL SERUM Collect serum between 8-10 am in a fasting condition & freeze within 30 mins | F 4 weeks | Arsenazo III, CLIA, ECLIA, Molybdate UV | S: Mon 4 pm R: Same day |
Z612 | Osteoscreen Panel *Calcium *Phosphorus *PTH- Intact *Vitamin D, 25- Hydroxy | 4 mL SERUM Collect fasting serum between 8- 10 am & freeze within 30 mins. | F 4 weeks | CLIA, Spectrophotometry | Daily |
Z803 | Ovarian Cancer Panel *CA 125 *Inhibin B | 4 mL SERUM | R 24 hrs F 2 weeks | CMIA, EIA | S: Mon 9 am R: Same day |
Z606 | Ovarian Reserve Panel *FSH * Estradiol *Anti Mullerian Hormone | 3 mL SERUM Specify day of menstrual cycle | R 24 hrs F 2 weeks | EIA, CLIA | S: Daily 9 am R: Same day |
U055 | Oxalate, 24 Hour Urine | 10 mL aliquot of 24 hr URINE Preservative 25 mL 50% concentrated HCl State Total Volume Avoidvitamin C and citrus fruits 48 hours prior to specimen collection. | R 1 week F 2 weeks | Spectrophotometry | S: Wed / Sat 9 am R:Same day |
U101 | Oxalate, Random Urine | 10 mL aliquot of random URINE Preservative 2 mL 6N HCl Avoid vitamin C and citrus fruits 48 hours prior to specimen collection. | R 1 week F 2 weeks | Spectrophotometry | S: Wed / Sat 9 am R:Same day |
D054 | Oxcarbazepine Metabolite | 2 mL SERUM No Additive Tube Separate serum within 2 hrs Recommended specimen: just before the next dose is due at steady state | R 1 week F 4 weeks | HomogenousEIA | S: Mon 4 pm R:Same day |
B165A | P1NP (Procollagen Type 1 Amino Terminal Propeptide), Total | 2 mL SERUM | R 5 days F 6 months | Electrochemiluminescence | S:Mon / Thu 4 pm R: Same day |
P093 | Packed Cell Volume, Body Fluid | 3 mL BODY FLUID | R 48 hrs F Unacceptable | Calculated | Daily |
H002 | Packed Cell Volume (PCV); Hematocrit | 3 mL EDTA WB | R 48 hrs F Unacceptable | Calculated | Daily |
OS174 | Pan Fungal Detection, PCR | 4 mL EDTA WB or 2 mL CSForSputumor Fluids or TISSUE in Normal saline. | R 1 week F Unacceptable | PCR | S: Tue / Sat 11 am R: Thu / Mon |
OS175 | Pan Fungal Detection & Identification, PCR | 5 mL EDTA WB or 2 mL CSForSputumor Fluids or TISSUE in Normal saline. | R 1 week F Unacceptable | PCR | S: Tue / Sat 11 am R: Thu / Mon |
RW144 | Pancreatic Polypeptide | 2 mL EDTA PLASMA | R 7 days F 28 days | Extraction, RIA | S: By 7th of Month R: 2 - 3 weeks |
B152 | PAPP-A (Pregnancy Associated Plasma Protein-A) | 2 mL SERUM | R 24 hrs F 2 months | CLIA | S: Daily 9 am R: Same day |
S086 | Parietal Cell Antibody, IFA | 2 mL SERUM | R 1 week F 2 weeks | IFA | S:Daily 11 am R: Same day |
S087 | Parietal Cell Antibody, IFA in dilutions | 2 mL SERUM | R 1 week F 2 weeks | IFA | S:Daily 11 am R: Next day |
RW145 | Paroxetine | 2 mL SERUM No Additive Tube Separate serum within 2 hrs | R 2 weeks F 2 weeks | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
Z496 | Paroxysmal Nocturnal Hemoglobinuria (PNH) Confirmatory Test *CD55 * FLAER on Monocytes and Granulocytes *CD59 on RBC | 3 mL EDTA WB + 3 mL Heparinized WB | 18 -22°C within 24 hrs | Flow Cytometry | S: Daily 9 am R: Same day |
H014 | Partial Thromboplastin Time, Activated; PTT; APTT | 3 mL Citrated PPP Separate plasma & freeze immediately | F 2 weeks | Photo-optical Clot Detection | Daily |
Z185 | Parvovirus B19 Antibodies Panel, IgG & IgM | 2 mL SERUM | R 1 week F 1 week | EIA | S:Fri 9 am R:Same day |
S143 | Parvovirus B19 Antibody, IgM | 2 mL SERUM | R 1 week F 1 week | EIA | S:Fri 9 am R:Same day |
S142 | Parvovirus B19 Antibody, IgG | 2 mL SERUM | R 1 week F 1 week | EIA | S:Fri 9 am R:Same day |
N124 | Parvovirus B19, Qualitative PCR | 3 mL EDTA WB / 2 mL CSF | R 72 hrs F Unacceptable | PCR | S: Mon / Thu 11 am R:Wed / Sat |
H224 | PAS (Periodic Acid Schiff) Stain, Blood / Bone Marrow | 2 mL EDTA WB or Heparinized BONE MARROW | R 72 hrs F Unacceptable | Cytochemical Staining | S: Daily 6 pm R: 3 days |
RW146 | PCNA (Proliferating Cell Nuclear Antigen), Antibody | 2 mL SERUM No Additive tube | R 14 days F 30 days | IFA | S: By 7th of Month R: 2 - 3 weeks |
B170 | PCOD (Polycystic Ovarian Disease) Panel *FSH *LH *Testosterone, Total *Prolactin *Insulin, fasting *Glucose, fasting * TSH Ultrasensitive | 4 mL SERUM + 2 mL Fluoride PLASMA Collect 4 hrs after patient has awakened. Overnight fasting mandatory. | R 48 hrs F 1 week | Hexokinase,CLIA, CMIA | Daily |
Z838 | PCOD (Polycystic Ovarian Disease) Comprehensive Panel *FSH *LH *Testosterone, Total *Prolactin *Insulin, fasting *Glucose, fasting * TSH Ultrasensitive *DHEAS *AMH *Lipid Profile, Screen *HOMA-IR | 4 mL SERUM + 2 mL Fluoride PLASMA Collect 4 hrs after patient has awakened. Overnight fasting mandatory. | R 48 hrs F 1 week | Hexokinase, CLIA, CMIA, Spectrophotometry | S:Daily 4 pm R:Same day |
Z516 | Peritoneal Dialysis Adequacy Test | 10 mL aliquot of 24 hr Peritoneal dialysate FLUID + 10 mL aliquot of 24 hr Urine + 2 mL SERUM + 2 mL Fluoride PLASMA | R 72 hrs F Unacceptable | Spectrophotometry | Daily |
Z517 | Peritoneal Equilibrium & Adequacy Test | 10 mL aliquot of Peritoneal dialysate FLUID at 0 hr, 2 hr, 4 hr, overnight & 24 hr intervals. + 10 mL aliquot of 24 hr URINE + 2 mL SERUM + 2 mL Fluoride PLASMA | R 72 hrs F Unacceptable | Spectrophotometry | Daily |
Z515 | Peritoneal Equilibrium Test (PET) | 10 mL aliquot of Peritoneal dialysate FLUID at 0 hr, 2 hr, 4 hr & overnight intervals + 2 mL SERUM + 2 mL Fluoride PLASMA both along with 2 hr samples only. | R 72 hrs F Unacceptable | Spectrophotometry | Daily |
Z826 | Pernicious Anemia Panel *Vitamin B12 *Gastrin *Intrinsic Factor Antibody *Parietal Cell Antibody | 5 mL SERUM Protect from light Overnight fasting mandatory | R 48 hrs F 2 weeks | EIA, CLIA, IFA | S:Mon 9 am R:Same day |
K016 | Phencyclidine (PCP), Screen, Urine | 15 mL aliquot of random URINE | R 48 hrs F 4 weeks | Lateral Flow Immunoassay | Daily |
D050 | Phenobarbitone | 2 mL SERUM drawn just before next dose No Additive Tube | R 48 hrs F 1 week | CLIA | Daily |
V603 | Phenol | 10 mL aliquot of random urine collected at the end of the shift on last working day of the week. | R 1 week F 3 months | HPLC | S: Tue 7 am R: 2 weeks |
R160 | Phenylalanine, Newborn Screen | 1 drop heel prick blood each on 3 spots of filter paper | R 1 week F 1 week | Fluoroimmunoassay | S: Tue / Thu / Sat 5 pm R: 2 days |
D049 | Phenytoin | 2 mL SERUM drawn just before next dose No Additive Tube | R 48 hrs F 1 week | CLIA | Daily |
Z144 | Pheochromocytoma Profile VMA *Metanephrines *Catecholamines * Chromogranin A | 50 mL aliquot of 24 hr URINE Preservative 50% HCl State Total Volume AvoidAlpha-one blockers, Aminophylline, Amphetamines, Ampicillin, Beta-blockers, Ephedrine, Imipramine, Methyldopa, Buspiron, Codeine, L-Dopa, MAO inhibitors, Nicotine, Phenacetin, Phenothiazine, Theophylline, Vasodilators, Aspirin,PAS, Alpha-two agonists, Bromocriptine, Calcium channel blockers (long term use), Clofibrate, Propranolol, Penicillin, Reserpine, Thyroxine, Alpha-methyldopa, Isoproterenol, Labetalol, Mandelamine, Paracetamol, Cimetidine, Metoclopramide, vigorous exercise, alcoholic beverages, teaorcoffee, tobacco, chocolate, pepper, vanilla & banana at least 72 hours before and during specimen collection. | F 4 weeks | HPLC, TRACE | S: Wed / Sat 9 am R: 2 days |
Z167 | Phosphatidylserine Antibodies Panel, IgG & IgM | 2 mL SERUM | R 5 Days F 3 months | EIA | S:Tue 11 am R:Fri |
S120 | Phosphatidylserine Antibody, IgG | 2 mL SERUM | R 5 Days F 3 months | EIA | S:Tue 11 am R:Fri |
S121 | Phosphatidylserine Antibody, IgM | 2 mL SERUM | R 5 Days F 3 months | EIA | S:Tue 11 am R:Fri |
S240 | Phospholipase A2 Receptor Antibody (PLA2R), Qualitative | 2 mL SERUM | R 1 week F 2 weeks | IFA | S:Mon 9 am R:Wed |
S255 | Phospholipase A2 Receptor Antibody (PLA2R), Quantitative | 3 mL SERUM | R 2 weeks F 4 weeks | EIA | S:Thu 9 am R:Same day |
Z287 | Phospholipid Antibodies Panel, IgG & IgM | 2 mL SERUM | R 5 Days F 6 months | EIA | S:Mon through Sat 9 am R:Same day |
S191 | Phospholipid Antibody, IgG | 2 mL SERUM | R 5 Days F 6 months | EIA | S:Mon through Sat 9 am R:Same day |
S192 | Phospholipid Antibody, IgM | 2 mL SERUM | R 5 Days F 6 months | EIA | S:Mon through Sat 9 am R:Same day |
Z377 | Phospholipid Syndrome Panel *Cardiolipin Antibodies IgG & IgM *Phospholipid Antibodies Panel *Lupus Anticoagulant by dRVVT | 3 mL SERUM + 3 mL Citrated PPP Freeze serum & plasma immediately Patient to discontinue Heparin for 1 day & Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | EIA, Electromechanical Clot Detection | S: Daily 3 pm R: Next day |
U012 | Phosphorus, 24 Hour Urine | 10 mL aliquot of 24 hr URINE State Total Volume | R 1 week F 4 weeks | Molybdate UV | Daily |
U074 | Phosphorus, Random Urine | 10 mL aliquot of random URINE | R 1 week F 4 weeks | Molybdate UV | Daily |
B043 | Phosphorus, Serum | 2 mL SERUM | R 4 days F 4 weeks | Molybdate UV | Daily |
RW262 | Pigeon Feathers, IgE | 3 mL SERUM No Additive Tube | R 14 days F 30 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
S257 | Placental Growth Factor (PlGF) | 2 mL SERUM | R 8 hrs F 4 months | ECLIA | S:Tue / Thu / Sat 9 am R:Same Day |
N114 | PIK3CA Mutation Analysis | Paraffin BLOCK | NA | PCR, Sequencing | S: Tue 11 am R:Mon |
R072 | Plasma Renin Direct | 3 mL EDTA PLASMA Separate plasma & freeze immediately Draw between 8-10 a.m Patient to be Ambulatory or Upright at least 2 hrs prior to test | F 4 weeks | CLIA | S: Tue / Fri 9 am R:Same day |
RW147 | Plasminogen Activator Inhibitor -1 (PAI-1) Activity | 2 mL Citrated PLASMA Separate plasma & freeze immediately Overnight fasting mandatory | F 60 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
OS178 | Plasminogen Activator Inhibitor -1 / Serpine-1, 4G / 5G Genotyping | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Tue 11 am R: 9 days |
H010 | Platelet Count | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence | Daily |
H251 | Platelet Count, Fluorescent (PLT-F) | 3 mL EDTA WB | R 12 hrs F Unacceptable | Fluorescent Flow Cytometry | Daily |
H210 | Platelet Distribution Width; PDW | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence | Daily |
N038 | PML RARA t(15;17)(q22;q12) Gene Rearrangement Qualitative, PCR | 5 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR | S:Mon / Wed / Fri 9 am R: Tue / Thu / Sat |
N095 | PML RARA t(15;17)(q22;q12) Gene Rearrangement Quantitative, PCR | 5 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR | S:Mon / Wed / Fri 9 am R: Tue / Thu / Sat |
M221 | Pneumocystis, IFA | Sputum / Induced Sputum / BAL FLUID | R 24 hrs F Unacceptable | Direct IFA | S: Daily 9 am R: Same day |
P097 | Polarizing Microscopy, Body Fluids | 5 mL Body FLUIDS | R 72 hrs F Unacceptable | Polarizing Microscopy | S: Daily 2 pm R: Same day |
G128 | Pompe Disease, Quantitative, Blood Tests deficiency of Alpha Glucosidase | 10 mL EDTA or Heparinized WB | R 48 hrs F Unacceptable | Enzyme assay | S: Daily 4 pm R: 4 Days |
U029 | Porphobilinogen (PBG), Qualitative, Urine | 10 mL aliquot of random URINE Protect from light | R 1 week F 4 weeks | Column Chromatography | S: Tue / Fri 9 am R: Same day |
U098 | Porphobilinogen (PBG), Quantitative, Urine | 10 mL aliquot of random URINE Protect from light | R 1 week F 4 weeks | Column Chromatography | S: Tue / Fri 9 am R: Same day |
U053 | Porphyrins Total Qualitative, Random Urine | 10 mL aliquot of random URINE Protect from light | R 1 week F 4 weeks | Column Chromatography | S: Daily 1 pm R: Same day |
U003 | Porphyrins Total, Quantitative 24 Hour Urine | 10 mL aliquot of 24 hr URINE Protect from light | R 1 week F 4 weeks | Column Chromatography | S: Daily 1 pm R: Same day |
U058 | Potassium, 24 Hour Urine | 10 mL aliquot of 24 hr URINE State Total Volume | R 72 hrs F 1 week | Indirect ISE | Daily |
P098 | Potassium, Fluid | 2 mL FLUID | R 72 hrs F 1 week | Indirect ISE | Daily |
U014 | Potassium, Random Urine | 10 mL aliquot of random URINE | R 72 hrs F 1 week | Indirect ISE | Daily |
B045 | Potassium, Serum | 2 mL SERUM Separate serum within 1 hr | R 72 hrs F 1 week | Indirect ISE | Daily |
OS179 | Prader-Willi Syndrome Mutation Detection, Methylation Specific, PCR | 4 mL EDTA WB | R 1 week F Unacceptable | Methylation specific PCR | S: Sat 11 am R: 12 days |
RW151 | Prealbumin | 2 mL SERUM No Additive tube | R 2 weeks F 12 weeks | Nephelometry | S: By 7th of Month R: 2 - 3 weeks |
Z841 | Pre-eclampsia Predictor Panel *PLGF * sFLT *sFLT-1 : PLGF Ratio | 2 mL SERUM | R 8 hrs F 1 month | ECLIA | S: Tue / Thu / Sat 9 am R: Same day |
Z883 | Pre-Eclampsia Screening Panel *Placental Growth Factor (PlGF) * Pregnancy Associated Plasma Protein A (PAPP-A) Done on FMF accredited (Roche) platform | 2 mL SERUM Provide maternal Date of birth (dd/mm/yy); Height, weight, IVF, Smoking,History of blood pressure, Diabetes and Preeclampsia in previous pregnancy, Number of Fetuses (Single/ Twins); Blood pressure measurement of right & left arm; USG for CRL & Uterine aretery PI in Preclampsia screening form. Test is valid between 10-13 weeks gestation | R 8 hrs F 12 weeks | ECLIA | S: Tue / Thu / Sat 9 am R: Same day |
S006 | Pregnancy Test Urine | 10 mL aliquot of 1st morning URINE | R 48 hrs F 1 week | ICT | Daily |
RW152 | Pregnenolone | 2 mL SERUM No Additive Tube | R 1 week F 6 weeks | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
XX053 | Prenatal Comprehensive Screening Panel 1 *Aneuploidy detection for Trisomy 13, 18, 21 & Sex chromosomes * Microdeletions for DiGeorge syndrome, Prader Willi syndrome & William Beuren syndrome | 10 mL Amniotic Fluid in sterile screw capped container after 15 weeks gestation. Prenatal consent form is mandatory. | 18 - 22°C within 24 hrs | FISH | S: Daily 4 pm R: 4 Days |
G133 | Prenatal Diagnosis Panel 1, Chorionic Villus Biopsy This Panel tests the following diseases: *Metachromatic Leucodystrophy (Code Y556) *GM 1 Gangliosidosis (Code Y557)*GM 2 Gangliosidosis (Code Y558)*Gaucher Disease (Code Y559) *Niemann Pick Disease (Code Y560 )*Fabry Disease (Code Y561)*Pompe Disease (Code Y562) *MPS-1 (Hurler) (Code Y563) | 20 mg chorionic villus BIOPSY in special culture medium at 10- 13 weeks gestation Signed consent form mandatory Prior appointment required | R 6 hrs F 24 hrs | Enzyme assay | S: Daily 4 pm R: 5 Days |
G134 | Prenatal Diagnosis Panel 2, Amniotic Fluid * Mucopolysaccharidoses (MPS) | 10 ml Amniotic Fluid after 16 weeks gestation. Signed consent form mandatory Prior appointment required | 18 - 22°C within 24 hrs | Two Dimensional Electrophoresis | S: Daily 4 pm R: 10 Days |
Z614 | Pre-Operative panel *Blood Group & Rh Factor *Urea *Creatinine *Glucose Random *HIV Rapid *HBsAg Rapid *HCV Rapid *Prothrombin Time *Hemoglobin *Urine R/E | 3 mL SERUM +2 mL Fluoride PLASMA + 3 mL EDTA WB +3 mL Citrated PPP +10 mL aliquot of random URINE | R 48 hrs F 2 weeks | See individual assays | Daily |
RW153 | ProcainamideIncludes metabolite N- acetylprocainamide | 2 mL SERUM drawn just before next dose No Additive Tube | R 1 week F 2 weeks | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
B176 | Procalcitonin | 2 mL SERUM | R 24 hrs F 3 months | ECLIA | Daily |
R011 | Progesterone, Serum | 2 mL SERUM | R 1 week F 3 months | CMIA | Daily |
RW154 | Proinsulin | 2 mL SERUM No Additive Tube Separate serum within 1 hr | R 72 hrs F 6 weeks | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
R082 | Prolactin, Serum | 2 mL SERUM Collect 4 hrs after patient has awakened. Pooling equal volume of 3 serum samples at 15 min. intervals recommended | R 48 hrs F 4 weeks | CLIA | Daily |
RW155 | Properdin Factor B;C3 Proactivator | 2 mL SERUM No Additive Tube | R 72 hrs F 30 days | Nephelometry | S: By 7th of Month R: 2 - 3 weeks |
K020 | Propoxyphene Screen, Urine | 10 mL aliquot of random Urine | R 72 hrs F 4 weeks | Lateral Flow Immunoassay | Daily |
Z016 | Protein & Immunoglobulin Panel * Protein Electrophoresis, Serum * Immunoglobulin Profile, Serum | 3 mL SERUM | R 72 hrs F 6 months | Immunoturbidimetry, Capillary Electrophoresis | S: Daily 9 am R: Same day |
RW157 | Protein C Antigen | 2 mL Citrated PPP Separate plasma & freeze immediately | F 60 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
U087 | Protein ; Creatinine Ratio, Urine | 20 mL aliquot of 1st morning or random URINE | R 24 hrs F Unacceptable | Spectrophotometry | Daily |
Z186 | Protein Electrophoresis & IFE, Serum Includes total protein, electrophoretic fractions, densitometric tracing of immunofixation electrophoresis. | 2 mL SERUM Recommended only for patients with known M Protein in serum | R 72 hrs F 6 months | Capillary Electrophoresis, Agarose gel Immunofixation Electrophoresis | S: Daily 9 am R: Next day |
E001 | Protein Electrophoresis, SerumIncludes total protein, electrophoretic fractions with densitometric tracing. | 2 mL SERUM | R 2 weeks F 6 months | Capillary Electrophoresis | S: Mon through Sat 9 am R: Same day |
E003 | Protein Electrophoresis, 24 Hour Urine | 20 mL aliquot of 24 hr URINE State Total Volume | R 24 hrs F 6 months | Agarose gel electrohoresis | S: Daily 9 am R: 4 days |
RW158 | Protein S Antigen | 3 mL Citrated PPP Separate plasma & freeze immediately | F 30 days | Immunoturbidimetry | S: By 7th of Month R: 2 - 3 weeks |
H252 | Protein S (Free) Antigen | 3 mL Citrated PPP Separate plasma & freeze immediately Patient to discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Immunoturbidimetry | S: Daily 11 am R: Same day |
H061 | Protein C Functional | 3 mL Citrated PPP Separate plasma & freeze immediately Patient to discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Chromogenicassay | S: Daily 11 am R: Same day |
P089 | Protein Total Body Fluids | 2 mL Synovial FLUID or 10 mL other Body FLUIDS | R 72 hrs F Unacceptable | Biuret | Daily |
U004 | Protein Total, 24 Hour Urine | 20 mL aliquot of 24 hr URINE State Total Volume | R 72 hrs F Unacceptable | Spectrophotometry | Daily |
B090 | Protein Total, CSF | 1 mL CSF | R 48 hrs F Unacceptable | Spectrophotome try | Daily |
U020 | Protein Total, Random Urine | 15 mL aliquot of random URINE | R 72 hrs F Unacceptable | Spectrophotometry | Daily |
Z211 | Protein Total, Serum *Total Protein * Albumin * A:G Ratio | 2 mL SERUM | R 1 week F 4 weeks | Biuret, BCG | Daily |
N048 | Prothrombin Gene Mutation Analysis | 3 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
H131 | Prothrombin Time Studies *Prothrombin Time (PT) *Prothrombin Ratio (PR) *International Normalised Ratio (INR) | 3 mL Citrated PPP Separate plasma & freeze immediately | F 2 weeks | Photo-optical Clot Detection | Daily |
Z262 | PSA Profile *PSA, Total * PSA, Free * Free / Total Percent | 2.5 mL SERUM Avoid draw within 7 days of Digital Rectal Examination or Rectal Prostatic Ultrasonography | R 24 hrs F 4 weeks | CMIA | Daily |
F017 | PSA (Prostate Specific Antigen), Free | 2 mL SERUM Avoid draw within 7 days of Digital Rectal Examination or Rectal Prostatic Ultrasonography | R 24 hrs F 4 weeks | CMIA | Daily |
F014 | PSA (Prostate Specific Antigen), Total | 3 mL SERUM Avoid draw within 7 days of Digital Rectal Examination or Rectal Prostatic Ultrasonography | R 24 hrs F 4 weeks | CMIA | Daily |
R038 | PTH (Parathyroid Hormone) Intact | 3 mL SERUM Draw fasting serum between 8- 10 am Separate serum within 30 mins & freeze immediately | F 4 weeks | CLIA | Daily |
RW160 | PTH-rP; Parathyroid Hormone Related Peptide | 2 mL Heparinized PLASMA Separate plasma immediately | R 7 days F 28 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
RW161 | Purkinje Cell (Yo) Antibody Screen with Reflex to Titer and Western Blot, CSF | 3 mL CSF | R 1 week F 6 weeks | IFA | S: By 7th of Month R: 2 - 3 weeks |
RW162 | Purkinje Cell (Yo) Antibody Screen with Reflex to Titer and Western Blot, Serum | 3 mL SERUM | R 14 days F 21 days | IFA | S: By 7th of Month R: 2 - 3 weeks |
G148 | Pyruvate; Pyruvic Acid | 3 mL Fluoride WB. Mix WB with 7% Perchloric acid & centrifuge. Separate supernatent & submit | R 1 week F 4 weeks | Spectrophotometry | S: Daily 4 pm R: Same day |
RW165 | Q Fever Antibodies (Coxiella burnetti), Antibodies, IgG & IgM | 2 mL SERUM | R 7 days F 30 days | IFA | S: By 7th of Month R: 2 - 3 weeks |
M175 | Rapid TB antigen MPT64 | Pure Growth of AFB | R 4 weeks F Unacceptable | ICT | Daily |
H004 | Red Blood Cells; RBC Count | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence | Daily |
H019 | Red Cell Distribution Width; RDW | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence | Daily |
Z815 | Respiratory Comprehensive Panel *Respiratory Panels 1-8 (33 Pathogens) | Throat or Nasal SWABS in special collection medium or 5 mL Sputum or BAL FLUID | R 72 hrs F 4 weeks | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N098 | Respiratory Panel 1 *Influenza A & B *Rhino Virus | Throat or Nasal SWABS in special collection medium or 5 mL Sputum or BAL FLUID | R 72 hrs F 4 weeks | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N099 | Respiratory Panel 2 *Parainfluenza viruses 2, 3 & 4 | Throat or Nasal SWABS in special collection medium or 5 mL Sputum or BAL FLUID | R 72 hrs F 4 weeks | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N100 | Respiratory Panel 3 *Coronaviruses NL63, 229E, OC43 & HKU1 | Throat or Nasal SWABS in special collection medium or 5 mL Sputum or BAL FLUID | R 72 hrs F 4 weeks | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N101 | Respiratory Panel 4 *Parainfluenza Virus 1 *Human Metapneumovirus A/B *Bocavirus, *Mycoplasma pneumoniae | Throat or Nasal SWABS in special collection medium or 5 mL Sputum or BAL FLUID | R 72 hrs F 4 weeks | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N102 | Respiratory Panel 5 *Respiratory syncytial virus A/B *Cytomegalovirus *Enterovirus / Parechovirus *Adenovirus | Throat or Nasal SWABS in special collection medium or 5 mL Sputum or BAL FLUID | R 72 hrs F 4 weeks | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N103 | Respiratory Panel 6 *Staphylococcus aureus *Streptococcus pneumoniae *Chlamydia pneumoniae *Haemophilus influenzae Type B | Throat or Nasal SWABS in special collection medium or 5 mL Sputum or BAL FLUID | R 72 hrs F 4 weeks | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N104 | Respiratory Panel 7 *Klebsiella pneumoniae*Legionella *Pneumocystis jiroveci *Salmonella species | Throat or Nasal SWABS in special collection medium or 5 mL Sputum or BAL FLUID | R 72 hrs F 4 weeks | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N105 | Respiratory Panel 8 *Moraxella catarrhalis *Bordetella pertussis *Influenza C *Haemophilus influenzae | Throat or Nasal SWABS in special collection medium or 5 mL Sputum or BAL FLUID | R 72 hrs F 4 weeks | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
M205 | Respiratory Syncytial Virus (RSV), Antigen | Nasal / Nasopharyngeal / BAL / Respiratory secretions | R 24 hrs F Unacceptable | ICT | S: Daily 1 pm R: Same day |
RW166 | Reticulin Antibody, IgA | 2 mL SERUM | R 14 days F 30 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
H011 | Reticulocyte Count | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical Impedence | Daily |
OS180 | Rett Syndrome Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S: Sat 11 am R: 13 days |
Z096 | Rheumatoid Autoimmune Panel *ANA * Anti- ds-DNA * Sm * U1RNP * Rheumatoid Fator * C3 * C4 | 3 mL SERUM | R 1 week F 4 weeks | S: Tue / Fri 9 am R: Same day | |
Z097 | Rheumatoid Autoimmune, Comprehensive Panel *ANA *Anti-ds DNA *Sm *U1RNP *Rheumatoid Factor *C3 *C4 *SS-A (Ro) *SS-B (La) *Centromere Antibody | 6 mL SERUM | R 1 week F 4 weeks | EIA, Immunoturbidimetry | S: Tue / Fri 9 am R: Same day |
B072 | Rheumatoid Factor (RA), Serum | 2 mL SERUM | R 1 week F 3 months | Immunoturbidimetry | Daily |
P070 | Rheumatoid Factor (RA), Synovial Fluid | 2 mL Synovial FLUID | R 48 hrs F 2 weeks | Immunoturbidimetry | Daily |
S154 | Rheumatoid Factor, IgA | 2 mL SERUM | R 1 week F 4 weeks | EIA | S:Sat 9 am R:Same day |
Z143 | Rheumatoid Arthritis Panel *ANA *Rheumatoid Factor *Anti Cyclic Citrullinated Peptide | 3 mL SERUM | R 1 week F 4 weeks | EIA, Immunoturbidimetry, CMIA | S: Mon through Sat 9 am R: Same day |
RW167 | Ribosomal P Antibody, IgG | 2 mL SERUM | R 7 days F 30 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
RW168 | Rickettsia Antibody Panel *Rocky Mountain Spotted Fever IgG & IgM *Typhus Fever, IgG & IgM | 2 mL SERUM | R 14 days F 30 days | IFA | S: By 7th of Month R: 2 - 3 weeks |
RW169 | Ristocetin Cofactor | 3 mL Citrated PPP Separate plasma & freeze immediately | F 30 days | Platelet Agglutination | S: By 7th of Month R: 2 - 3 weeks |
RW170 | Rocky Mountain Spotted Fever Antibodies *Rickettsia rickettsii IgG & IgM (Both Screen and Titer) | 2 mL SERUM | R 14 days F 30 days | IFA | S: By 7th of Month R: 2 - 3 weeks |
Z673 | ROMA; Risk of Ovarian Malignancy Algorithm *CA125 *HE4 *Menopausal status risk estimation | 2 mL SERUM Provide menopausal status | R 72 hrs F 2 weeks | CMIA | S: Mon / Thu 4 pm R:Same day |
M212 | Rotavirus Antigen, Stool | 5 g Fresh STOOL | R 24 hrs F Unacceptable | ICT | S: Daily 1 pm R:Same day |
Z190 | Rubella (German Measles) Antibodies Panel, IgG & IgM | 2 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
S040 | Rubella (German Measles) Antibody, IgG | 2 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
S016 | Rubella (German Measles) Antibody, IgM | 2 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
B158 | Rubella (German Measles) Avidity, IgG | 2 mL SERUM | R 4 days F 4 weeks | EIA | S: Daily 9 am R: Same day |
OS181 | Rubella Detection, PCR | 4 mL EDTA PLASMA OR 3 mL CSF or Amniotic FLUID or Nasopharyngeal SWAB | R 72 hrs F 1 week | PCR | S: Daily 11 am R:6 days |
M232 | Salmonella Typhi And Salmonella Paratyphi A Antigen Detection | 1 mL SERUM OR 2 g STOOL | R 72 Hrs F Unacceptable | Immunochromat ography | S: Daily 3.30 pm R:Same day |
N133 | SCA-1 (Spinocerebellar Ataxia) ATXN1 Gene Mutation | 4 mL EDTA WB | R 1 week F Unacceptable | PCR, Fragment | S: Tue 11 am A R:Sat |
N134 | SCA-2 (Spinocerebellar Ataxia) ATXN2 Gene Mutation | 4 mL EDTA WB | R 1 week F Unacceptable | PCR, Fragment Analysis | S: Tue 11 am R:Sat |
N135 | SCA-3 (Spinocerebellar Ataxia) ATXN3 Gene Mutation | 4 mL EDTA WB | R 1 week F Unacceptable | PCR, Fragment Analysis | S: Tue 11 am R:Sat |
N136 | SCA-6 (Spinocerebellar Ataxia) CACNA1A Gene Mutation | 4 mL EDTA WB | R 1 week F Unacceptable | PCR, Fragment Analysis | S: Tue 11 am R:Sat |
N137 | SCA-7 (Spinocerebellar Ataxia) ATXN7 Gene Mutation | 4 mL EDTA WB | R 1 week F Unacceptable | PCR, Fragment Analysis | S: Tue 11 am R:Sat |
N146 | SCA-12 (Spinocerebellar Ataxia) PPP2R2B Gene Mutation | 4 mL EDTA WB | R 1 week F Unacceptable | PCR, Fragment Analysis | S: Tue 11 am R:Sat |
Z863 | SCA (Spinocerebellar Ataxia) Comprehensive Profile *ATXN1 *ATXN2 *ATXN3 *ATXN7 *CACNA1A & PPP2R2B gene mutations | 4 mL EDTA WB | R 1 week F Unacceptable | PCR, Fragment Analysis | S: Tue 11 am R:Sat |
S065 | Scl-70 (Scleroderma), Antibody | 2 mL SERUM | R 72 hrs F 2 weeks | EIA | S:Tue / Fri 9 am R:Same day |
Z192 | Scleroderma Panel *Scl-70 *Centromere Antibody | 3 mL SERUM | R 1 week F 4 weeks | EIA | S:Tue / Fri 9 am R:Same day |
V086 | Scrub Typhus (Tsutsugamushi) Antibody | 2 mL SERUM | R 5 days F 2 weeks | ICT | S:Daily 1 pm R:Same day |
C048 | Selenium, 24 Hour Urine | 10 mL aliquot of 24 hr URINE State Total volume Metal Free container Use powderless gloves. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
C047 | Selenium, Random Urine | 10 mL aliquot of random URINE Metal Free container Use powderless gloves. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
C032 | Selenium, Serum | 2 mL (Z-No Additive) SERUM Metal Free container Use powderless gloves. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
P006 | Semen Analysis, Seminogram | SEMEN ejaculate by masturbation only Avoidejaculation 2-7 days prior to collection Patient to urinate, wash genital area with warm water, dry the part & collect entire ejaculate Outstation samples not accepted. | 37°C within 1 hr | Physical examination, Microscopy | S: Daily 1 pm R: Same day |
P022 | Semen Fructose, Qualtitative | SEMEN ejaculate Freeze immediately | F 1 week | BiochemicalAnalysis | Daily |
Z804 | Sepsis Panel *Procalcitonin * Lactate * C- Reactive Protein *Blood culture *CBC | 5 mL SERUM + 3 mL EDTA WB +2 mL Fluoride PLASMA + 10 mL WB in Special Aerobic culture bottle | R 48 hrs F Unacceptable | ECLIA, Spectrophotometry, Immunoturbidim etry, Rapid Automated Aerobic culture, Electrical Impedence, VCS | S: Daily 3.30 pm R: Interim 24 & 48 hrs Final 6 days |
RW173 | Serotonin (5-HT), Serum | 3 mL SERUM Separate serum & freeze immediately Avoidfood rich in indoles like avocado, banana, tomato, plum, walnut, pineapple, egg plant (brinjal) and also avoid tobacco, tea and coffee 3 days prior to specimen collection. | F 42 days | HPLC, Fluorescencedetection | S: By 7th of Month R: 2 - 3 weeks |
B140 | Serum Ascites Albumin Gradient (SAAG) | 2 mL SERUM + 2 mL Ascitic FLUID | R 72 hrs F 6 months | BCG | Daily |
R070 | Sex Hormone Binding Globulin; SHBG | 2 mL SERUM | R 1 week F 4 weeks | CLIA | S: Mon / Thu 4 pm R:Same day |
B032 | SGOT; Aspartate Aminotransferase (AST) | 2 mL SERUM | R 72 hrs F 1 week | IFCC | Daily |
B033 | SGPT; Alanine Aminotransferase (ALT) | 2 mL SERUM | R 72 hrs F 1 week | IFCC | Daily |
OS187 | Sickle Cell Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Mon / Wed 11 am R:10 days |
OS188 | Sickle Cell Mutation Detection, Prenatal | 4 mL EDTA WB from both parents + 10 mL Amniotic Fluid Consent form mandatory | R 1 week F Unacceptable | PCR | S: Mon / Wed 11 am R:10 days |
H042 | Sickling Screening Test | 2 mL EDTA WB | R 48 hrs F Unacceptable | Deoxygenation | S: Daily 9 am R: Next day |
G144 | Silver Nitroprusside test, Urine | 10 mL aliquot of random URINE | R 1 week F 2 weeks | Chemical | S: Daily 4 pm R: Same day |
C066 | Silver, Serum | 3 ml (Z tube- No Additive) SERUM. Metal free tube. Use powderless gloves. Avoidsilver containing medication or food-supplements 3 days prior to sample collection. | R 1 week F 1 week | ICPMS | S: Tue / Fri 6 pm; R: 2 days |
G162 | Sirolimus (Rapamycin) | 3 mL EDTA WB drawn 1 hr before next dose | R 7 days F Unacceptable | LC-MS/MS | S: Daily 5 pm R: Same day |
Z142 | Sjogren's Syndrome Antibodies *SS-A / Ro *SS-B/La | 2 mL SERUM | R 1 week F 4 weeks | EIA | S: Tue / Fri 9 am R: Same day |
Z814 | SLE (Systemic Lupus Erythematosus) Panel *ANA * ds-DNA Antibody * Sm antibody * Phospholipid antibody IgG * Phospholipid antibody IgM | 4 mL SERUM | R 48 hrs F 2 weeks | EIA | S: Tue / Fri 9 am R: Same day |
S038 | Sm (Smith) Antibody, IgG | 2 mL SERUM | R 1 week F 2 weeks | EIA | S: Tue / Fri 9 am R: Same day |
P028 | Smear Examination, Gonococcus | 2 air dried SMEARS Fixative 95% ethanol for 1 min | NA | Gram Stain | Daily |
P018 | Smear Examination, Routine | 2 air dried Nasal or Cervical or Vaginal or Throat or Pus or Other SMEARS | NA | Light Microscopy, Giemsa Stain | Daily |
S045 | Smooth Muscle Antibody (ASMA), IFA | 2 mL SERUM | R 1 week F 2 weeks | IFA | S: Daily 11 am R: Same day |
S084 | Smooth Muscle Antibody (ASMA), IFA in dilutions | 3 mL SERUM | R 1 week F 2 weeks | IFA | S: Daily 11 am R: Next day |
B183 | Sodium : Osmolality Ratio, Serum | 2 mL SERUM Separate serum within 1 hr | R 72 hrs F 1 week | Indirect ISE, Freezing Point Depression, Calculated | Daily |
U025 | Sodium, 24 Hour Urine | 10 mL aliquot of 24 hr URINE State Total Volume | R 72 hrs F Unacceptable | Indirect ISE | Daily |
P079 | Sodium, Fluid | 2 mL FLUID | R 72 hrs F Unacceptable | Indirect ISE | Daily |
U013 | Sodium, Random Urine | 10 mL aliquot of random URINE | R 72 hrs F Unacceptable | Indirect ISE | Daily |
B044 | Sodium, Serum | 2 mL SERUM | R 72 hrs F 1 week | Indirect ISE | Daily |
RW174 | Somatostatin, Plasma | 4 mL EDTA PLASMA Draw in prechilled tube Separate plasma & freeze immediately | F 28 days | Extraction, Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
U018 | Specific gravity, Urine | 10 mL aliquot of random or 24 hr URINE Outstation samples not acceptable | R 72 hrs F Unacceptable | Automated Strip Test | Daily |
G130 | Sphingolipidosis Panel 1 *Metachromatic Leucodystrophy *GM 1 Gangliosidosis *GM 2 Gangliosidosis *Gaucher Disease *Niemann Pick Disease | 10 mL EDTA or Heparinized WB | R 48 hrs F Unacceptable | Enzyme Assay | S: Daily 4 pm R: 4 days |
G131 | Sphingolipidosis Panel 2 *Gaucher Disease *Niemann Pick Disease | 10 mL EDTA or Heparinized WB | R 48 hrs F Unacceptable | Enzyme Assay | S: Daily 4 pm R: 4 days |
G132 | Sphingolipidosis Panel 3 *GM 1 Gangliosidosis *Gaucher Disease *Niemann Pick Disease | 10 mL EDTA or Heparinized WB | R 48 hrs F Unacceptable | Enzyme Assay | S: Daily 4 pm R: 4 days |
N119 | Spinal Muscular Atrophy (SMA), Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | MLPA | S: Mon 11 am R: Sat |
N120 | Spinal Muscular Atrophy (SMA), Carrier Detection | 4 mL EDTA WB | R 1 week F Unacceptable | MLPA | S: Mon 11 am R: Sat |
P027 | Sputum Examination, AFB *Auramine Stain * ZN Stain | SPUTUM | R 48 hrs F Unacceptable | Fluorescent & Conventional microscopy | S: Daily 3.30 pm R: Same day |
P016 | Sputum, Examination, Routine | SPUTUM or 2 air dried SMEARS | R 48 hrs F Unacceptable | Giemsa Stain, Light Microscopy | Daily |
P067 | Sputum Examinationn, Ova & Parasites | SPUTUM | R 48 hrs F Unacceptable | Light Microscopy | Daily |
P066 | Sputum for Eosinophils | SPUTUM or 4 air dried SMEARS | R 48 hrs F Unacceptable | Light Microscopy | Daily |
S066 | SS-A / Ro Antibody | 2 mL SERUM | R 1 week F 4 weeks | EIA | S: Tue / Fri 9 am R: Same day |
S067 | SS-B / La Antibody | 2 mL SERUM | R 1 week F 4 weeks | EIA | S: Tue / Fri 9 am R: Same day |
Z314 | STD Panel *VDRL *HIV 1 & 2, Antibodies Screening test *HSV 1 & 2, IgG & IgM *Chlamydia trachomatis IgG Antibody *TPHA | 5 mL SERUM | R 1 week F 4 weeks | Slide flocculation, CMIA, EIA, Hemagglutinati on | S: Fri 9 am R: Next day |
G190 | Steroid Panel, 21 Hydroxylase Deficiency/Stress Diferentiation *17 Hydroxyprogesterone * Androstenedione *Cortisol *17-Hydroxyprogesterone + Androstenedione : Cortisol Ratio | 2 mL SERUM No Additive tube Collect sample between 8 -10 am / 4-6 pm. | R 7 days F 7 weeks | LC-MS/MS | S: Daily 4 pm R: 2 days |
G191 | Steroid Panel for Congenital Adrenal Hyperplasia (CAH) *Androstenedione *Cortisol *11-Deoxycortisol * DHEA *17-α-Hydroxyprogesterone *Progesterone *Testosterone, Total | 2 mL SERUM No Additive tube Collect sample between 8 -10 am / 4-6 pm. | R 7 days F 7 weeks | LC-MS/MS | S: Daily 4 pm R: 2 days |
G192 | Steroid Panel for Polycystic Ovary Syndrome (PCOS) *Androstenedione *DHEA *Testosterone, Total | 2 mL SERUM No Additive tube Collect sample between 8 -10 am / 4-6 pm. | R 7 days F 7 weeks | LC-MS/MS | S: Daily 4 pm R: 2 days |
G193 | Steroid Panel for PCOS / CAH Differentiation *Androstenedione *11- Deoxycortisol * DHEA *17-α- Hydroxyprogesterone * Testosterone, Total | 2 mL SERUM No Additive tube Collect sample between 8 -10 am / 4-6 pm. | R 7 days F 7 weeks | LC-MS/MS | S: Daily 4 pm R: 2 days |
G194 | Steroid Panel for Premature Adrenarche *Androstenedione * DHEA * DHEAS *17-α-Hydroxyprogesterone *Testosterone, Total *Estradiol | 2 mL SERUM No Additive tube Collect sample between 8 -10 am / 4-6 pm. | R 7 days F 7 weeks | LC-MS/MS | S: Daily 4 pm R: 2 days |
G195 | Steroid Panel 1, 5 Steroids *Aldosterone *Corticosterone *Cortisol *Cortisone *11-Deoxycortisol | 2 mL SERUM No Additive tube Collect sample between 8 -10 am / 4-6 pm. | R 7 days F 7 weeks | LC-MS/MS | S: Daily 4 pm R: 2 days |
G196 | Steroid Panel 2, 8 Steroids *Androstenedione *DHEA *DHEAS *Dihydrotestosterone (DHT) *Estradiol *17-α- Hydroxyprogesterone * Progesterone *Testosterone, Total | 2 mL SERUM No Additive tube Collect sample between 8 -10 am / 4-6 pm. | R 7 days F 7 weeks | LC-MS/MS | S: Daily 4 pm R: 2 days |
G197 | Steroid Panel 3, 13 Steroids *Aldosterone *Androstenedione *Corticosterone *Cortisol *Cortisone *11-Deoxycortisol *DHEA *DHEAS *Dihydrotesterone (DHT) * Estradiol *17α-Hydroxyprogesterone *Progesterone *Testosterone, Total | 2 mL SERUM No Additive tube Collect sample between 8 -10 am / 4-6 pm. | R 7 days F 7 weeks | LC-MS/MS | S: Daily 4 pm R: 2 days |
C031 | Stone analysis with picture | Gall or Kidney STONE | NA | FTIR, Digital Photography | S: Daily 9 am R: Next day |
T013 | Stool Examination, Hanging Drop Preparation | 5 mL STOOL | 37°C within 1 hr | Light Microscopy | S: Daily 5.30 pm R: 2 hrs |
T010 | Stool Examination, pH & Reducing substances | 5 g STOOL Outstation samples not acceptable | R 72 hrs F Unacceptable | pH, Strip test, Benedict’s Test | Daily |
T002 | Stool Examination, Occult Blood | 5 g STOOL Avoidmeat products, pain killers, iron tablets, Vitamin C (Ascorbic Acid) and hard tooth brush for 3 days prior to specimen collection. | R 24 hrs F Unacceptable | Standard Guaiac | Daily |
T001 | Stool Examination, Routine; Stool R/E | 5 g STOOL Outstation samples not acceptable | R 24 hrs F Unacceptable | Light Microscopy | Daily |
S149 | Streptococcus Group B Antigen detection | 2 mL SERUM or CSF or 10 mL random URINE | R 24 hrs F 2 weeks | Latex Agglutination | Daily |
RW175 | Streptozyme | 2 mL SERUM | R 7 days F 30 days | Slide Hemagglutinatio n | S: By 7th of Month R: 2 - 3 weeks |
S100 | Striated / Skeletal / Muscle Antibody, IFA | 2 mL SERUM | R 1 week F 2 weeks | IFA | S: Tue / Sat 9 am R: 4 days |
S174 | Striated / Skeletal / Muscle Antibody, IFA in dilutions | 2 mL SERUM | R 1 week F 2 weeks | IFA | S: Tue / Sat 9 am R: 4 days |
G163 | Succinylacetone, Blood | 1 drop heel prick blood each on 3 spots of filter paper | R 1 week F Unacceptable | LC-MS/MS | S:Mon / Wed / Fri 9 am R: Wed / Fri / Mon |
G171 | Succinylacetone, Urine | 10 mL aliquot of random URINE | R 72 hrs F 4 weeks | GC-MS | S: Daily 5 pm R: 5 days |
H226 | Sudan Black B Stain, Blood / Bone Marrow | 2 mL EDTA WB or Heparinized BONE MARROW | R 72 hrs F Unacceptable | Cytochemical Staining | S: Daily 6 pm R: 3 days |
J058 | Sudan IV Stain | 5 g STOOL or 10 mL URINE or 5mL Body FLUIDS | R 48 hrs F Unacceptable | Special Stain, Microscopy | S: Daily 1 pm R: Next day |
S252 | Syphilis Serology | 2 mL SERUM | R 1 week F 4 weeks | CLIA | S: Mon / Thu 9 am R: Same day |
N062 | t(1;19) (q23;p13.3); TCF3- BX1(E2A-PBX1), PCR Qualitative | 3 mL EDTA WB or BONE MARROW | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N065 | t(11;19) (q23;p13.3); (MLL- ENL), PCR Qualitative | 3 mL EDTA WB or BONE MARROW | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N063 | t(12;21) (p13;q22); ETV6- RUNX1 (TEL-AML1), PCR Qualitative | 3 mL EDTA WB or BONE MARROW | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N064 | t(4;11) (q21;q23); (MLL-AF4), PCR Qualitative | 3 mL EDTA WB or BONE MARROW | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
N066 | t(9;11) (p21-22;q23); (MLL-AF9), PCR Qualitative | 3 mL EDTA WB or BONE MARROW | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
H254 | T Regulatory Cells (TREGS) *CD4 *CD25 *FOXP3 *CD45RA | 3 mL EDTA WB + 3 mL Heparinized WB Clincal history & CBC report mandatory | 18-22°C within 72 hrs | Flow Cytometry | S: Daily 11 am R: Next day |
Z392 | T3 & T4 Total | 2 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
RW176 | T3 Antibody | 2 mL SERUM | R 14 days F 28 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
R090 | T3, Free; FT3 | 2 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
RW177 | T3, Reverse | 2 mL SERUM | R 7 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
R050 | T3, Total | 2 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
RW178 | T4 Antibody | 2 mL SERUM | R 14 days F 28 days | Radiobinding assay | S: By 7th of Month R: 2 - 3 weeks |
R091 | T4, Free; FT4 | 2 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
Z194 | T4, Free & T3, Free; FT4 & FT3 | 2 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
Z195 | T4, Free & TSH Ultrasensitive | 2 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
R051 | T4, Total | 2 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
N111 | Tacrolimus Genotyping (CYP3A5) | 3 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
G160 | Tacrolimus; FK506 | 3 mL EDTA WB drawn just before next dose | R 72 hrs F Unacceptable | LC-MS/MS | S: Daily 5 pm R: Same day |
B160 | TB Gold, Interferon Gamma Release Assay (IGRA) | 1 mL WB from set of Special QuantiFERON-TB Gold tubes Shake tubes to ensure thorough mixing Do not centrifuge if sending within 16 hrs OR incubate at 37 C for 16-24 hrs & centrifuge. | R 72 hrs F Unacceptable | EIA | S: Mon through Sat 4 pm R: Next day |
M230 | TB Platinum, Interferon Gamma Release Assay (IGRA) | 5 mL Heparinized WB | R 12 hrs F Unacceptable | EIA | S: Daily 9 am R: Next day |
RW179 | TBG; Thyroxine Binding Globulin | 2 mL SERUM | R 7 days F 28 days | Chemiluminesce nce | S: By 7th of Month R: 2 - 3 weeks |
RW180 | TBII; Thyrotropin - Binding Inhibitory Immunoglobulin | 2 mL SERUM | R 7 days F 30 days | Radioreceptorassay | S: By 7th of Month R: 2 - 3 weeks |
OS193 | T- cell Gene Rearrangement, Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Daily 11 am R: 13 days |
RW182 | Testosterone, Free, Bioavailable & Total | 3 mL SERUM No Additive tube | R 1 week F 6 weeks | LC-MS/MS, Spectrophotometry | S: By 7th of Month R: 2 - 3 weeks |
Z384 | Testosterone Panel, Total & Free | 3 mL SERUM | R 24 hrs F 4 weeks | RIA, CLIA | S: Mon through Sat 9 am R:Same day |
Z083 Y114 Basal Y115 Post HCG 72 hrs Y116 Customized | Testosterone Stimulation by HCG | 2 mL SERUM for each timed specimen; Draw fasting baseline sample on Day 1; Administer HCG 5000 IU IM; draw additional sample after 72 hrs | R 1 week F 3 months | CLIA | Daily |
R009 | Testosterone, Free | 3 mL SERUM | R 24 hrs F 4 weeks | RIA, CLIA | S:Mon through Sat 9 am R:Same day |
Z196 | Testosterone, Free & Sex Hormone Binding Globulin | 3 mL SERUM | R 24 hrs F 4 weeks | RIA, CLIA | S:Mon / Thu 9 am R:Same day |
R010 | Testosterone, Total | 2 mL SERUM | R 1 week F 3 months | CLIA | Daily |
RW183 | Tetanus Antitoxoid | 2 mL SERUM | R 14 days F 30 days | EIA | S: By 7th of Month R: 2 - 3 weeks |
Z049 | Thalassemia Profile *Iron Studies *Complete Blood Count *Hemoglobin HPLC/Electrophoresis | 2 mL SERUM + 5 mL EDTA WB | R 48 hrs F Unacceptable | Spectrophoto metry, Electrical Impedence, VCS & HPLC | S: Daily 9 am R: Next day |
N093 | Thalassemia Beta, Mutation Analysis | 4 mL EDTA WB | R 72 hrs F Unacceptable | PCR, Reverse hybridization | S: Mon 11 am R: Sat |
C043 | Thallium, 24 Hour Urine | 10 mL aliquot of 24 hr URINE Metal free container State Total Volume Use powderless gloves If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
C042 | Thallium, Blood | 4 mL (K2EDTA) WB Metal free container Use powderless gloves If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F Unacceptable | ICPMS | S: Daily 6 pm R: Next day |
C044 | Thallium, Random Urine | 10 mL aliquot of random URINE Metal free container Use powderless gloves If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
P017 | Throat Swab, Routine | Throat SWAB + 2 air dried SMEARS | R 48 hrs F Unacceptable | Light Microscopy, Giemsa Stain | Daily |
H038 | Thrombin Time ; TT | 2 mL Citrated PPP Separate plasma & freeze immediately | F 2 weeks | Electromechanical Clot detection | Daily |
Z497 | Thrombophilia Comprehensive Panel *Protein C, Functional *Protein S (Free) Antigen *Antithrombin Activity Functional *Factor V Leiden Mutation *Prothrombin Gene Mutation *MTHFR gene mutation *Lupus anticoagulant | 6 mL Citrated PPP + 5 mL EDTA WB It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | PPP: F 2 weeks WB: R 72 hrs F Unacceptable | Electromechanical Clot Detection, Chromogenic, PCR, Immunoturbidimetry | S: Mon / Thu 11 am R: Wed / Sat |
Z319 | Thrombopilia Profile *Protein C, Functional *Protein S (Free) Antigen *Antithrombin Activity Functional *Factor V Leiden Mutation *Prothrombin Gene Mutation *MTHFR gene mutation | 3 mL Citrated PPP + 5 mL EDTA WB It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | PPP: F 2 weeks WB: R 72 hrs F Unacceptable | Chromogenic,PCR, Immunoturbidimetry | S: Mon / Thu 11 am R: Wed / Sat |
H246 | Thrombotic Risk Screen *Protein C Functional *Protein S (Free) Antigen *Antithrombin Activity Functional *APCR | 6 mL Citrated PPP It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. | F 2 weeks | Electromechanical Clot Detection, Chromogenic, Immunoturbidim etry | S: Wed 9 am R: Next day |
F012 | Thyroglobulin; Tg | 2 mL SERUM Perform test minimum 6 weeks after thyroidectomy or needle biopsy or Iodine 131 therapy | R 48 hrs F 4 weeks | CLIA | Daily |
Z045 | Thyroid Profile, Free *Free T3 *Free T4 *TSH, Ultrasensitive | 3 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
Z284 | Thyroid Profile, Total *T3 Total *T4 Total *TSH | 3 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
Z120 | Thyroid Comprehensive Panel *Free T3 *Free T4 *TSH, Ultrasensitive * Antithyroid antibodies | 5 mL SERUM | R 1 week F 4 weeks | CLIA | Daily |
S196 | Tissue Transglutaminase (tTG) Antibody, IgA | 2 mL SERUM | R 1 week F 4 weeks | EIA | S: Daily 9 am R: Same day |
S251 | Tissue Transglutaminase (tTG) Antibody, IgG | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S: Thu 9 am R: Same day |
S228 | Tissue Transglutaminase TTG- DGP Screen | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S: Thu 9 am R: Same day |
P083 | TLC (Total Leucocyte Count), Fluid | 5 mL FLUID | R 24 hrs F Unacceptable | Manual count | Daily |
H003 | TLC (Total Leucocyte Count) | 3 mL EDTA WB | R 48 hrs F Unacceptable | Electrical impedence,VCS | Daily |
RW253 | Topiramate | 3 mL SERUM No Additive Draw peak (2-4 hrs) after dose or Trough (0.5 - 1 hr) before dose | R 14 days F 30 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
OS194 | TORCH DNA Detection *Toxoplasma* Rubella* Cytomegalovirus* Herpes simplex* | 4 mL EDTA PLASMA or 3 mL CSF or Amniotic FLUID | R 72 hrs F Unacceptable | PCR | S: Daily 11 am R: 8 days |
B155 | TORCH Panel Avidity, IgG | 3 mL SERUM | R 4 days F 4 weeks | EIA | S: Daily 9 am R: Same day |
Z028 | TORCH Panel, IgG & IgM *Toxoplasma * Rubella * Cytomegalovirus *Herpes Simplex 1 + 2 | 5 mL SERUM | R 4 days F 4 weeks | CLIA | Daily |
Z776 | TORCH Panel, IgG & IgM Extended *Toxoplasma IgG & IgM *Rubella IgG & IgM *Cytomegalovirus IgG & IgM *Herpes Simplex 1 IgG & IgM * Herpes Simplex 2 IgG & IgM | 3 mL SERUM | R 4 days F 4 weeks | CLIA, EIA | S: Tue / Fri 9 am R: Same day |
Z777 | TORCH Panel, IgG Extended *Toxoplasma IgG *Rubella IgG*Cytomegalovirus IgG *Herpes Simplex 1 IgG * Herpes Simplex 2 IgG | 3 mL SERUM | R 4 days F 4 weeks | CLIA, EIA | S: Tue / Fri 9 am R: Same day |
Z027 | TORCH Panel, IgG *Toxoplasma * Rubella * Cytomegalovirus *Herpes Simplex 1 + 2 | 3 mL SERUM | R 4 days F 4 weeks | CLIA | Daily |
Z778 | TORCH Panel, IgM Extended *Toxoplasma IgM *Rubella IgM *Cytomegalovirus IgM *Herpes Simplex 1 IgM * Herpes Simplex 2 IgM | 3 mL SERUM | R 4 days F 4 weeks | CLIA, EIA | S: Tue / Fri 9 am R: Same day |
Z026 | TORCH Panel, IgM *Toxoplasma * Rubella * Cytomegalovirus *Herpes Simplex 1 + 2 | 3 mL SERUM | R 4 days F 4 weeks | CLIA | Daily |
RW186 | Toxicology Screen, Blood; Drug Screen | 5 mL SERUM No Additive tube | R 7 days F 30 days | Gas Chromatography , Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
Z197 | Toxoplasma Antibodies Panel, IgG & IgM | 2 mL SERUM | R 4 days F 4 weeks | CLIA | Daily |
S039 | Toxoplasma Antibody, IgG | 2 mL SERUM | R 4 days F 4 weeks | CLIA | Daily |
S015 | Toxoplasma Antibody, IgM | 2 mL SERUM | R 4 days F 4 weeks | CLIA | Daily |
B157 | Toxoplasma Avidity, IgG | 2 mL SERUM | R 4 days F 4 weeks | EIA | S: Daily 9 am R: Same day |
OS195 | Toxoplasma DNA Detection | 4 mL EDTA WB or 3 mL Amniotic FLUID or CSF or URINE or Cord Blood or Chorionic Villus BIOPSY | R 72 hrs F Unacceptable | PCR | S: Tue / Sat 11 am R: Sat / Wed |
S001 | TPHA ;Treponema pallidum Hemagglutination | 2 mL SERUM | R 1 week F 4 weeks | Hemagglutinatio n | S:Mon / Wed / Fri 9 am R:Same day |
N071 | TPMT (Thiopurine Methyl Transferase), Genotyping | 4 mL EDTA WB | R 48 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
H128 | Transferrin | 2 mL SERUM | R 1 week F 4 weeks | Immunoturbidim etry | Daily |
P055 | Triglycerides, Fluid | 2 mL FLUID | R 72 hrs F 2 weeks | GPO-POD | Daily |
B026 | Triglycerides, Serum | 2 mL SERUM 12 hour overnight fasting mandatory | R 1 week F 4 weeks | GPO-POD | Daily |
RW188 | Trimipramine | 2 mL SERUM or 2 mL Heparinized PLASMA No Additive tube | R 1 week F 3 months | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
B110 | Troponin - I, High Sensitive (hsTnI) | 2 mL SERUM | R 72 hrs F 4 weeks | CMIA | Daily |
B085 | Troponin -T, High Sensitive | 2 mL SERUM | R 24 hrs F 6 months | Electrochemilum inescence | Daily |
RW189 | Trypsin | 2 mL SERUM Patients who have undergone in- vivo isotope therapy should refrain from testing for atleast 6 weeks. | R 7 days F 28 days | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
RW190 | Tryptase | 2 mL SERUM No Additive tube Separate serum within 2 hrs | R 5 days F 30 days | Fluorescence Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
RW191 | Tryptophan, Quantitative, Plasma | 2 mL Heparinized PLASMA Separate within 2 hrs & freeze Overnight fasting mandatory | F 30 days | Liquid Chromatography , Mass Spectrometry | S: By 7th of Month R: 2 - 3 weeks |
R052 | TSH (Thyroid Stimulating Hormone) | 2 mL SERUM | R 48 hrs F 4 weeks | CLIA | Daily |
R092 | TSH (Thyroid Stimulating Hormone), Ultrasensitive | 2 mL SERUM | R 48 hrs F 4 weeks | CLIA | Daily |
RW192 | TSH Antibody | 2 mL SERUM | R 14 days F 28 days | RIA | S: By 7th of Month R: 2 - 3 weeks |
S229 | TSH Receptor Antibody | 2 mL SERUM | R 72 hrs F 4 weeks | ECLIA | S: Daily 4 pm R: Same day |
Z274 Y117 Basal Y118 30 min Y119 60 min Y120 Customized | TSH Stimulation by TRH (Thyrotropin Releasing Hormone) | 2 mL SERUM for each timed specimen; Draw fasting baseline sample; Administer TRH IV bolus 7 ug or Kg body wt over 30 sec; draw additional samples at 30 & 60 min | R 1 week F 4 weeks | CLIA | Daily |
R159 | TSH, Newborn Screen | 1 drop heel prick blood each on 3 spots of filter paper | R 1 week F 1 week | Fluoroimmunoassay | S: Tue / Thu / Sat 5 pm R: 2 days |
RW194 | TSI; Thyroid Stimulating Immunoglobulin | 2 mL SERUM | R 3 weeks F 6 weeks | Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
B146 | Tumor Necrosis Factor (TNF), Alpha | 2 mL SERUM | R 48 hrs F 4 weeks | CLIA | S: Mon 4 pm R: Same day |
H062 | Typhi dot / Salmonella typhi, IgM | 2 mL SERUM | R 1 week F 1 week | ICT | Daily |
OS196 | Typhoid DNA Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Daily 11 am R: 10 days |
RW195 | Typhus Fever (Rickettsia) Antibodies, IgG & IgM | 2 mL SERUM | R 14 days F 30 days | IFA | S: By 7th of Month R: 2 - 3 weeks |
S068 | U1RNP Antibodies | 2 mL SERUM | R 1 week F 2 weeks | EIA | S: Tue / Fri 9 am R: Same day |
OS197 | UGT1A1 Gene Polymorphism (Nucleotide 'TA' Repeats), Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Wed / Sat 11 am R: 10 days |
U026 | Urea Nitrogen, 24 Hour Urine | 10 mL aliquot of 24 hr Urine State Total Volume Refrigerate during & after collection | R 1 week F 4 weeks | Urease UV | Daily |
U102 | Urea Nitrogen, Random Urine | 10 mL aliquot of random Urine | R 1 week F 4 weeks | Urease UV | Daily |
G180 | Urea Cycle Disorder Panel | 10 mL aliquot of random Urine + 2 mL Heparinized PLASMA | R 48 hrs F 2 weeks | LC-MS/MS, GC / MS | S: Daily 5 pm R: 5 days |
U028 | Urea, 24 Hour Urine | 10 mL aliquot of 24 hr URINE State Total Volume Refrigerate during & after collection | R 1 week F 4 weeks | Urease UV | Daily |
U076 | Urea, Random Urine | 10 mL aliquot of random URINE | R 1 week F 4 weeks | Urease UV | Daily |
P087 | Urea, Fluid | 2 mL FLUID | R 1 week F 4 weeks | Urease UV | Daily |
B021 | Urea, Serum | 2 mL SERUM | R 1 week F 4 weeks | Urease UV | Daily |
U010 | Uric Acid, 24 Hour Urine | 10 mL aliquot of 24 hr URINE State Total Volume | R 1 week F 4 weeks | Uricase | Daily |
U078 | Uric Acid, Random Urine | 10 mL aliquot of random URINE | R 1 week F 4 weeks | Uricase | Daily |
B024 | Uric Acid, Serum | 2 mL SERUM | R 1 week F 4 weeks | Uricase | Daily |
U001 | Urine Examination, Routine; Urine R/E | 10 mL aliquot of 1st morning URINE | R 24 hrs F Unacceptable | Automated Strip Test, Chemical, Light Microscopy | Daily |
U065 | Urine for Eosinophils | 10 mL aliquot of 1st morning URINE | R 72 hrs F Unacceptable | Light Microscopy | Daily |
U082 | Urine, Glucose | 10 mL aliquot of 1st morning URINE | R 24 hrs F Unacceptable | Automated Strip Test / Benedicts Test | Daily |
U080 | Urine, Reducing Substances | 10 mL aliquot of 1st morning URINE | R 24 hrs F Unacceptable | Dipstick, Benedicts Test | Daily |
U066 | Urine Dysmorphic RBC | 10 mL aliquot of random URINE | R 24 hrs F Unacceptable | Phase Contrast Microscopy | S: Daily 2 pm R: Same day |
U061 | Urobilinogen, Qualitative, 24 Hour Urine | 10 mL aliquot of 24 hr Urine Protect from light Refrigerate during collection | R 72 hrs F 1 week | Dipstick | Daily |
D031 | Valproic Acid; Valproate | 2 mL SERUM drawn just before next dose No Additive tube | R 48 hrs F 2 weeks | CLIA | Daily |
D053 | Vancomycin | 2 mL SERUM | R 1 week F 4 weeks | CMIA | S:Daily 4 pm R: Same day |
M220 | Vancomycin Resistant Enterococci (VRE), Screening | Rectal / Wound SWAB / Pure ISOLATE | R 24 hrs F Unacceptable | Chromogenic | S:Daily 1 pm R: Next day |
Z199 | Varicella Zoster Virus (VZV) Antibodies Panel, IgG & IgM *Chicken Pox * Herpes Zoster *Shingles | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S: Mon / Thu 9 am R: Same day |
S077 | Varicella Zoster Virus (VZV) Antibody, IgG *Chicken Pox * Herpes Zoster *Shingles | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S: Mon / Thu 9 am R: Same day |
S074 | Varicella Zoster Virus (VZV) Antibody, IgM *Chicken Pox * Herpes Zoster *Shingles | 2 mL SERUM | R 48 hrs F 4 weeks | EIA | S: Mon / Thu 9 am R: Same day |
N128 | Varicella Zoster Virus (VZV), Qualitative PCR | 3 mL EDTA WB / 3 mL CSF | R 72 hrs F Unacceptable | Real Time PCR | S:Mon / Thu 11 am R: Wed / Sat |
Z613 | Vasculitis Panel *ANA *ANCA-MPO *ANCA-PR3 *Anti - ds-DNA | 3 mL SERUM | R 72 hrs F 2 weeks | EIA | S:Tue / Thu / Sat 9 am R: Same day |
RW196 | Vasoactive Intestinal Polypeptide; VIP | 3 mL EDTA PLASMA Separate plasma within 2 hrs & freeze | F 28 days | Extraction, Immunoassay | S: By 7th of Month R: 2 - 3 weeks |
S008 | VDRL (RPR), Serum | 2 mL SERUM | R 48 hrs F 1 week | Slide Flocculation | Daily |
S011 | VDRL (RPR), CSF | 2 mL CSF | R 48 hrs F 1 week | Slide Flocculation | Daily |
N018 | Venous Thrombosis Risk Analysis Profile *Factor V Leiden Mutation *Prothrombin Gene Mutation * MTHFR Gene Mutation | 5 mL EDTA WB | R 72 hrs F Unacceptable | Real Time PCR | S: Mon / Thu 11 am R: Wed / Sat |
RW272 | Very Long Chain Fatty Acids | 2 mL SERUM No Additive tube. 12-14 hours fasting is mandatory. Avoid alcohol 24 hours prior to sample collection. | R 7 days F 30 days | LC-MS | S: By 7th of Month R: 2 - 3 weeks |
S250 | VGKC (Voltage Gated Potassium Channel), Antibody | 2 mL SERUM | R 1 week F 2 weeks | IFA | S: Mon 11 am R: 5 days |
RW197 | Viscosity, Serum | 3 mL SERUM | R 2 weeks F 6 weeks | Kinetic Viscometer | S: By 7th of Month R: 2 - 3 weeks |
RW200 | Vitamin B12 Binding Capacity, Unsaturated ; Transcobalamin | 2 mL SERUM Separate serum within 1 hr | R 4 days F 30 days | Radiobinding Assay | S: By 7th of Month R: 2 - 3 weeks |
R174 | Vitamin B12, Active; Holotranscobalamin | 2 mL SERUM | R 72 hrs F 6 months | CMIA | S: Daily 4 pm R: Same day |
R047 | Vitamin B12 (Cyanocobalamin) | 3 mL SERUM Protect from light Overnight fasting mandatory | R 48 hrs F 8 weeks | CLIA | Daily |
RW201 | Vitamin B2 ; Riboflavin | 2 mL EDTA PLASMA Separate plasma within 1 hr & freeze Protect from light | F 30 days | HPLC, Fluorometricdetection | S: By 7th of Month R: 2 - 3 weeks |
RW202 | Vitamin B6 ; Pyridoxine | 2 mL EDTA PLASMA Separate plasma & freeze immediately Protect from light Avoidvitamin supplements & alcohol 24 hours prior to sample collection. Overnight fasting mandatory | F 42 days | LC-MS/MS | S: By 7th of Month R: 2 - 3 weeks |
RW203 | Vitamin C; Ascorbic Acid | 2 mL SERUM Separate serum within 3 hrs Protect from light Avoidvitamin supplements & fruits 24 hours prior to sample collection. | F 28 days | Capillary electrophoresis | S: By 7th of Month R: 2 - 3 weeks |
R118 | Vitamin D, 1, 25 - DihydroxyThis assay measures both D2 and D3 components | 3 mL SERUM | R 72 hrs F 3 weeks | CLIA | S:Tue / Thu / Sat 9 am R: Same day |
R119 | Vitamin D, 25 - Hydroxy This assay measures both D2 and D3 components | 3 mL SERUM | R 72 hrs F 3 weeks | Chemiluminesce nce | Daily |
Z617 | Vitamin D Comprehensive *Calcium *Phosphorus *Alkaline Phosphatase *Vitamin D 25 Hydroxy | 3 mL SERUM | R 72 hrs F 2 weeks | CLIA, Spectrophotometry | Daily |
Z616 | Vitamin D Screen *Calcium *Vitamin D 25 Hydroxy | 3 mL SERUM | R 72 hrs F 2 weeks | CLIA, Spectrophotometry | Daily |
G183 | Vitamin D, Ultrasensitive *25-Hydroxy Vitamin D2, D3 & 3 epi 25 Hydroxy Vitamin D3 | 3 mL SERUM | R 72 hrs F 3 weeks | LC-MS/MS | S:Daily 5 pm R: Next day |
R117 | Vitamin E; Tocopherol | 3 mL SERUM No Additive tube Separate serum within 1 hr Protect from light Overnight Fasting mandatory | R 12 hrs F 3 weeks | HPLC | S: Fri 9 am R: Tue |
RW204 | Vitamin K | 4 mL Heparinized PLASMA Separate plasma within 1 hr & freeze Protect from light | F 90 days | HPLC | S: By 7th of Month R: 2 - 3 weeks |
R096 | Vitamin A (Retinol) | 3 mL SERUM No Additive tube Separate serum within 1 hr Protect from light Overnight Fasting mandatory | R 12 hrs F 3 weeks | HPLC | S: Fri 9 am R: Tue |
RW199 | Vitamin B1 (Thiamine) | 3 mL EDTA WB or PLASMA or SERUM No additive tube Separate plasma or serum & freeze within 4 hrs Protect from light | F 30 days | HPLC | S: By 7th of Month R: 2 - 3 weeks |
Z876 | Vitamin Screen *Vitamin B12 Active Holotranscobalamin *Vitamin D 25 Hydroxy | 3 mL SERUM | R 72 hrs F 3 weeks | Chemiluminesce nce, CMIA | S: Daily 4 pm R: Same day |
U006 | VMA (Vanil Mandelic Acid ), 24 Hour Urine | 50 mL aliquot of 24 hr URINE Preservative 50% HCl State Total Volume AvoidTheophylline, chocolate, vanilla, banana, alcoholic beverages, teaorcoffee, tobacco and strenuous exercise at least 72 hrs before and during specimen collection. | R 7 days F 30 days | HPLC | S: Wed / Sat 9 am R: 2 days |
U030 | VMA (Vanil Mandelic Acid ), Random Urine | 50 mL aliquot of random URINE Preservative 50% HCl AvoidTheophylline, chocolate, vanilla, banana, alcoholic beverages, teaorcoffee, tobacco and strenuous exercise at least 72 hrs before and during specimen collection. | R 7 days F 30 days | HPLC | S: Wed / Sat 9 am R: 2 days |
H130 | von Willebrand Factor Antigen; vWF Ag | 3 mL Citrated PPP Separate plasma & freeze immediately | F 2 weeks | EIA | S: 1st & 3rd Mon R: Next day |
OS199 | Warfarin Sensitivity Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR Sequencing | S: Daily 11 am R: 13 days |
S002 | Weil Felix Test *Proteus Antigen OX19, OX2 & OXK | 2 mL SERUM | R 48 hrs F 1 week | Latex Agglutination | S: Daily 3.30 pm R: Next day |
S026 | Widal Slide Agglutination Test | 2 mL SERUM | R 48 hrs F 72 hrs | Slide Agglutination | Daily |
S199 | Widal Tube Agglutination Test | 2 mL SERUM | R 48 hrs F 72 hrs | Tube Agglutination | S: Daily 3.30 pm R: Next day |
OS200 | Wilson disease ATP7B Gene, Mutation Detection | 4 mL EDTA WB | R 1 week F Unacceptable | PCR | S: Daily 11 am R: 2 months |
Z834 | Wilson disease Panel *CBC *LFT *Ceruloplasmin *Copper. Serum *Copper. Random Urine | 3 mL EDTA WB + 2 mL SERUM + 2 mL ( Z-No Additive) SERUM + 10 mL aliquot of random URINE in Metal Free container | R 48 hrs F Unacceptable | Spectrophotom etry, Nephelometry, Electrical Impedence, VCS, ICPMS | S: Mon through Sat 6 pm R: Next day |
OS201 | WT-1 Mutation Detection | 4 mL EDTA WB or BONE MARROW | R 1 week F Unacceptable | PCR Sequencing | S: Daily 11 am R: 18 days |
OS202 | Y-Chromosome Microdeletion Detection, PCR | 4 mL EDTA WB | R 1 week F Unacceptable | Multiplex PCR | S: Wed / Sat 11 am R: 10 days |
M136 | Yeast (Candida species) Susceptibility Testing | Positive culture GROWTH | R 48 hrs F Unacceptable | Rapid Automated Susceptibility testing | S: Daily 3.30 pm R: 3 days |
M135 | Yeast (Candida species) Identification | Positive culture GROWTH | R 48 hrs F Unacceptable | Rapid Automated Identification | S: Daily 3.30 pm R: 3 days |
M216 | Yersinia enterocolitica Antigen | 5 g Fresh STOOL | R 24 hrs F Unacceptable | ICT | S: Daily 1 pm R: Same day |
C033 | Zinc, 24 Hour Urine | 10 mL aliquot of 24 hr URINE Metal free container State total volume Use powderless gloves during specimen collection. Avoidsea or fresh water fish 3 days prior to specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
C035 | Zinc, Random Urine | 10 mL aliquot of random URINE Metal free container Use powderless gloves during specimen collection. Avoidsea or fresh water fish 3 days prior to specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
C036 | Zinc, Serum / Plasma | 3 mL (Z- No Additive) SERUM or (K2EDTA) PLASMA Metal free container Use powderless gloves during specimen collection. Avoidsea or fresh water fish 3 days prior to specimen collection. If gadolinium or iodine containing contrast media has been administered, the specimen should not be collected for 96 hours. | R 48 hrs F 1 week | ICPMS | S: Daily 6 pm R: Next day |
M191 | Z-N; Ziehl Neelsen Stain | Sputum or Urine Pus or Body FLUIDS or SWABS or Heparinized BONE MARROW or Gastric lavage | R 24 hrs F Unacceptable | Conventional Microscopic examination | S: Daily 3.30 pm R: Same day |